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Indoor dampness and mold in work environments are associated 
with adverse respiratory health effects, of which asthma is the 
most frequently diagnosed disease. 
This study assessed methods for the diagnosis of occupational 
asthma induced by indoor dampness and mold. A retrospective 
analysis of a group of patients examined at the Finnish Institute 
of Occupational Health in 1995–2004 was conducted. All of the 
examined 2200 workers had respiratory symptoms appearing in 
workplaces with suspected moisture and mold damage. A fol-
low-up survey with a questionnaire was carried out 3–12 years 
later to determine whether prolonged asthma-like symptoms 
appearing in relation to workplace dampness and mold lead to the 
development of asthma later. In addition, the long-term effects on 
the quality of life and work ability of these workers were evaluated. 
Finally, for the use of occupational health services, the book pre-
sents a suggestion for an individual-level, practical approach to 
disability prevention for workers with asthma related to workplace 
dampness.
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3AbSTRACT 
Indoor dampness and mold in work environments are associated with 
adverse respiratory health effects, of which asthma is the most frequently 
diagnosed disease. According to the Finnish Register of Occupational 
Diseases, indoor-air molds have been the most frequently reported 
cause of occupational asthma (OA) since 2001. The diagnostics are not 
straightforward, mainly due to difficulties in identifying the specific 
causative agent and demonstrating the relationship between asthma and 
this unknown factor. Respiratory ill-health and multiple non-specific 
symptoms related to building dampness are usually transient, but per-
sistent symptoms appear to be common for some persons, even despite 
building repairs or a change to an alternative work environment.
One aim of this thesis was to assess and develop methods for the 
diagnosis of OA induced by indoor dampness and mold. Another aim 
was to determine whether prolonged asthma-like symptoms appearing 
in relation to workplace dampness and mold lead to the development 
of asthma later. The objective was also to evaluate long-term outcomes 
with respect to the quality of life (QOL) and work ability among workers 
with asthma or respiratory symptoms previously related to damp indoor 
work environments.
The study population was 2200 patients examined at the Finnish In-
stitute of Occupational Health (FIOH) from 1995 through 2004 because 
of a suspected occupational respiratory disease. All of the patients had 
experienced work-related respiratory symptoms that manifested in damp 
and moldy indoor environments. At the time of the exposure, most of 
the patients had worked in office-like surroundings, schools, hospitals, 
or children day-care centers. In 2007 (3–12 years after the baseline ex-
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aminations), the patients were followed up with a questionnaire survey. 
Altogether 1295 (61%) of the 2114 persons participated.
At the time of the study, specific inhalation challenge (SIC) tests 
with commercial mold extracts were a routine procedure with which to 
confirm OA, and the patients for the analyses were selected from the 
694 patients who underwent this test. The clinical investigations had 
included the assessment of specific sensitization to molds and serial peak 
expiratory flow (PEF) measurements at and away from work.
A retrospective review of the medical files was conducted of the 
patients who had been suspected of having occupational asthma. An 
evaluation of each patient’s exposure at work was assessed by classifying 
the intensity of microbial exposure on the basis of the available infor-
mation in the medical files. The information included technical reports 
on building-structure damage and microbial measurements. For these 
analyses, the patients were divided into three categories according to the 
probability of OA consistent with the international diagnostic criteria 
for OA.
An OA diagnosis was considered as probable for 156 patients. The 
diagnosis was based on verified mold exposure, work-related asthma 
symptoms with onset after entrance into the workplace, lung function 
changes compatible with asthma, and objectively demonstrated work-
relatedness of asthma by work-related changes in serial PEF monitoring 
or positive SIC tests with mold extracts or both. Specific immunoglobulin 
(Ig) E sensitization to molds was found for 20% of the patients classified 
as probable OA. The agreement between the serial PEF measurements 
and the SIC tests (both being either positive or negative) was 56%. For 
the patients with a positive SIC test, the agreement with the serial PEF 
monitoring was 78%.
The study contributed some new information pertaining to the diag-
nostics of OA induced by workplace dampness and molds. An individual 
exposure assessment can be based on descriptions of the extent and loca-
tion of the moisture and mold damage in the building structures and on 
microbial measurements.  Serial PEF monitoring can be regarded as an 
applicable method in the clinical evaluation of OA induced by indoor 
dampness and molds. This in particular considering the flaws of the SIC, 
for example due to the complex exposure situation. Unlike SIC testing, 
the serial PEF records reflect the entire exposure at the workplace. The 
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major weakness is that they do not accurately differentiate between 
work-exacerbated asthma (WEA) and OA. Specific IgE-mediated sen-
sitization to molds occurs, but in a small proportion of cases only. The 
mechanisms of dampness-induced asthma remain largely unknown. The 
results support the epidemiological evidence that indoor dampness and 
mold induce new-onset adult asthma.
Of the 483 patients who participated in the questionnaire study and 
who had had asthma-like symptoms (cough, dyspnea, wheezing) but lung 
function within a normal range at baseline, 62 (13%) reported having 
developed physician-diagnosed asthma during the follow-up period. 
Continued exposure to a damp work environment was associated with 
a more than fourfold increase in the risk of asthma. Working in a non-
remediated environment at follow-up was the strongest risk factor for 
developing asthma. The remediation of damp buildings seemed to be 
associated with a decrease in the risk of asthma.
Preventive measures to avoid further exposure seem to be relevant in 
order to prevent the development of asthma. In practice, such measures 
would involve the remediation of moisture and mold damage or the 
relocation of workers with asthma-like symptoms to a non-moisture 
damaged environment. In the interpretation of the results, the limita-
tions of the data collection by questionnaire must be taken into account. 
Follow-up at occupational health services is recommended for patients 
with respiratory symptoms related to workplace dampness.
A high proportion of patients with OA caused by indoor dampness 
and mold had an impaired QOL 3–12 years after their initial diagnosis 
when the patients were compared with those with WEA and those with 
no asthma but with symptoms related to the exposure. Not working 
was a strong determinant of deteriorated QOL. As estimated by the use 
of asthma medication, the asthma symptoms of the OA patients were 
both more persistent and more severe than those of the WEA patients. 
Greater use of asthma medication was a determinant of a worse QOL 
physical component.
The diagnosis of OA was associated with a strong, nearly sixfold risk 
of withdrawal from work due to early retirement or unemployment, in 
a comparison with a reference group with upper-respiratory symptoms 
only. A perceived poor social climate at work and poor experiences with 
the supervisor’s cooperation at an early stage of symptoms were determi-
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nants for impaired self-assessed work ability and early withdrawal from 
work. In addition, multiple, persistent, indoor-air symptoms at follow-
up increased the risk of poor self-assessed work ability. The results are in 
accordance with the widely recognized fact that the causes of disability 
are multifactorial and are not associated with medical conditions only.
The results of this study corroborate the clinical impression that a pro-
portion of patients with asthma in relation to exposure to moisture- and 
mold-damaged workplaces has long-standing limitations in everyday life 
and remains symptomatic and unable to work. Patients diagnosed with 
OA had worse outcomes than did patients with WEA or only respiratory 
symptoms without asthma at baseline. The reasons for this phenomenon 
remain to be elucidated. Acknowledgement of, and compensation for, 
dampness-induced asthma as an occupational disease does not seem to 
be beneficial in preventing disability. More apt measures, for example, 
early support and workplace management practices concerning work 
ability, are required.
7YhTEENvETO
Työpaikan kosteus- ja homevaurioiden on osoitettu olevan yhteydessä 
haitallisiin hengitystievaikutuksiin, joista yleisin diagnosoitavissa oleva 
sairaus on astma. Työterveyslaitoksen Työperäisten sairauksien rekis-
terin mukaan vuodesta 2001 alkaen kosteusvauriohomeet ovat olleet 
yleisin ammattiastman aiheuttaja Suomessa. Kosteusvaurioympäristöstä 
johtuva ammattiastma on vaikea todeta, koska täsmällistä ammattiast-
man aiheuttajaa ei tiedetä. Tavallisesti kosteusvaurioympäristöön liit-
tyvät hengitystie- ja yleisoireet menevät ohi, kun rakennuksen vauriot 
korjataan. Osalla potilaista oireet kuitenkin pitkittyvät rakennuksen 
korjaustoimenpiteistä tai työpisteen vaihdosta huolimatta.
Väitöskirjan tavoitteena oli arvioida ja kehittää kosteusvaurioympäris-
töstä aiheutuvan ammattiastman diagnostiikkaa. Toisena tavoitteena oli 
arvioida kosteusvaurioympäristössä ilmenevien astmankaltaisten oireiden 
merkitystä astman riskitekijänä. Tavoitteena oli myös selvittää työpaikan 
kosteusvaurioihin liittyvän hengitystiesairauden pitkäaikaisvaikutuksia 
elämänlaatuun ja työkykyyn.
Tutkimusaineistona oli 2 200 Työterveyslaitoksella ammattitauti-
epäilyn takia vuosina 1995–2004 tutkittua potilasta, joilla oli ollut 
työpaikan kosteusvaurioon liittyviä hengitystieoireita. Suurin osa poti-
laista oli työskennellyt toimistossa, koulussa, sairaalassa tai päiväkodissa. 
Seuranta toteutettiin kyselytutkimuksella vuoden 2007 alussa 3–12 
vuotta Työterveyslaitoksen tutkimusten jälkeen. Kyselyyn vastasi 1 295 
henkilöä (61 %).
Tutkimusjakson aikana ammattiastman osoittamiseen käytettiin hen-
gitysteiden spesifistä altistuskoetta homeuutteilla. Yhteensä 694 potilaalla 
oli epäilty olevan kosteusvauriohomeiden aiheuttama ammattiastma, 
minkä vuoksi heille oli tehty altistuskoe. Tutkimuksiin oli kuulunut 
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myös PEF-työpaikkaseuranta sekä homeherkistymisen toteamiseksi 
ihopistokokeita ja seerumin IgE-määrityksiä.
Väitöskirjatutkimusta varten potilaiden sairauskertomustietoja tarkas-
teltiin jälkikäteen. Potilaiden altistuminen kosteusvauriomikrobeille luo-
kiteltiin voimakkuudeltaan kolmiportaisesti sen mukaan, kuinka laajoja 
työpaikan kosteusvauriot olivat, ja mitä mikrobianalyyseissä löydettiin. 
Tiedot kerättiin potilasasiakirjoihin liitetyistä työpaikan rakennustek-
nisistä ja sisäilmatutkimusraporteista. Ammattiastman todennäköisyys 
arvioitiin kansainvälisten ammattiastman kriteerien mukaisesti. 
Ammattiastman arvioitiin olevan todennäköinen 156 potilaalla. 
Diagnoosi perustui siihen, että työpaikalla oli todettu kosteus- ja 
homevaurioita, astmaoireet liittyivät työhön ja ne olivat alkaneet kos-
teusvaurioympäristössä, keuhkojen toimintakokeissa oli astmalle tyy-
pillisiä muutoksia ja yhteys työpaikan altisteisiin oli osoitettavissa joko 
PEF-työpaikkaseurannalla tai altistuskokeilla. Ammattiastmapotilaista 
20 %:lla todettiin IgE-välitteinen herkistyminen homeille. PEF-työ-
paikkaseuranta ja spesifiset hengitysteiden altistuskokeet olivat yhden-
mukaisia (molemmat tutkimukset olivat joko myönteisiä tai kielteisiä) 
56 %:ssa tapauksia. Kun altistuskoe oli positiivinen, yhdenmukaisuus 
PEF-työpaikkaseurannan kanssa oli 78 %.
Tutkimus antaa uutta tietoa kosteusvaurioympäristön aiheuttaman 
ammattiastman diagnostiikkaan. Altistumisen arvioinnin perusteena 
voidaan käyttää kuvauksia työpaikan kosteus- ja homevaurioiden laa-
juudesta ja sijainnista sekä mikrobimäärityksiä. Yhteys altistumisen ja 
astman välillä voidaan osoittaa PEF-työpaikkaseurannalla, joka kuvastaa 
työpaikan altistumistilannetta kokonaisuudessaan toisin kuin altistuskoe. 
Heikkoutena on, että PEF-työpaikkaseurannalla ei voida luotettavasti 
erotella ammattiastmaa ja työssä pahenevaa astmaa. IgE-välitteistä home-
herkistymistä esiintyy vain osalla ammattiastmapotilaista. Kosteusvaurio-
ympäristön aiheuttaman astman syntymekanismit ovat edelleen pääosin 
tuntemattomia. Tutkimus vahvistaa epidemiologista tutkimustietoa 
kosteusvaurioympäristön ja astman yhteydestä.
Kyselytutkimukseen osallistui 483 potilasta, joilla oli ollut kosteus-
vauriotyöpaikkaan liittyviä astmankaltaisia oireita (yskää, hengenah-
distusta tai vinkunaa), mutta astman diagnostiset kriteerit eivät olleet 
täyttyneet Työterveyslaitoksen ammattitautitutkimuksissa. Vastaajista 
62 (13 %) ilmoitti, että seuranta-aikana lääkäri oli todennut heillä ast-
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man. Jos nykyisessäkin työpaikassa oli kosteusvaurio, astmariski oli yli 
nelinkertainen verrattuna vastaajiin, jotka ilmoittivat, ettei työpaikalla 
ole kosteusvaurioita. Entisissä, korjaamattomissa kosteusvauriotiloissa 
työskentelyyn liittyi merkittävä astman kehittymisen riski. Kosteusvau-
rioiden korjaaminen näytti vähentävän astmariskiä.
Tutkimustulokset viittaavat siihen, että kosteusvaurioiden korjaami-
sella tai oireilevan työntekijän siirtämisellä pois kosteusvaurioituneista 
tiloista voidaan vaikuttaa astmariskiin. Tulosten tulkinnassa on huo-
mioitava kyselytutkimuksen rajoitukset. Työterveyshuollon seuranta 
on tarpeen työntekijöille, joilla on kosteusvaurioympäristöön liittyviä 
hengitystieoireita.
Elämänlaatu oli 3–12 vuoden seurannan jälkeen huonompi ammatti-
astmadiagnoosin saaneilla verrattuna potilaisiin, joilla oli työssä paheneva 
astma tai hengitystieoireita ilman astmaa. Työelämän ulkopuolelle jäämi-
nen oli myös yhteydessä heikentyneeseen elämänlaatuun. Potilaat, joilla 
oli diagnosoitu ammattiastma, käyttivät enemmän astmalääkkeitä kuin 
muut astmaa sairastavat. Runsas astmalääkkeiden käyttö oli yhteydessä 
heikentyneeseen elämänlaatuun.
Ammattiastmadiagnoosiin liittyi lähes kuusinkertainen riski ennenai-
kaiseen poistumiseen työelämästä (työkyvyttömyyseläkkeen, tapaturma-
eläkkeen tai työttömyyden takia), kun ammattiastmadiagnoosin saaneita 
verrattiin potilaisiin, joilla oli hengitystieoireita ilman astmaa. Huonoksi 
koettu esimiehen toiminta ja huonoksi koettu työilmapiiri aikaisemmassa 
kosteusvauriotyöpaikassa olivat yhteydessä alentuneisiin työkyvyn indi-
kaattoreihin. Myös mitä enemmän pitkittyneitä sisäilmaoireita seuran-
nassa ilmoitettiin, sitä huonommaksi työkyky koettiin. Tulokset sopivat 
aikaisempaan tietoon, että työkyvyn alenemisen syyt koostuvat monesta 
tekijästä eivätkä johdu pelkästään terveydellisistä syistä.
Tutkimus toi esille kosteusvaurioympäristöön liittyvän astman yhtey-
den heikentyneeseen elämänlaatuun, huonoksi koettuun työkykyyn ja 
ennenaikaiseen poistumiseen työelämästä. Ammattitautilainsäädännön 
suomista etuuksista huolimatta ammattiastmaa sairastavien elämänlaatu 
ja työkyky olivat huonompia kuin muuta astmaa sairastavilla tai hen-
gitystieoireisilla potilailla, joilla ei ollut astmaa. Syyt jäävät pohdinnan 
ja jatkoselvitysten varaan. Työkyvyn tukemiseksi tarvitaan varhaisia ja 
aikaisempaa tehokkaampia toimia työpaikalla ja työterveyshuollossa.
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AbbREvIATIONS
ABPA allergic bronchopulmonary aspergillosis
BRS building-related symptoms
cfu colony-forming unit(s)
CI confidence interval
COPD chronic obstructive pulmonary disease
ERS European Respiratory Society
FEV1 forced expiratory volume in 1 second
FIOH Finnish Institute of Occupational Health
FROD Finnish Register of Occupational Diseases
ICF International Classification of Disability, Functioning and Health
Ig immunoglobulin (E and G)
IOM Institute of Medicine
MCS multiple chemical sensitivity
MMVF man-made vitreous fiber
mVOC microbial volatile organic compound
OA occupational asthma
ODTS organic dust toxic syndrome
OR odds ratio
PAR population attributable risk
PEF peak expiratory flow
QOL quality of life
RADS reactive airways dysfunction syndrome
RR relative risk
SBS sick building syndrome
SCHER Scientific Committee on Health and Environmetal Risks
SD standard deviation
SF-12 Short Form Health Survey 12-Item Questionnaire
SIC specific inhalation challenge
SPT skin prick test
VAS visual analogue scale
VCD vocal cord dysfunction
VOC volatile organic compound
WEA work-exacerbated asthma
WHO World Health Organization
WRA work-related asthma
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1  INTRODuCTION
Problems associated with indoor environments are one of the most com-
mon environmental health issues that most clinicians face (Redlich et 
al. 1997). Typically, the patient reports symptoms that worsen while in 
the building of concern and improve when away from it. Occasionally, 
it is easy to find the cause of the complaints, for example, when there is 
obvious moisture and mold damage, but quite often the situation is far 
more complex (Reijula and Sundman-Digert 2004). Moisture problems 
often occur simultaneously with several other factors that may impair 
indoor-air quality, such as inadequate ventilation, material emissions, or 
dustiness. Specific etiological agents cannot always be identified. 
Asthma is the most common diagnosable disease that is connected 
with damp indoor environments. The patients often seem to have a wider 
variety of symptoms than merely those that belong to the clinical picture 
of asthma. Epidemiological data indicate with increasing plausibility that 
indoor dampness and mold play a role as risk factors for the exacerbation 
of asthma and new-onset asthma, as well as for respiratory infections and 
symptoms (reviewed by Mendell et al. 2011). Measured microbiologic 
agents have shown less consistent associations with health effects than 
qualitative assessments like visible dampness or mold odor. However, in 
clinical practice, evaluating relationships between indoor dampness, or 
dampness-related factors, and suspected building-related health effects 
is difficult for multiple of reasons. A major limitation is the inability to 
equate environmental measurements directly to personal exposure. There 
are no health-based guideline values for indoor dampness, microbes, or 
other indoor-air contaminants in nonindustrial environments. These 
factors typically occur at low levels in normal indoor and outdoor envi-
ronments. In addition, clinical evaluations are hampered by the facts that 
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the conceivable exposures are complex, the exact causative factors and 
mechanisms behind the health effects are seldom known, the symptoms 
are non-specific in nature and overlap with other conditions, and also 
the available medical tests are not specific enough (Andersson 2008; 
Bernstein et al. 2008; WHO 2009).
Even though there are gaps in the basic scientific knowledge related 
to dampness problems, a great deal of existing research has enabled some 
recommendations to be made for managing such problems. According 
to a World Health Organization (WHO) expert group, the prevention 
and remediation of indoor dampness and mold are likely to reduce health 
risks (WHO 2009). Good practices for the indoor-air quality evaluation 
have been developed for buildings (Salonen 2009). Case studies suggest 
that problems can be handled efficiently if a multiprofessional team is 
involved in the renovating process at a workplace, and both the physi-
cal and psychosocial environment is focused on (Lahtinen et al. 2009). 
However, there are only a few intervention studies available on the effects 
of repairing buildings damaged by dampness and mold on respiratory 
health, and more research is needed to find the most effective ways to 
minimize respiratory hazards (Sauni et al. 2011).
Another challenge that clinicians face is the persistent disability ex-
perienced by some patients. They seem to develop sensitivities to many 
environmental factors with symptoms that persist despite improvements 
in the initial environment (Redlich et al. 1997). As the patients react to 
factors that are ubiquitous in the environment, avoiding these factors 
completely is usually impractical and very limiting for the patient (GINA 
2011). It seems that the intensity of subjective symptoms often correlates 
only poorly with the degree of impairment, as defined by organ dysfunc-
tion (Hodgson 2002). Due to a lack of a specific diagnosis, the patients 
may get the impression that physicians do not listen to their concerns. 
A better understanding of the origin of such symptoms is needed if the 
ability to manage the condition effectively and prevent disability is to 
be improved.
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2.1 Indoor work environments and health
2.1.1  Overview
Many people associate adverse health effects with non-industrial, indoor 
work environments where there are no traditional health hazards. It has 
been suspected that building design, operation, and maintenance can 
significantly affect workers’ health. WHO reported its concern about 
indoor-air quality as early as the 1970s, and this concern has led to the 
organization of numerous task forces for the management of the prob-
lem (WHO 1983). Now, over 30 years later, a great deal of effort has 
been made to improve non-industrial indoor environments in order to 
create healthier conditions, even though the reporting of symptoms has 
not ceased.
First, the problem manifested itself in the form of case reports for 
office buildings in which up to 30% of the employees reported building-
related symptoms, a higher prevalence than in the general population 
(WHO 1983). The term “sick building” was used to describe such build-
ings. Primarily the reports were from the Scandinavian countries and 
the United States (WHO 1983). Later, similar symptoms were reported 
in work environments such as hospitals, schools, and children day-care 
centers. The buildings were investigated in an attempt to find causative 
factors, and sometimes the problems could be attributed, for example, 
to inadequate ventilation, emissions from furnishings or construction 
materials, or moisture damage with mold growth in the structures of the 
building (Redlich et al. 1997; Thörn 1999; Burge 2004).
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As building occupants typically report that the symptoms occur while 
in the building and diminish when away from the building, the symp-
toms can be referred to as building-related symptoms (BRS) (Mendell 
2003). The concept “sick building syndrome” (SBS) was first used and 
is still more often used to describe this non-specific symptom complex 
with often an unclear cause (WHO 1983; Thörn 1999; Norbäck 2009). 
The term is confusing and is not approved by all researchers, as it is the 
workers rather than the building that are sick and suffer from the symp-
toms (Burge 2004). Furthermore, indoor environment complaints are 
not only common in “sick buildings”, but also can be found in “healthy 
buildings” with no obvious indoor environment problems (Bakke et al. 
2007; Brightman et al. 2008; Brauer and Mikkelsen 2010).
The variety of symptoms includes upper- and lower-respiratory symp-
toms, a combination of general symptoms, as well as symptoms involving 
the mucosal membranes and skin as follows (WHO 1983; Thörn 1999): 
•	 Irritation of the eyes, nose and throat; cough
•	 Experience of dry skin, rash, pruritus
•	 Fatigue, headache, lack of concentration
•	 High frequency of respiratory tract infections
•	 Hoarseness, wheezing, shortness of breath
•	 Nausea, dizziness
•	 Enhanced or abnormal odor perception
The list is of limited value to clinicians, as the symptoms are non-specific 
and may refer to many clinical conditions. In addition, there is a lack of 
objective biomarkers that would help relate symptoms with indoor envi-
ronmental exposures (Bernstein et al. 2008). Both the types and severity 
of symptoms can vary greatly among people within the same building. 
The symptoms, although not life-threatening, can be very unpleasant 
and disruptive, causing absence from work, reduced productivity, and 
disability (Redlich et al. 1997; Niemelä et al. 2006). Distress about more 
serious health risk is also common (Redlich et al. 1997).
In a Finnish survey from the 1990s, the Indoor Air Questionnaire 
of the Finnish Institute of Occupational Health (FIOH) was used to 
determine the symptoms related to the indoor environment of 11 154 
employees from 122 workplaces (Reijula and Sundman-Digert 2004). 
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In all of the workplaces, indoor-air problems had been suspected before 
the survey was conducted. The most common symptoms that had oc-
curred every week during the past 3 months were irritated, stuffy or 
runny nose (20%), eye symptoms (17%), fatigue (16%), skin symptoms 
(15%), or hoarse, dry throat (14%) (Reijula and Sundman-Digert 2004). 
The symptom spectrums were similar in Finnish surveys conducted in 
the 2000s in office environments (Salonen et al. 2009a) and hospitals 
(Hellgren et al. 2011).
Norbäck (2009) has divided human reactions to indoor-air pollution 
into the following three main categories: 1) the most common effects 
are complaint reactions due to poor subjective indoor-air quality (e.g., 
thermal discomfort, complaints of stuffy air, dry air or malodors); 2) 
diseases or specific building-related illnesses that may be caused by fac-
tors in the indoor environment (e.g., building-related asthma, allergic 
alveolitis and legionellosis); and 3) medical symptoms with an unclear 
cause, but with a possible relation to the indoor environment. In this 
grouping, the latter constitutes SBS. Norbäck regards SBS as a group 
phenomenon rather than as a syndrome, as it is normally defined in 
medicine and considers individual diagnostics as a difficult issue. The 
difference between a building-related illness and SBS is not always clear, 
and the two may overlap (Crook and Burton 2010).
2.1.2 Risk factors for building-related symptoms
Building-related symptoms, or SBS, are regarded as being multi-fac-
torial in origin (Redlich et al. 1997). One factor or a combination of 
several factors may be responsible for the symptoms and complaints of 
the occupants, and different types of symptoms and health outcomes 
may appear in individuals depending on personal susceptibility (Jaak-
kola and Jaakkola 2010). The simplified model presented in Figure 1 
illustrates several types of relations that exist between environmental 
determinants and health outcomes (Jaakkola and Jaakkola 2010). 
The outer circle illustrates a non-industrial work environment, which 
is divided into physical and social environments. The worker, in the 
inner circle, is viewed as having two different domains, one belong-
ing to physical phenomena and the other belonging to psychological 
phenomena. The model describes how environmental determinants 
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can affect human health and well-being and can cause both physical 
and mental outcomes, and how a disease or health state can have both 
physiological and psychological underlying mechanisms and manifesta-
tions (Jaakkola and Jaakkola 2010).
 
 
 
 
 
 
Figure 1. The oﬃce environment model (Jaakkola and Jaakkola 2010). 
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Figure 1. The office environment model (Jaakkola and Jaakkola 2010).
Risk factors in the physical environment
Indoor air may contain chemicals, particles, and biological materials with 
potential health effects (SCHER 2007). Table 1 lists the main indoor 
pollutants and exposures in physical non-industrial work environments, 
as well as their typical sources and associated health effects. Inadequate 
ventilation is one of the most important factors contributing to indoor-
air quality (SCHER 2007). Many other factors also influence air quality 
(e.g., cleaning conditions, properties of buildings, moisture damage, 
products used in indoor areas, and outdoor air). The compositions and 
concentrations of the different components vary widely, and the different 
types of pollutants may give rise to combined effects (SCHER 2007). The 
indoor concentrations of the pollutants in non-occupational environ-
ments are generally orders of magnitude below occupational threshold 
limits (Wolkoff et al. 2006). In addition, the absence of dose–response 
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data is common to these indoor-air pollutants (Wolkoff et al. 2006). 
Very little information is available regarding permissible exposure levels 
that would be health-based (Bernstein et al. 2008).
Ventilation is necessary to remove indoor generated pollutants from 
indoor air or dilute their concentration to acceptable levels (Seppänen 
and Fisk 2004). Low ventilation rates generally increase risks of building-
related symptoms in offices, whereas higher ventilation rates reduce 
symptoms (Sundell et al. 2011). Some studies suggest that indicators of 
inflammation, rates of respiratory infections, the frequency of asthma and 
allergy symptoms, and rates of short-term sick leave increase with lower 
ventilation rates (Sundell et al. 2011). Low ventilation rates, as well as 
carbon dioxide concentrations in indoor air, have also been found to be 
associated with low task performance and productivity (Seppänen and 
Fisk 2004). On the average, the prevalence of building-related symptoms 
is higher in air-conditioned buildings than in naturally ventilated build-
ings (Seppänen and Fisk 2004). In relation to requirements in guide-
lines and standards, poor ventilation conditions have been shown to be 
common in many buildings, especially in schools, according to Swedish 
studies (Sundell et al. 2011). Ventilation standards are based primarily on 
data that pertain to occupants’ perceptions of indoor-air quality rather 
than to risk-related aspects of indoor-air pollutant exposure (Sundell et 
al. 2011). Low-level ventilation may lead to moisture accumulation in 
building structures and materials, which may, in turn, lead to increased 
dust mite populations and microbial growth (Seppänen and Fisk 2004). 
In the case of moisture damage due to other reasons, inadequate ventila-
tion may increase the level of moisture-related pollutants in indoor air 
(Bornehag et al. 2005).
Dustiness and man-made vitreous fibers (MMVFs), formerly called 
man-made mineral fibers, are commonly found in office environments 
(Schneider 2008a). In indoor air, MMVFs are airborne fibers, typically 
glass wool and mineral wool, released by thermal and acoustic insula-
tion products. MMVFs with diameters of >5 μm have the potential to 
cause skin irritation, and coarse fibers at high airborne concentrations 
may also irritate mucous membranes of the eyes and respiratory tract, 
but a diameter dependence is not known (Schneider 2008a). In 258 
examined office buildings with a background of indoor-air problems in 
the Helsinki area, over 60% of the surface dust and almost 90% of the 
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samples collected from supply air ducts contained MMFVs. In buildings 
where workers reported irritation of the upper-respiratory tract, eyes, and 
skin, the occurrence of MMVFs was nearly 70% (Salonen et al. 2009b).
As potential causes of the reporting of indoor-air symptoms, attention 
has focused on the emission of volatile organic compounds (VOCs) from 
building materials and products (Wolkoff et al. 2006). New building 
materials may contribute substantially to the indoor concentrations of 
VOCs, and temporarily high concentrations are also obtained during 
many human activities and processes, such as cleaning and using copy-
ing machines (Wolkoff et al. 2006). More than 900 VOCs have been 
identified at detectable levels in indoor air, but normally the number 
identified in one air sample varies from 20 to 150 (Salonen et al. 2009a). 
In a study of 176 Finnish office buildings, acetic acid, ethylacetate, 
2-ethyl-1-hexanol, and xylene had the highest irritation potency of the 
VOCs (Salonen et al. 2009a). Mainly sensory irritation of the eyes and 
respiratory tract (occurring from stimulation of receptors on trigeminal 
nerves) has been found to be associated with VOCs, but the available 
evidence on VOCs in causing health effects in indoor environments is 
not conclusive (SCHER 2007). Several studies have reported associations 
between VOCs and asthma symptoms (SCHER 2007). According to a 
review article, there is no consistent association between indoor VOC 
exposures and new-onset asthma (Nielsen et al. 2007). Odor thresholds 
for VOCs are generally much lower than sensory irritation thresholds, 
and the reported sensory irritation may be the result of odor annoyance 
(Wolkoff et al. 2006). Low relative humidity may exacerbate the sensory 
irritation impact (Wolkoff et al. 2006). Formaldehyde is a strong irritating 
chemical substance, and it has been found in indoor-air at concentrations 
capable of irritating mucous membranes and causing respiratory tract 
symptoms (Salonen 2009).
Phthalates are common contaminants in indoor environments, 
and polyvinyl chloride flooring material is among the most important 
sources (SCHER 2007). Phthalates are not skin or respiratory sensitizers. 
Polyvinyl chloride and different surface material have been found to be 
associated with respiratory effects in epidemiological studies (Jaakkola et 
al. 2006a), but there is no consistent evidence indicating that phthalates 
should be of high concern as chemicals in indoor-air (SCHER 2007; 
Jaakkola and Knight 2008).
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Individual risk factors
In several studies, female gender has been found to be associated with 
a higher prevalence of several kinds of SBS symptoms (Björnsson et al. 
1998; Brasche et al. 2001; Runeson et al. 2006; Bakke et al. 2007). The 
gender difference has been suggested to be a reflection of a general excess 
of psychosomatic symptoms among women (Stenberg and Wall 1995) 
or of the fact that women more often hold occupations that predispose 
to them to SBS than men do (Björnsson et al. 1998). It has also been 
Table 1. Varied indoor-air pollutants and factors in non-industrial 
work environments and associated health effects. 
Pollutant / factor Typical sources Associated health 
effects
Low ventilation rates Building and its services Symptom reporting
Too high or low 
temperature
Building and its services Discomfort
Low relative humidity Building and its services Skin symptoms, eye 
irritation, nasal dryness
Mold and other dampness- 
related factors
Building moisture 
damage
Respiratory symptoms, 
asthma, allergic alveolitis, 
symptom reporting
Particles Outdoor air, ETS, 
combustion, room dust, 
moisture damage
Respiratory and 
cardiovascular effects
Man-made vitreous fibers Building materials Eye, skin, and respiratory 
tract irritation
Allergens Occupants’ clothing (e.g. 
from pets)
Allergic airway symptoms
Viral infections Occupants Asthma and respiratory 
tract symptoms
VOCs Building materials and 
furnishings, office 
equipment, cleaning 
products
Sensory irritation, asthma 
symptoms
Formaldehyde Furnishings, insulation, 
consumer products, 
office equipment
Eye and respiratory tract 
irritation
Radon Diffusion through soil Lung cancer
ETS=environmental tobacco smoke; VOCs=volatile organic compounds.
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claimed that men and women perceive psychosocial work conditions dif-
ferently and may react differently to job stressors (Runeson et al. 2006).
No consistent association between age and SBS has been found in 
different studies (Norbäck 2009).
Self-reported allergy has been shown to be associated with a higher 
prevalence of SBS (Norbäck 2009). Atopy was found to be associated 
with SBS symptoms in a study in which atopy was defined as a positive 
skin prick test (SPT) to common environmental allergens and tested in 
a population sample (Björnsson et al. 1998). In another study, specific 
immunoglobulin (Ig) E, total IgE, familiar allergy, and ever eczema were 
not associated with mucosal symptoms (Bakke et al. 2008). 
Psychological factors have been investigated in several studies. Björns-
son et al. (1998) found an association between anxiety and depression 
and SBS symptoms. In addition, a tendency towards somatization has 
been shown to be associated with reports of SBS symptoms (Berglund 
and Gidlöf Gunnarsson 2000). Of the personality traits, neuroticism 
(or negative affectivity, meaning tendency to experience negative mood 
states) seems to be associated with the reporting of SBS symptoms 
(Gomzi et al. 2007). One experimental study has suggested that, for 
women high in negative affectivity, stress-inducing conditions are more 
important predictors of distress in response to poor indoor-air quality 
than the indoor-air quality itself (Fiedler et al. 2008). Several other per-
sonality factors have been shown to be related to a high occurrence of 
SBS symptoms (Runeson et al. 2004; Runeson and Norback 2005). In 
addition a low sense of coherence has been shown to be associated with 
SBS (Runeson et al. 2003).
Brauer and Mikkelsen (2010) investigated the perception of the 
indoor environment among 3281 employees in 39 randomly selected 
Danish non-industrial workplaces. Only non-problem buildings were 
included. They found that persons with an increased tendency to report 
symptoms were more likely to complain about the indoor environment 
(Brauer and Mikkelsen 2010).
Risk factors in the psychosocial environment
In principal, both work and home environments can be sources of adverse 
psychosocial factors (WHO 1985). The effect of work conditions on 
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SBS were studied already in the 1980s and 1990s, and, according to the 
studies, psychosocial factors are strongly associated with SBS (Lahtinen 
et al. 1998). Several factors have been shown to be associated with SBS 
symptoms, for example, work stress, work dissatisfaction, poor climate of 
co-operation at work, lack of support from supervisors, heavy workload, 
and conflicting demands in work (Lahtinen et al. 1998). In the studies 
reviewed by Lahtinen et al. (1998), the associations were similarly con-
firmed in the buildings that were, beforehand, defined as problem cases 
and also in those with no previous information on their status.
Associations have also been found in more recent studies. Using the 
demand–control–support model by Karasek and Theorell, a Swedish 
community-based study measured the psychosocial work conditions of 
532 office workers. It was found that SBS is influenced by a combina-
tion of low social support and either a passive or strained work situation. 
The lowest symptom score was recorded in a relaxed work situation, 
irrespective of social support. The authors concluded that the demand–
control–support model can predict symptoms compatible with SBS 
(Runeson et al. 2006).
Stress load, as measured by a non-verbal drawing test, proved to be 
a predictor of SBS symptoms in a questionnaire study (Runeson et al. 
2007).
The Whitehall II study, which is an ongoing longitudinal study of civil 
service office workers in the United Kingdom, showed that the physical 
environment appears to be less important than the psychosocial work 
environment in explaining differences in symptom prevalence (Marmot 
et al. 2006). Altogether 4052 participants were included in this part of 
the study. The physical environment included exposure to airborne fungi 
with a limit of 500 colony forming units per m3 (cfu/m3) air. High job 
demands and low support at work were associated with higher symptom 
reporting. The ability of people to exert control over the environment of 
their local workstation was related to a lowering of reported symptoms 
(Marmot et al. 2006).
In the aforementioned study by Brauer and Mikkelsen (2010), psy-
chosocial work environment factors at the individual level, but not at 
the workplace level, were associated with the individual perception of 
the indoor-air. Variables such as job demands, job support, effort–re-
ward imbalance, workloads, social climate at work, motivation, stressful 
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work, stimulating work, and satisfaction with work were studied. There 
were large differences between individuals in the same building, and 
these differences, the authors concluded indicated that some occupants 
of a building perceive problems in the indoor environment even in the 
absence of a general indoor-air problem (Brauer and Mikkelsen 2010).
2.2 Indoor dampness and mold
2.2.1 Prevalence
Moisture and microbial growth are present in all buildings (IOM 2004). 
It is evident that there are situations in which the presence of moisture 
can be regarded as normal, as well as situations in which the material 
contains excess moisture that is potentially harmful and there is a need 
to make a distinction between the two (Haverinen 2002).
The term indoor dampness has been used to define a variety of mois-
ture problems in buildings, including high relative humidity, condensa-
tion, and signs of excess moisture (IOM 2004). The severity of dampness 
varies widely, from occasional minor condensation on windows to the 
wetting of a large portion of a building due to water leaks. There is no 
agreed-on basis for determining the severity of damage from either the 
engineering or the health point of view (IOM 2004). The term moisture 
damage is used to describe damage caused by dampness in a building 
structure or on a surface of a material (Haverinen 2002). Moisture dam-
age is any visible, measurable, or perceived outcome caused by excess 
moisture (or dampness). Common sources of moisture damage are 
sources outdoors (condensation through cold gaps or faulty insulation 
from outdoor air humidity or moisture in the ground), wet construction 
materials (e.g., fresh concrete structures, timber), leaking services (e.g., 
burst pipes, defective pipe joints), spillage (e.g., cleaning and washing 
activities), and flooding (Haverinen 2002).
Microbial growth starts in building materials and structures when the 
conditions are favorable. Moisture is the only limiting factor for mold 
growth in indoor environments; usually there is enough light, oxygen, 
nutrients, and warmth for such growth (Haverinen 2002). Therefore, 
excess moisture on almost all indoor materials leads to the growth of 
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microbes, such as mold, fungi and bacteria, which subsequently emit 
spores, cells, fragments, and volatile compounds into indoor air (WHO 
2009). Microbes differ in their needs for conditions for optimal growth. 
The materials used in the building determine the type of microbes whose 
growth will be favored (IOM 2004). Some microbes are hydrophilic, 
requiring substrates with a high moisture content, while some are xero-
philic, growing in relatively dry environments (Haverinen 2002). The 
time it takes for microbes to grow varies depending on the conditions. 
The growth can start in a day in optimal conditions, or it can take several 
weeks or months (IOM 2004).
As there is no gold standard for building dampness, the exact preva-
lence of indoor dampness cannot be established. Reports by occupants 
and inspectors indicate that it is likely to be on the order of 10%–50% 
in developed countries (WHO 2009). According to studies from 31 Eu-
ropean countries, dampness or mold problems can be expected to occur 
in one of every six dwellings in Europe (Haverinen-Shaughnessy 2012). 
In the 1990s, a random sample of 450 houses surveyed by trained civil 
engineers revealed that approximately 55% of Finnish private houses 
were in need of repair or more thorough inspection due to moisture 
problems (Nevalainen et al. 1998). The severity of the moisture damage 
was only minor in 94% of the cases, and the faults were estimated to be 
repairable at a reasonable cost. 
Systematic surveys assessing the prevalence of dampness and mold in 
school buildings, offices, institutional buildings, and other non-industrial 
workplaces are sparse. In a survey evaluating the state of Finnish hospital 
buildings in 2003–2005, altogether 15% of the total area of the studied 
hospital buildings was found to need immediate repair according to 
thorough investigations of 10 central hospitals by construction engi-
neers and indoor-air experts (Hellgren et al. 2008). The most common 
causes of the need for immediate repairs were dampness problems in 
moist facilities, found in 80% of the targeted hospitals. Other typical 
problems causing a need for immediate repairs were moisture damage 
in the foundation structures or intermediate floors and damage in outer 
walls, which included, for example, contaminated and moist insulation 
in buildings without a crawl space (Hellgren et al. 2008).
According to the “Work and Health in Finland 2009” survey (based 
on interviews of 2355 respondents), one in five employees in the health, 
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social, or education sector reported the smell of mold indoors at work 
(Reijula 2010). 
Globally, climate change and its effects on the weather (i.e., storms 
and heavy rainfall) have been predicted to further increase the propor-
tion of buildings with damp problems (WHO 2009).
2.2.2 microbial and non-microbial factors associated  
 with indoor dampness
Mold growth is usually accompanied by bacterial growth. Many specific 
components of mold and bacteria may be responsible for health effects: 
spores and hyphal fragments of fungi, spores and cells of bacteria, al-
lergens of microbial origin, structural components of fungal and bacte-
rial cells, and such products as microbial volatile organic compounds 
(mVOCs) and mycotoxins. In more advanced damage, also protozoa and 
higher organisms such as mites and insects are present. Moisture may 
also trigger the degradation of building materials and contribute to the 
release of non-microbial chemicals into the indoor air (IOM 2004). No 
specific measure of microorganisms or microbial substances has resulted 
in a more specific or sensitive exposure assessment relevant to health 
effects; in other words, specific causal agents have not been identified 
conclusively (WHO 2009). Microbial exposure is often suggested to 
play a causal role (WHO 2009).
Many of the bacterial and fungal species detected in damp environ-
ments are the same as those detected in normal indoor air, but their 
concentrations may be higher (SCHER 2007). There are also spe-
cies that are normally not present in indoor air, but typically exist in 
moisture-damaged environments and are called indicator species of the 
dampness problem. Low concentrations of these species can be found 
also in non-moisture-damaged buildings (Salonen et al. 2007). The 
spectrum of microbes varies according to time and space. The material, 
its moisture contents, and other circumstances regulate the microbial 
profile, and also the toxicity. There is geographic and also building-to-
building variation. Several lists of indicator species have been cited by 
different laboratories. The indicator species most commonly presented to 
describe Finnish circumstances are Stachybotrys, Trichoderma, Aspergillus 
versicolor, Aspergillus fumigatus, Chaetomium, Phialophora, Fusarium, and 
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actinomycetes (mainly Streptomycetes) (STM 2003). However, the most 
common fungi detected in indoor air and settled dust samples in Finnish 
offices are Penicillium, yeasts, and Cladosporium, both in mold-damaged 
and non-damaged buildings (Salonen et al. 2007). These species are also 
typical outdoors. Penicillium, A. fumigatus, and yeasts have been the best 
indicators of mold damage (Salonen et al. 2007).
Many fungi and some yeasts replicate by producing numerous spores 
that are well adapted to airborne dispersal. Spores can stay airborne for 
long periods. Fungi also release smaller fungal fragments, which are 
derived from broken spores and hyphae. Fungal spores, hyphae, and 
fragments are known to contain allergens, many of which are glycopep-
tides with enzymatic properties (WHO 2009). The viability of spores 
is important for allergenic expression, and non-viable fungal spores and 
fungal fragments also contain potentially harmful compounds such as 
(1– >3)-β-D-glucans and mycotoxins (WHO 2009). Both spores and 
fungal components may be involved in mold-related adverse health ef-
fects.
Many fungi and bacteria are able to produce compounds called 
secondary metabolites, depending on the growth conditions and the 
substrate. Many secondary metabolites are toxic or otherwise bio-
logically active, among them, mycotoxins and bacterial toxins, some 
of which are toxic to animals and human beings (WHO 2009). Some 
fungal species may produce various mycotoxins. Typical toxigenic fungi 
found in buildings or building materials are Stachybotrys, A. versicolor, 
A. fumigatus, Aspergillus flavus, Penicillium, Trichoderma, Fusarium, and 
Chaetomium (IOM 2004). The mycotoxins that have received the most 
attention are the trichothecenes, produced by Stachybotrys chartarum. Of 
the bacteria, Streptomycetes are among the potentially toxic types (IOM 
2004). Microbial toxins are not volatile, but they may be carried by 
spores. Mycotoxins and bacterial toxins have been shown to be present 
in indoor environments (Tuomi et al. 2000; Peltola et al. 2001; Brasel 
et al. 2005; Täubel et al. 2011).
Endotoxins are components of the outer membrane of gram-negative 
bacteria and are composed of proteins, lipids, and lipopolysaccharides 
(WHO 2009). The term endotoxin refers to a toxin on the bacterial cell 
wall, which is liberated as a result of cell lysis. Airborne endotoxins are 
usually associated with dust particles or aqueous aerosols (WHO 2009). 
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Endotoxin exposure has been found to be associated with occupational 
lung disease among workers exposed at high levels of endotoxins (e.g., 
in farming) (IOM 2004). The terms endotoxins and lipopolysaccharides 
are often used interchangeably in the scientific literature (WHO 2009).
(1– >3)-β-D-glucans are non-allergenic, water-insoluble, structural-cell 
wall components of most fungi and some bacteria (Douwes 2005). Meth-
ods exist with which to analyze (1– >3)-β-D-glucan concentrations in dust 
or air samples. Observational and experimental studies suggest that some 
association exists between indoor (1– >3)-β-D-glucan exposure, airway 
inflammation, and symptoms. However, the results are mixed, and specific 
symptoms and potential underlying inflammatory mechanisms associated 
with exposure can not yet be identified (Douwes 2005).
Mite allergen concentrations have been shown to be higher in houses 
with mold damage than in non-damaged houses (van Strien et al. 2004). 
In a Finnish study estimating mite exposure in moldy buildings, mites 
were found (counted and identified microscopically) both in moisture-
damaged buildings and non-damaged buildings, somewhat more often 
in moisture-damaged buildings however (Pennanen et al. 2007). Mites, 
especially storage mites, were found in workplaces and homes in a total 
of 26% of the dust samples but seldom at high concentrations (Pennanen 
et al. 2007). In addition, amoebae have been shown to be present in 
more than 20% of the building material samples taken from moisture-
damaged buildings (Yli-Pirilä et al. 2004).  
VOCs emitted from microbial growth (mVOCs) include those that 
are known as mold odor. mVOCs are often similar to common industrial 
chemicals, and more than 200 of these compounds derived from differ-
ent fungi have been identified (WHO 2009). Few of these compounds 
are specific to fungi; therefore measuring mVOCs is of limited use in 
attempts to identify indoor fungal growth (WHO 2009).
Damp concrete floors have been shown to increase the chemical 
degradation of the plasticizer in floor coatings and adhesives made of 
polyvinyl chloride, resulting in emissions of VOCs, like 2-ethyl-1-hexanol 
and 1-butanol (Tuomainen et al. 2004, Wieslander 2010). Induced by 
dampness, the self-leveling flooring compound used in Europe in the 
late 1970s and early 1980s may emit ammonia (WHO 2009). The off-
gassing of formaldehyde from composite wood products has been shown 
to increase as the relative air humidity increases (WHO 2009).
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2.2.3 Exposure assessment
Exposure is defined as an event during which people come into contact 
with a pollutant at a certain concentration during a certain length of time 
(WHO 2009). The interpretation of concentrations is a difficult ques-
tion, as there are no health-based exposure limits for indoor biological 
agents (WHO 2009). It is likely that the major route of the exposure to 
dampness-related agents is via the airways. Exposures to fungal agents 
may occur through dermal contact and the incidental ingestion of house 
dust as a consequence of hand-to mouth activity, but the significance of 
these routes is probably low with respect to adults (IOM 2004). At pre-
sent, there is a lack of valid, quantitative methods for assessing exposure 
to microbial and other agents associated with indoor dampness (WHO 
2009). Therefore, indicators of exposure are used to estimate the micro-
bial exposure of occupants and to find abnormal sources of microbes. 
The methods used to estimate exposure include 1) information from 
occupants and their perceptions in the form of inquiries or question-
naires, which elicit occupants’ perceptions of conditions such as marks of 
water leaks or moldy odors and which are used in most epidemiological 
studies; 2) visual inspection of buildings or a more specific investigation 
of building construction, which may include structural openings; and 
3) environmental sampling  (Salonen 2009; WHO 2009).
When moisture damage is suspected in a building, a technical inves-
tigation is performed, and the ventilation system is inspected. The aim 
is to recognize and localize the sources and mechanisms of the moisture 
damage in order to remediate the mold damage and repair structures, 
and then to insure that recurrence is prevented.
Traditional microbial exposure assessment is based on culturing. 
In cold climates, the presence of visible mold is unusual, and therefore 
sampling is needed to demonstrate mold (Nevalainen et al. 1998).
Bulk sampling from building materials is a principal sampling 
method if mold growth is suspected in constructions (Salonen 2009). 
The results of material samples help to locate the microbial contamina-
tion and indicate the need for remediation. The results are expressed as 
concentrations of culturable microbes per gram of material (cfu/g). By 
measuring air pressure differences between spaces or locating air leaks 
with tracer gases, it is possible to verify whether pollutants migrate from 
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spaces with moisture-damaged structures to working spaces (Haverinen-
Shaughnessy et al. 2008).
Airborne concentrations of microorganisms can be studied from air 
samples or settled dust samples (WHO 2009). They can be used to clarify 
hazard identification when the results of a “walk-through” inspection 
reveal no significant moisture or mold damage in constructions (Salonen 
et al. 2007) and the cause of symptoms among occupants is unclear. 
Generally, a so-called six-stage impactor is used to collect air samples. As 
the collecting time is short, usually 15 minutes, air sampling represents a 
momentary situation. The result is expressed in colony forming units per 
cubic meter of air (cfu/m3). As indoor microbial concentrations in air vary 
temporally and spatially, the representativeness of the sampling improves 
when several samples are taken. A low concentration of microbes in one 
sample does not exclude the presence of an abnormal microbial source in 
structures. For example, for school investigations, 10–12 indoor-air samples 
per building are recommended (Meklin et al. 2007). The outdoor air is 
a major source of indoor microbes. In subarctic countries like Finland, 
the outdoor concentrations of microbes vary seasonally and are very low 
in winter, when the ground is covered with snow. Therefore, outdoor air 
sampling is needed as a reference for indoor-air sampling from spring to 
late autumn, when the earth is not frosted. Settled dust samples reflect 
long-term exposure conditions, but the microbial concentrations and flora 
may differ from those in the indoor air (Salonen 2009).
Several other aspects must also be considered in the interpretation 
of microbial measurements. Both concentrations and fungal genera are 
assessed. Proper interpretation of indoor measurements requires detailed 
information about sampling and an awareness of the problems associ-
ated with these procedures (WHO 2009). The methods used must be 
taken into account, as the detected microbial concentrations are method 
specific. Reference values have been suggested for Finnish home envi-
ronments (STM 2003), school environments (Meklin et al. 2007), and 
office environments (Salonen et al. 2007). Higher levels of fungi and 
bacteria exist in homes than in non-industrial work environments, as 
homes have diverse natural sources of microbes, like pets, firewood, and 
foodstuff. The recommended levels are not health-based, but they can 
be used for identifying abnormal indoor sources of microbes. In other 
words, they should not be used for evaluating health risks.
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Cultivation methods may underestimate the real exposure to fungi, 
because only viable microbes can grow on culture media. New methods 
of collecting fungi have been presented, but the experience with them 
is limited (WHO 2009). Quantitative polymerase chain reaction has 
proven to be a feasible method for revealing unusual microbial concen-
trations in house dust from moisture-damaged buildings (Lignell et al. 
2008). The method has, however, not yet been well validated; hence 
normal levels are not known (Haverinen-Shaughnessy et al. 2008). 
Most methods for measuring microbial constituents (e.g., endotoxins, 
fungal allergens, (1– >3)-β-D-glucans, ergosterol, and muramic acid) 
are experimental and do not differentiate between moisture-damaged 
and non-damaged buildings (WHO 2009). The same is true for the 
measurement of mVOCs and non-volatile secondary metabolites (e.g., 
toxins). The presence of microbial toxins has been found in the indoor 
air of environments with microbial contamination (Brasel et al. 2005). 
This measurement method has, however, not yet been validated and is 
thus far not practicable. Measuring general toxicity in dust or air samples 
is an experimental method that is being tested for its usefulness.
2.2.4 Risk assessment
The expert group of the Scientific Committee on Health and Envi-
ronmental Risks (SCHER) of the European Committee recommends 
using the basic paradigm for toxicological risk assessment in indoor-air 
risk assessment (SCHER 2007). Risk assessment consists of 1) hazard 
identification, 2) dose–response assessment, 3) exposure assessment 
evaluating the duration and concentration of exposure, and 4) risk 
characterization (SCHER 2007). A hazard implies the potential to cause 
harm, and a risk specifies the likelihood and seriousness of the occurring 
harm. Thus risk assessment involves deciding on whether a given level 
of exposure is or is not associated with some risk of adverse effects on 
health (Maynard 2010).
Currently, there is a lack of valid, quantitative methods for assessing 
exposure to microbial and other agents associated with indoor dampness, 
and this lack seriously hampers risk assessment (WHO 2009). Although 
some studies suggest that respiratory symptoms increase with increas-
ing severity of moisture damage (Haverinen et al. 2001; Hellgren et al. 
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2008), dose–response data are not available for the setting of health-based 
criteria for exposure. SCHER demands flexible use of the risk assessment 
paradigm; when it is not possible to compare the exposure with relevant 
health-based guidelines, a scientifically based hazard characterization 
should be attempted (SCHER 2007). However, it should be taken into 
account that complaints and diseases related to indoor exposures may 
have a complex cause–effect relationship (SCHER 2007). 
When unacceptable indoor conditions, like extreme heat, a lack of 
ventilation, excessive dirtiness, or excessive microbial growth and damp-
ness are present and there are diseases or a risk of diseases, symptoms, or 
complaints obviously related to these conditions, risk management can 
be carried out directly without further detailed risk assessment (SCHER 
2007). Regarding building dampness and mold, tools for assessing risk 
and planning the remediation processes require an overall evaluation 
using available exposure assessment methods (see Section 2.2.3) and a 
simultaneous assessment of the symptoms and complaints of the occu-
pants (Reijula and Sundman-Digert 2004; Haverinen-Shaughnessy et 
al. 2008; Schneider 2008b; Lahtinen et al. 2009, STM 2009). Clinical 
guidelines on the recognition of health effects are sparse (Majvik 1998; 
Storey et al. 2004; Majvik 2007). Often a multiprofessional approach 
to risk assessment is necessary, and technical experts, the workplace, and 
occupational health professionals have their own roles to play (Lahtinen 
et al. 2008).
Risk communication should be added as an essential component of 
risk management (Maynard 2010). The success of the technical remedies 
is the first priority, but investment in information, communication, and 
cooperation help to attain the confidence of the occupants in order to 
succeed in solving the indoor-air problem (Lahtinen et al. 2009).
2.3 health effects related to indoor    
 dampness and mold
Many epidemiological studies have found associations between evident 
indoor dampness or mold and respiratory health effects on children and 
adults in many geographical regions (Bornehag et al. 2001; Bornehag 
et al. 2004; IOM 2004; Fisk et al. 2007; Antova et al. 2008; WHO 
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2009; Fisk et. al 2010; Mendell et al. 2011). The evidence is not strong 
enough to document causal relationships, and this lack of strength is 
likely attributable to an uncertainty about the causal agents and a lack 
of valid exposure assessment methods for these unknown agents (WHO 
2009, Mendell et al. 2011). A WHO expert group has concluded that, 
although not established conclusively, it is plausible that heavy exposure 
to indoor mold or other microbial agents plays a causal role (WHO 
2009). However, conventional quantitative exposures to mold or other 
microbiological exposures, such as culturable airborne fungi, have shown 
less consistent associations with health effects than have qualitative assess-
ments of visible dampness or mold, or mold odor (Mendell et al. 2011). 
It has been suggested that visible mold may better represent long-term 
exposure to molds than direct measurements during a short sampling 
time do (Antova et al. 2008).
The studies have also other limitations. The methods assessing expo-
sure and health outcomes vary. Many of them have used subjective reports 
for assessing exposure or health and thus have a potential for reporting 
bias (WHO 2009). The microbial measurements used in many studies 
may not target actual causal factors. For example, although glucans and 
endotoxins have been shown to cause inflammation, they have also been 
suggested to have health protective associations, and this possibility is 
consistent with the hygiene hypothesis that postulates that growing up 
in a more microbiologically hygienic environment early in life may in-
crease the risk of atopy and allergic disease (von Hertzen and Haahtela 
2004; Mendell et al. 2011). However, there is no indication that living 
or working in a damp building with heavy exposure to mold prevents 
the development of allergies and respiratory disease (WHO 2009). They 
seem only to increase rather than decrease the development of respiratory 
disease, both in allergic and non-allergic persons (Mendell et al. 2011).
The scientific literature concerning the health effects of indoor 
dampness and mold has been reviewed by several groups. The reviews 
NORDDAMP (Bornehag et al. 2001) and EUROEXPO (Bornehag et 
al. 2004) cover the literature up to 2000. The expert group of the Insti-
tute of Medicine (IOM) has reviewed  the literature up to 2003 (IOM 
2004) and that of WHO up to 2007 (WHO 2009). The latest review on 
the epidemiological evidence concerning respiratory and allergic health 
effects was carried out by Mendell et al. (2011); it covers the literature 
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up to 2009. In addition, three meta-analyses have been published that 
combine data of multiple studies with qualitative dampness and mold 
factors into quantitative summaries of the association between dampness 
or mold and specific respiratory outcomes (Fisk et al. 2007; Antova et 
al. 2008; Fisk et al. 2010). 
IOM focused its review on epidemiological studies. The quality of 
the evidence concerning a relation was classified into the following five 
categories: 1) sufficient evidence of a causal relationship, 2) sufficient 
evidence of an association, 3) limited or suggestive evidence of an as-
sociation, 4) inadequate or insufficient evidence to determine whether 
an association exists, and 5) limited or suggestive evidence of no associa-
tion (IOM 2004). The expert group of WHO separately reviewed the 
epidemiological evidence and the clinical and toxicological evidence.
Table 2 shows how, based on the epidemiological evidence, the level of 
confidence of associations (using the IOM classification) between indoor 
dampness and related factors has increased over the years (IOM 2004; 
WHO 2009; Mendell et al. 2011). For none of the outcomes, is there 
sufficient evidence of a causal relationship. Table 2 also shows that there 
is epidemiological evidence only for respiratory health outcomes. For 
other effects, like effects related to skin, eyes, fatigue, nausea, headache 
and insomnia, the WHO report notes that only limited research has been 
reported (WHO 2009), and therefore the associations are not assessable.
Clinical studies provide evidence for rare outcomes, for which the 
epidemiological approach is not reasonable due to difficulties in defining 
exposure. The WHO report (2009) also weighed the evidence of clinical 
studies. These studies were based on small groups, or are case reports, 
and both the exposure and outcomes are characterized better than in the 
epidemiological studies (WHO 2009). The WHO experts concluded 
that clinical evidence indicates that associations exist between mold and 
other dampness-associated microbiological agents and allergic alveolitis 
in susceptible persons (reviewed in more detail in Section 2.3.5), mold 
infections in immune-suppressed or otherwise susceptible persons (see 
Section 2.3.7), and humidifier fever (from contaminated humidifiers) and 
inhalation fevers (from the handling of moldy material) (see Section 2.3.6).
Toxicological studies provide an understanding of the pathological 
processes and are needed in consideration of the biological plausibility 
of potential causal associations (see Section 2.3.9).
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Table 2. The level of confidence of associations between indoor 
dampness or dampness-related agents and health outcomes, based 
on epidemiological evidence according to systematic literature 
reviews. NA, not assessed. 
Outcome IOM conclusion 
(2004)
WHO conclusion 
(2009)
Conclusion by 
Mendell et al. 
(2011)
Asthma 
exacerbation
Sufficient evidence Sufficient evidence Sufficient evidence 
(strongly suggestive 
of causation)
Asthma 
development
Limited or 
suggestive evidence 
Sufficient evidence Sufficient evidence 
Cough Sufficient evidence Sufficient evidence Sufficient evidence 
Wheeze Sufficient evidence Sufficient evidence Sufficient evidence 
Dyspnea Limited or 
suggestive evidence 
Sufficient evidence Sufficient evidence 
Upper respiratory 
tract symptoms
Sufficient evidence Sufficient evidence Sufficient evidence 
Allergic rhinitis NA Limited or 
suggestive evidence 
Sufficient evidence 
Respiratory 
infections
NA Sufficient evidence 
(except otitis media)
Sufficient evidence 
Bronchitis NA Limited or 
suggestive evidence 
Sufficient evidence 
Allergic alveolitis (Association based 
on clinical evidence)
(Association based 
on clinical evidence)
Inadequate or 
insufficient evidence
Organic dust toxic 
syndrome (ODTS)
Inadequate or 
insufficient evidence 
Inadequate or 
insufficient evidence
NA
Gastrointestinal 
tract problems
Inadequate or 
insufficient evidence
NA NA
Fatigue Inadequate or 
insufficient evidence
NA NA
Neuropsychiatric 
symptoms
Inadequate or 
insufficient evidence
NA NA
Cancer Inadequate or 
insufficient evidence
Inadequate or 
insufficient evidence
NA
Rheumatological 
and other immune 
diseases
Inadequate or 
insufficient evidence
Inadequate or 
insufficient evidence
NA
Reproductive effects Inadequate or 
insufficient evidence
Inadequate or 
insufficient evidence
NA
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2.3.1 Respiratory symptoms
The increasing evidence from the 1990s to the 2000s provides convinc-
ing certainty for the associations of dampness and mold with cough, 
wheezing, and dyspnea, as well as with upper-respiratory symptoms 
(Table 2) (Bornehag et al. 2001; Bornehag et al. 2004; IOM 2004; 
WHO 2009). Fisk et al. (2007) have reported an odds ratio (OR) of 
1.52 (95% confidence interval [95% CI] 1.18–1.96) as a summary effect 
estimate for adult cough, an OR of 1.39 (95% CI 1.04–1.85) for adult 
wheezing, and an OR of 1.70 (95% CI 1.44-2.00) for upper-respiratory 
tract symptoms in adults and children. The meta-analyses by Antova et 
al. (2008) included only studies on children.
2.3.2 Development of asthma
The IOM (2004) concluded that there is limited or suggestive evidence 
of an association between exposure to a damp indoor environment and 
the development of asthma (for the definition of asthma, see Section 
2.4.1). For the presence of mold,  the existing evidence of an association 
had been inadequate or insufficient (IOM 2004).
Fisk et al. provided quantitative summary estimates of associations 
between qualitatively assessed dampness or mold in residences. The 
meta-analysis concerning asthma development was based on four studies 
(Yang et al. 1998; Thorn et al. 2001; Jaakkola et al. 2002; Jaakkola et al. 
2005) and ended up with an OR of 1.34 (95% CI 0.86–2.10).
WHO (2009) reviewed the epidemiological evidence up to 2007 and 
concluded that there is sufficient confirmation of an association between 
factors related to indoor dampness and asthma development.
The most recent review, by Mendell et al., identified five new studies 
on asthma development (Rönmark et al. 2002; Hyvärinen et al. 2006; 
Park et al. 2008; Cox-Ganser et al. 2009; Iossifova et al. 2009) that were 
not included in the IOM or WHO reports (Mendell et al. 2011). The 
authors ended up with the same conclusion as the authors of the WHO 
report (WHO 2009).
Torén et al. (2010) ended up with a different conclusion in their 
systematic review on asthma development in adults. They questioned 
whether the results of studies conducted on children can be generalized to 
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adults, as the mechanisms for asthma development may be different (e.g., 
allergy may be more important among children). The authors reviewed 
the epidemiological literature up to 2009 and did not find evidence to 
support the hypothesis that indoor dampness and mold would increase 
the risk of asthma development in adults (Torén et al. 2010).
Table 3 summarizes the epidemiological evidence of the studies on 
the association between asthma development and dampness-related fac-
tors among adults. Altogether six of the studies on asthma development 
have been conducted on adults, and the other eleven studies concerned 
children (presented in Appendix 1). Workplace dampness was the focus 
of three of the studies (Jaakkola et al. 2002; Park et al. 2008; Cox-Ganser 
et al. 2009).
In the so-called Pirkanmaa study, 521 new-onset adult asthma cases 
and 932 controls were examined in a population-based study (Jaakkola 
et al. 2002). An association with an OR of 1.54 (95% CI 1.01–2.32) was 
found between self-reported visible mold or mold odor at the workplace 
and new-onset asthma. The study controlled for gender, age, parental 
atopy or asthma, education, smoking, environmental tobacco smoke, 
pets, work indoors, self-reported occupational exposures, and signs of 
dampness or water damage (Jaakkola et al. 2002).
Park et al. (2008) found associations between physician-diagnosed 
post-occupancy-onset asthma and fungal exposure among employees 
in an office building with a long history of water damage.  The study 
population comprised 200 respiratory cases, of which 49 involved 
current asthma with a post-occupancy physician diagnosis, and 152 
asymptomatic referents. Dust samples collected from floors and chairs 
were analyzed for culturable fungi, ergosterol, and endotoxin. Post-
occupancy-diagnosed asthma showed statistically significant associations 
with exposure to hydrophilic fungi in models adjusted for age, gender, 
race, smoking status, building occupancy time, ergosterol, and endotoxin 
levels. The OR for hydrophilic fungi in floor dust was 2.09 (95% CI 
1.15–3.79), and for chair dust it was 1.79 (95% CI 1.79 (1.12–2.85) 
(Park et al. 2008).
A cross-sectional study of 1171 workers from a water-damaged 
hospital and a nearby hospital without indoor-air problems showed 
that post-hire asthma was positively associated with an observational 
assessment score of workplace dampness (Cox-Ganser et al. 2009). Of 
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the participants, altogether 79 workers had asthma with post-hire onset. 
The researchers assessed building dampness for selected areas, so that the 
dampness scores could be linked to 834 participants. For the highest 
dampness score, the OR of post-hire onset asthma was approximately 2.2 
with the lower limit of the 95% confidence interval above zero (presented 
graphically) (Cox-Ganser et al. 2009).
Studies conducted with children have found associations between 
asthma development and dampness-related factors with the OR rang-
ing from 0.63 to 6.16 (Appendix 1). The studies have had varying study 
designs and measures of dampness. A well-designed incident case–control 
study conducted in the Kuopio Hospital District (Pekkanen et al. 2007) 
has been found to provide some of the strongest evidence that dampness-
related exposures may cause asthma development in infants and children 
(WHO 2009; Mendell et al. 2011). The study showed an association 
between the risk of developing new asthma among children aged 1–6 
years and the presence of visible mold in the main living quarters, but not 
in other areas of the home (Pekkanen et al. 2007). Multivariate analyses 
showed dose–response relations, as the risk of asthma increased as the 
severity of moisture damage and the maximum severity of the damage 
increased, as assessed by civil engineers (Pekkanen et al. 2007).
2.3.3 Exacerbation of asthma
The latest systematic review (by Mendell et al. 2011) found 31 studies 
on dampness and mold and asthma exacerbation and considered the 
evidence sufficient to document an association, the ORs consistently 
exceeding 1.0 for adults. In retrospective studies, they ranged from 1.7 to 
2.6, and in cross-sectional studies they varied from 1.02 to 4.2 (Mendell 
et al. 2011). For children, the ORs were notably higher. On the basis of 
a well-designed intervention study by Kercsmar et al. (2006), the review 
concluded the evidence to be strongly suggestive of a causal association 
between indoor dampness and mold and exacerbations among children 
with asthma (Mendell et al. 2011). Comprehensive removal of dampness 
sources and visible mold caused dramatic reductions in the occurrence 
of asthma exacerbations among children (Kercsmar et al. 2006).
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2.3.4 Respiratory tract infections
Respiratory tract infections include upper (common cold, pharyngitis, 
and sinusitis) and lower (pneumonia, acute bronchitis, and acute ex-
acerbation of chronic bronchitis) respiratory tract infections and otitis 
media. These infections are generally viral or bacterial in origin, except 
chronic bronchitis which is non-infectious.
The IOM review in 2004 drew no conclusions about the associations 
between dampness or mold and respiratory tract infections (IOM 2004). 
The review by WHO concluded that there is sufficient evidence of an 
association between indoor dampness-related factors and respiratory 
infections, but only limited or suggestive evidence of an association with 
bronchitis (WHO 2009). 
The results of quantitative meta-analyses, performed by Fisk et al. 
(2010), indicated that dampness and mold in residences are associated 
with moderate but statistically significant increases in respiratory infec-
tions and bronchitis. Altogether 23 studies were selected for inclusion 
in the meta-analyses. For the two primary outcomes, bronchitis (13 
studies) and respiratory infections (19 studies, including otitis media), 
the OR estimates were 1.45 (95% CI 1.34–1.56) and 1.44 (95% CI 
1.32–1.58), respectively. The construction of a separate, overall respira-
tory infection group model for adults led to a similar OR, 1.50 (95% CI 
1.22–1.83) (Fisk et al. 2010). The authors concluded that the results of 
the meta-analyses were consistent with the WHO findings for respira-
tory infections (WHO 2009), but implied more strongly that dampness 
and mold are associated with bronchitis. They also concluded that the 
reported statistical associations do not prove that dampness and mold are 
causally related to bronchitis and respiratory infections (Fisk et al. 2010).
A meta-analysis published earlier analyzed pooled data from 12 Euro-
pean cross-sectional studies of visible mold in residences and bronchitis 
in children; the result was an OR of 1.38 (95% CI 1.29–1.47), which is 
comparable with the results reported by Fisk et al. (Antova et al. 2008).
2.3.5 Allergic alveolitis
Allergic alveolitis, also known as hypersensitivity pneumonitis or extrinsic 
allergic alveolitis, is an interstitial, granulomatous, cell-mediated lung 
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disease, which is caused by repeated inhalation exposure to antigens 
from microorganisms or other sources. The primary site of the allergic 
response is alveolar or bronchiolar tissue and the interstitium of the lung. 
The occurrence of allergic alveolitis in the general population is rare. 
The disease was originally recognized in adults with high antigen 
exposures in agricultural and industrial settings. For farmers, allergic 
alveolitis has been found to be associated with high exposure levels, the 
spore concentrations exceeding 109 spores/m3 (Malmberg et al. 1993). 
In a Finnish study, the level of exposure to fungi varied from 104 to 
107 cfu/m3 in the handling of hay and grain (Kotimaa et al. 1987). In 
moisture-damaged office buildings, the concentrations of viable airborne 
fungi are generally lower (101–104 cfu/m3) (Salonen 2009).
Only 1%–15% of those exposed develop allergic alveolitis (Bourke et 
al. 2001), although a larger portion of exposed persons may be sensitized. 
This pattern implies that, in addition to exposure to external antigens, 
genetic susceptibility must play a significant role (WHO 2009; Park 
and Cox-Ganser 2011). Host risk factors have been poorly character-
ized (Bourke et al. 2001). In susceptible persons, the exposure leads to 
a combined type III allergic reaction of Gell and Coombs and a type IV 
lymphocytic reaction (Bourke et al. 2001).
Sporadic case reports of allergic alveolitis in damp non-industrial 
indoor environments have been published, often in connection with the 
use of humidifiers (WHO 2009). “A summer-type hypersensitivity pneu-
monitis”, which is caused by seasonal mold contamination in the home 
environment, has been documented clinically and epidemiologically in 
Japan and some other countries with a similar climate (Ando et al. 1995). 
Seuri et al. (2000) described a respiratory disease outbreak, including one 
case of allergic alveolitis, among workers in a seriously water-damaged 
military hospital building. The case of allergic alveolitis was confirmed 
by inhalation provocation with Sporobolomyces salmonicolor from the 
hospital (Seuri et al. 2000). A case study from the United States reported 
a case of allergic alveolitis for a resident of a home contaminated by fungi 
found in water-damaged carpet and insulation materials (Apostolakos 
et al. 2001). Another case study from the United States reported restric-
tive lung disease suspected as chronic allergic alveolitis in a worker with 
repeated exposure to fungi in a water-damaged hotel (Trout et al. 2001). 
A report from Spain described two cases with allergic alveolitis caused 
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by domestic exposure to molds (Enriquez-Matas et al. 2007). A recent 
case study from Japan reported allergic alveolitis in a 75-year-old man, 
caused by fungi in his house (Katayama et al. 2008).
In a questionnaire study involving an office building with a long his-
tory of water damage, eight participants among 888 reported physician-
diagnosed hypersensitivity pneumonitis, 5 of which had post-occupancy 
onset (Cox-Ganser et al. 2005). The authors concluded that the rarity of 
allergic alveolitis in the general population suggested a building-related 
etiology for this cluster, although causal antigens and medical bases for 
the diagnoses were not reported (Cox-Ganser et al. 2005). 
Both IOM and WHO concluded that the clinical evidence indicates 
that associations exist between mold and other dampness-associated 
microbiological agents and allergic alveolitis among susceptible persons 
(IOM 2004; WHO 2009).There is no adequate epidemiological evidence 
however (Mendell et al. 2011).
2.3.6 Organic dust toxic syndrome
Organic dust toxic syndrome (ODTS), also known as inhalation fever, 
toxin fever, or toxic pneumonitis, is the result of substantial exposures 
to airborne organic dusts or aerosols, principally fungi (Iversen 2002). 
ODTS does not depend on immunological sensitization; therefore it 
can occur during or immediately after the first exposure (Iversen 2002). 
Exposure to organic dust causing ODTS is usually heavy. In studies of 
farmers, the measured concentrations of mold spores that led to ODTS 
have been shown to be notably higher than those that induce allergic 
alveolitis (Malmberg et al. 1993). In addition to farming, every occupa-
tion associated with the handling of organic material poses some risk. 
The clinical picture is an influenza-like reaction with fever (38.5–40.0°C) 
and myalgias, often accompanied by chest tightness, cough, headache, 
and nausea (Iversen 2002). The symptoms are self-limiting; they rarely 
persist beyond 1 or 2 days after the cessation of exposure, and there are 
no long-term consequences even with recurring episodes (Iversen 2002).
The report of IOM (2004) concluded that concentrations of organic 
dust consistent with the development of ODTS are very unlikely to be 
found in homes or public buildings, and the authors did not recognize 
studies in which ODTS should have been explored as a possible explana-
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tion of symptoms experienced by some occupants of highly contaminated 
indoor environments (IOM 2004). ODTS has been described for a 
museum worker who handled books covered with mold (Kolmodin-
Hedman et al. 1986).
2.3.7 Infection with mold
Serious respiratory infections with Aspergillus spp. or Fusarium spp. are 
well-known complications among patients who undergo cancer chemo-
therapy or organ transplantation, or are otherwise immune compromised 
(IOM 2004, WHO 2009). No studies have been conducted to link such 
infections to mold associated with the presence of moisture problems 
(WHO 2009). Rather, a susceptible person is a suitable host for the op-
portunistic molds that are ubiquitous (WHO 2009).
There are some other clinical disorders in association with which 
patients become infected with Aspergillus, and which have some features 
in common. They depend on the status of the host’s immune system, and 
it is usually not clear whether the exposure to Aspergillus occurred in the 
indoor environment or outdoors. These are allergic bronchopulmonary 
aspergillosis (ABPA), sinus disease secondary to the presence of Aspergil-
lus, and pulmonary aspergilloma (tumor in a lung cavity consisting of 
conglomerations of Aspergillus hyphae) (IOM 2004; Bush et al. 2006). 
ABPA affects patients with cystic fibrosis and less frequently those with 
asthma. The at-risk individuals have ongoing exposures caused by the 
ubiquitous nature of the fungi involved (Bush et al. 2006).
2.3.8 Other health disorders
Two case studies of clusters of rheumatic diseases associated with damp-
ness and mold have been reported, one in an office building (Myllykan-
gas-Luosujärvi et al. 2002) and another at a health center (Luosujärvi 
et al. 2003). The authors concluded that the underlying reasons for the 
accumulation of the rheumatic diseases remain elusive (Luosujärvi et 
al. 2003). An experimental study on human chondrocytes suggests that 
endotoxins may play a role in the pathogenesis of rheumatic diseases 
(Lorenz et al. 2006).
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Sarcoidosis, a granulomatous lung disease of unknown etiology, has 
been linked to exposure to microbial agents by some researchers (Park 
and Cox-Ganser 2011). A cluster of six cases of sarcoidosis was reported 
in a moisture-damaged office building with 1327 occupants (Laney et 
al. 2009).
Neither the report by IOM (2004) nor that by WHO (2009) found 
studies on the effects of exposure to building dampness and mold on 
reproductive health. The ingestion of mold-contaminated fodder has 
been shown to have reproductive toxicity in animals however.
Some mycotoxins are classified as carcinogenic or possibly carcino-
genic to humans on the basis of evidence on exposure through dietary 
consumption of, for example, mold-contaminated grain, maize, or nuts 
(IARC 1993; IARC 2002). There is no scientific evidence for an associa-
tion between the inhalation route of exposure to microbial agents indoors 
and cancers in humans (IOM 2004; WHO 2009).
2.3.9 mechanisms of health effects
The WHO expert group concluded that no single mechanism can 
explain the wide variety of effects associated with dampness and mold 
(WHO 2009). For the most part, the mechanisms through which adverse 
health effects develop are mainly unknown, although much toxicological 
research has been carried out. In vitro and in vivo studies have found 
diverse inflammatory, cytotoxic, and immunosuppressive responses after 
exposure to the spores, metabolites, and components of microbial species 
that appear in damp buildings. In addition, interactions between various 
microbial agents have been suggested by some studies. When the results 
of studies on experimental animals are being interpreted and attempts 
are being made to extrapolate the results to human exposures indoors, 
differences in relative doses should be considered. The exposures used 
for experimental animals may be orders of magnitude higher than those 
found in indoor environments (WHO 2009).
Inflammatory, non-allergic responses have been considered to play 
a central role in the development of health effects in damp buildings 
(Wolff 2011). The explanation is biologically plausible as health effects 
manifest as inflammation-related diseases, like asthma (WHO 2009). 
Increased levels of inflammatory mediators have been found in nasal 
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laval fluid and induced sputum from occupants of damp buildings 
(WHO 2009). The role of mycotoxins as a potential explanation for 
inflammatory responses has been studied. In a murine model, exposure 
to Stachybotrys chartarum induced lung inflammation characterized by 
the infiltration of neutrophils and lymphocytes, which was regulated by 
proinflammatory cytokines and leucocyte-attracting chemokines (Leino 
et al. 2003). The inflammatory responses were stronger in allergic mice 
and enhanced by S. chartarum exposure, the result suggesting that health 
effects associated with exposure to damp building molds may depend 
on the immunological status of the exposed person (Leino et al. 2006). 
Trichothecene mycotoxins (produced by S. chartarum), together with 
lipopolysaccharides, could synergistically activate inflammatory responses 
mediated by interleukin IL-1β and IL-18 in human macrophages (Kank-
kunen et al. 2009).
Many fungal species produce type I allergens, and IgE sensitization 
to the most common outdoor and indoor fungal species, like Alternaria, 
Penicillium, Aspergillus, and Cladosporium spp., is known to be strongly 
associated with allergic respiratory disease, especially asthma (Jaakkola 
et al. 2006b; WHO 2009; Knutsen et al. 2012). Fungal sensitization, 
particularly to A. fumigatus, is reported to be common in patients with 
severe asthma (Knutsen et al. 2012). SPTs and specific serum IgE tests 
are used to determine sensitization to various fungi (Knutsen et al. 
2012). Depending on the climatic conditions, 2.4%–12.6% of the 
general population and up to 39.4% of atopics have been shown to have 
IgE antibodies to Alternaria alternata (Leino 2006; Simon-Nobbe et al. 
2008). IgE sensitization to molds occurs generally in atopic persons as 
part of polysensitization (Bush et al. 2006; Simon-Nobbe et al. 2008). 
The occurrence of IgE-mediated sensitivity to common fungal allergens 
has been found to be rare, up to 2.8%, in Finnish patients with symptoms 
that suggested allergy (Reijula et al. 2003). Of the those exposed to damp 
buildings, only a small percentage develops allergies to molds (Immonen 
et al. 2001). In a study of the occupants of a water-damaged building, 
persons with post-occupancy onset asthma had a lower prevalence of 
positive reactions to molds in SPTs than persons with pre-occupancy 
onset asthma (Cox-Ganser et al. 2005). Fungi are also well-known 
sources of type III (or IgG-inducing) allergens. At high concentrations, 
fungi may be involved in combined type III and IV allergic reactions, 
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including allergic alveolitis (WHO 2009). A WHO expert group has 
concluded that one of the mechanisms underlying the health effects 
of exposure to indoor microbial agents may be IgE-mediated allergic 
responses (WHO 2009).
Whether mold or mycotoxin exposure can induce disorders of im-
mune regulation has also been considered. The increased frequency of re-
spiratory infections observed in some studies suggests immunosuppressive 
effects (WHO 2009). Several microbes or toxins have been shown to have 
immunosuppressive effects in vitro, and those of mycotoxins have been 
confirmed in experimental animals (WHO 2009). No toxicological data 
are available on autoimmune responses caused by microbes or microbial 
substances found in damp buildings (Bush et al. 2006; WHO 2009).
Many factors in indoor air in damp buildings are potentially irritative 
and many of the respiratory tract symptoms appear as irritative in na-
ture. Some authors have suggested a link between exposure to dampness 
and excess mold growth and the development of aeroirritant symptoms 
(Hope and Simon 2007). Especially, a strong association between VOCs 
and mucous-membrane irritation has been suggested by several studies 
(SCHER 2007; Salonen 2009). It has been reported that, except for a 
few known airway irritants like formaldehyde, the typical concentra-
tions of VOCs and mVOCs cannot explain the reported complaints 
in non-industrial work environments (Wolkoff et al. 2006).  However, 
there are large differences in the sensitivities to VOCs between persons 
(Salonen 2009).
The role of toxigenic mold species as a cause of health effects in 
damp indoor environments has remained controversial thus far (Yike 
and Dearborn 2011). The existing scientific information does not of-
fer sufficient evidence that could lead to a better understanding of the 
problem. Efforts have been made to find measurements to serve as suit-
able biomarkers of toxic mold exposure (Yike et al. 2006). Many animal 
studies on the pulmonary effects of a toxigenic mold, S. chartarum, have 
been published. In addition to inflammation, the common finding has 
been lung injury (Yike and Dearborn 2011). Recently, the remodeling 
of pulmonary arteries in mice has been described as a result of inhala-
tion exposure to the spores of S. chartarum (Nagayoshi et al. 2011). It 
is known that molds growing indoors are capable of producing toxins. 
The question is whether exposure to mycotoxins via inhalation occurs 
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in sufficient levels indoors to cause adverse health effects in humans. No 
study has thus far shown it (WHO 2009). The mechanisms are likely to 
be complex and multifactorial (WHO 2009). 
2.4 Asthma and its association to work
2.4.1 Overview of asthma
According to an international definition (GINA 2011), asthma is a 
chronic inflammatory disorder of the airways, which involves several 
inflammatory cells, like mast cells, eosinophils, and T-lymphocytes, as 
well as multiple mediators like chemokines and cytokines. In ways that are 
still not well understood, this pattern of inflammation is associated with 
airway hyper-responsiveness and recurrent episodes of asthma symptoms 
(wheezing, breathlessness, chest tightness, and coughing) particularly at 
night or in the early morning (GINA 2011). These episodes are usually 
associated with widespread, but variable, airway obstruction within 
the lung that is often reversible either spontaneously or with treatment 
(GINA 2011). Since the pathogenesis of asthma is not clear, much of 
its definition is descriptive, and the clinical spectrum varies. Factors that 
influence the risk of asthma can be divided into those that cause the 
development of asthma and those that trigger asthma symptoms. The 
former include host factors (which are primarily genetic), and the latter 
are usually environmental factors, like allergens, infections, and tobacco 
smoke. Occupational sensitizers belong in both categories (GINA 2011).
There is good evidence that the global burden of asthma was rising 
until 1990, while some recent findings suggest that the previous upward 
trend in asthma prevalence has reached a plateau in Western Europe 
(Bjerg et al. 2011). A survey from Helsinki, Finland, showed that the 
prevalence of physician-diagnosed asthma was 6.8% in 1996 and 9.4% 
in 2007 (Pallasaho et al. 2011). The annual incidence rate of asthma from 
1996 to 2007 was 3.7/1000 a year, being significantly higher for women 
(4.3/1000 a year) than for men (2.8/1000 a year) (Pallasaho et al. 2011).
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2.4.2 Asthma attributable to work
A recent review, based on longitudinal studies, indicated that a population 
attributable risk (PAR), also referred to as the population attributable 
fraction or the etiological fraction, for adult-onset asthma caused by oc-
cupational exposures is 16.3% (Torén and Blanc 2009). An attributable 
risk refers to the proportion of a disease that would not have occurred 
without a specific exposure. The range of estimates in single studies varies 
widely, but the authors of the review considered the most accurate range 
of the likely population burden of asthma attributable to occupational 
exposures to be at least 15% and potentially as high as 20% (Torén and 
Blanc 2009). The evidence underscores the potential for prevention and 
the need for actions to reduce the occupational exposure likely to lead 
to asthma.
A study covering all 25- to 59-year-old employed Finns without pre-
existing asthma followed three temporal cohorts for five (or three) years 
(Karjalainen et al. 2001). The onset of asthma was determined through 
the Medication Reimbursement Register of The Social Insurance Insti-
tution of Finland so that the cases had clinically well-established asthma. 
There were 49 575 incident cases of asthma. Exposure was defined on 
the basis of occupational titles and dichotomized into occupational ca-
tegories. The incidence rate ratios of asthma were estimated on the basis 
of a comparison between non-administrative work and administrative 
work. The incident asthma PAR associated with occupational exposure 
(non-administrative work) was 29% for the men and 17% for the wo-
men (Karjalainen et al. 2001). In a study based on the same material, 
an excess risk of asthma among men was found in occupations with no 
generally recognized risk, for example, among shoemakers (relative risk 
[RR] 2.79, 95% CI 1.58–4.93), smiths (RR 2.37, 95% CI 1.51–3.74), 
and chimney sweeps (RR 2.34, 95% CI 1.61–3.41) (Karjalainen et al. 
2002). In other population-based studies, an increased risk of asthma has 
also been found not only for occupations with exposure to traditional 
sensitizers, but also for occupations with exposure to respiratory irritants 
like cleaning products (Kogevinas et al. 2007), construction and textile 
mill dusts, welding fumes, solvents, and other chemicals (Arif et al. 2002). 
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2.4.3 Work-related asthma
At the individual level, asthma is work-related when there is an associa-
tion between symptoms and work. Work-related asthma (WRA) is the 
broad term that includes the following two categories: work-exacerbated 
asthma (WEA) which is exacerbated by inhalation exposures in the 
workplace, and occupational asthma (OA) which is induced by them 
(Tarlo et al. 2008; Baur et al. 2012) (Figure 2). The different types of 
WRA should be distinguished between, since the implications for the 
worker and the occupational health management of the disease differ 
(Nicholson et al. 2005).
 
Work-related asthma 
(WRA) 
Occupational asthma 
(OA) 
Work-exacerbated 
asthma (WEA) 
IgE-mediated 
occupational 
asthma 
OA due to specific 
occupational agents  
with unknown 
pathomechanisms 
Irritant 
occupational 
asthma 
Figure 2. Work-related asthma and its subgroups (Baur et al. 2012).
2.4.4 Occupational asthma
OA is the most common chronic occupational lung disease in most 
industrialized countries (Nicholson et al. 2005). It is defined as asthma 
that is caused by a specific workplace exposure to certain substances 
and not to factors outside the workplace (Bernstein et al. 2006a). OA 
involves IgE-mediated asthma after a latency period; asthma due to 
specific occupational agents with unknown pathomechanisms, which 
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also frequently show a latency period; and irritant asthma with or with-
out a latency period, including reactive airways dysfunction syndrome 
(RADS), which results from high exposure(s) (Baur et al. 2012) (Figure 
2). Almost 90% of the cases of OA have a particular type of latency pe-
riod (Nicholson et al. 2005), being either the outcome of sensitization 
to an inhaled protein (high-molecular-weight agent, e.g., flours, animal-
derived proteins, or enzymes) or chemical (low-molecular-weight agent, 
e.g., di-isocyanates, anhydrides, or cleaning agents) (Tarlo et al. 2008). 
Sensitization to proteins is typically IgE-mediated, whereas, for a large 
number of chemicals, the mechanisms of induction remain unknown 
and some induce asthma through an IgE mechanism (Bernstein et al. 
2006a). The published literature includes between 300 and 400 agents 
recognized to have caused OA, and many new agents are reported each 
year (Malo and Chan-Yeung 2009).
In many industries or occupations workers are exposed to multiple 
agents, to several high-molecular-weight agents, low-molecular-weight 
agents, and irritants (Malo and Chan-Yeung 2009). Typical such indus-
tries are health care, hairdressing, and farming (Malo and Chan-Yeung 
2009).
OA, as well as asthma in general, is a complex disease that results 
from multiple interactions between environmental factors and host 
susceptibilities. Atopy has shown to be an important risk factor for OA 
induced by high-molecular-weight agents. There is some evidence that 
genetic factors, such as leukocyte antigen class II alleles, are associated 
with an increased risk of OA (Vandenplas 2011).
Disease definitions vary from country to country, tending to reflect 
medical practices and medico-legal considerations (Henneberger et al. 
2011). Countries with well-developed occupational health care systems 
tend to have a broader coverage, and this diversity likely leads to higher 
estimates of occurrence (Jaakkola and Jaakkola 2012). The estimates 
from the incidence of OA from national surveillance systems range from 
20–23 cases per million people in countries such as France, the United 
Kingdom, and the United States, to around 200 cases per million in 
Finland (Kogevinas et al. 2007). The data from a population-based 
survey (European Community Respiratory Health Survey) produced an 
estimate of 250–300 cases of new-onset asthma per million people as a 
result of occupational exposures (Kogevinas et al. 2007).
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Case definition of occupational asthma
In every adult whose asthma begins or worsens while working, the pos-
sibility of WRA should be considered and evaluated (Tarlo et al. 2008; 
Baur et al. 2012). Due to the multitude of agents that are encountered 
by a worker, it can be very difficult to confirm OA and demonstrate 
causation by a specific agent (Bernstein et al. 2006b). The investigati-
on of OA has been compared to an investigation by Sherlock Holmes 
(Rioux et al. 2008).
Several international guidelines for the diagnostics of OA have been 
published (EAACI 1992; Nicholson et al. 2005; Fishwick et al. 2008; 
Tarlo et al. 2008; Baur et al. 2012), of which the evidence-based gui-
delines by the European Respiratory Society (ERS) Task Force are the 
most recent (Baur et al. 2012). The ERS Task Force report is intended to 
supplement other work-related asthma guidelines. It provides evidence-
based statements and recommendations for each diagnostic test, grading 
the level of evidence (Baur et al. 2012). Diagnostics is usually carried out 
in a stepwise fashion using an algorithm (Tarlo et al. 2008).
The ERS Task Force report reasons that, in the diagnostics, the degree 
of proof required depends on the consequences of OA development for the 
individual worker (Baur et al. 2012). If the worker is likely to lose his or her 
job, the specific agent causing OA should be identified, and, accordingly, if 
it is possible to relocate the worker away from exposure without economic 
losses, a precise diagnosis is less important (Baur et al. 2012). The ERS 
Task Force recommends that OA be confirmed by objective physiological 
tests and, in cases of allergic pathogenesis, by immunological tests (Baur 
et al. 2012). The diagnostic tools are presented in Figure 3.
Asthma is confirmed through the demonstration of bronchial 
obstruction in spirometry, of non-specific bronchial hyper-reactivity, or 
of increased diurnal variability in the peak expiratory flow (PEF) rates 
(GINA 2011). Sputum eosinophilia and exhaled nitric oxide may be 
helpful to confirm asthma. All of these tests may be normal in those with 
OA confirmed with specific challenge tests (Baur et al. 2012).
Respiratory symptoms that improve on days away from work or du-
ring holidays are the best screening method for possible OA (Baur et al. 
2012). Improvement in symptoms typically occurs in times away from 
work and worsens on days with regular or intermittent exposures at work 
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(Tarlo et al. 2008). The symptoms include cough, wheezing, dyspnea, 
and chest tightness, and they may be accompanied by or preceded by 
symptoms of rhinitis or conjunctivitis (Tarlo et al. 2008). The history 
should also identify detailed information about work status and exposure 
characteristics (Figure 3). The factors or exposures that worsen asthma 
symptoms should be assessed (Tarlo et al. 2008).
Measuring lung function in relation to work exposure is the best 
method of confirming OA (Baur et al. 2012), of which the serial me-
asurement of PEF on days at and away from work is the best validated 
method (Moore et al. 2010). It should be the first confirmatory test, as 
it can only be done when the patient is still exposed to the suspected 
cause of the symptoms (Baur et al. 2012). Acceptable PEF series can be 
obtained for around two-thirds of those for whom a diagnosis of OA is 
being considered (Nicholson et al. 2005). The sensitivity and specificity 
of serial PEF measurements is high in the diagnosis of WRA (Moore et 
al. 2010; Baur et al. 2012). Workplace challenges are an alternative, but 
they are not standardized and lack external validation (Rioux et al. 2008).
Changes in non-specific bronchial hyper-responsiveness at and 
away from work have only moderate sensitivity and specificity for the 
diagnosis of WRA, nor are pre- to post-shift changes in lung function 
(by spirometry) recommended (Baur et al. 2012). There is only limited 
evidence for the use of measuring airway inflammation (induced sputum 
cell counts or exhaled nitric oxide) in the investigation of WRA (Tarlo 
et al. 2008; Baur et al. 2012).
The specific agent can be identified either by immunological testing 
or testing with a specific inhalation challenge (SIC) (Figure 3). Sensiti-
zation to occupational agents is investigated with immunological tests, 
either SPTs or serum measurements of specific IgE (Tarlo et al. 2008). 
For many low-molecular-weight agents, specific IgE measurements are 
not available. The ERS Task Force has stated that the presence of specific 
IgE in a worker with confirmed OA from workplace measurements is 
sufficient to identify the specific cause (Baur et al. 2012).
SIC testing is regarded as the gold standard for confirming the specific 
cause of OA (Vandenplas et al. 2006; Baur et al. 2012). The ERS Task 
Force has stated that SIC is the best method for confirming a specific 
cause of OA when workplace measurements are not possible or specific 
IgE measurements are not available (Baur et al. 2012). The tests consist 
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of exposing a worker in a laboratory to a possible offending agent and 
monitoring the airway caliber (Vandenplas et al. 2006). False negative 
SIC tests do occur (Rioux et al. 2008); therefore a negative test for a 
worker with otherwise good evidence of OA is not sufficient to exclude 
the diagnosis (Nicholson et al. 2005). In addition, false positive reac-
tions are possible; there are individuals who have been shown to have 
non-specific reactions to SICs at concentrations likely to be found in 
the workplace (Nicholson et al. 2005). 
Figure 3. Diagnostic tools for the evaluation of work-related asthma, 
adapted from the American College of Chest Physicians Consensus State-
ment (Tarlo et al. 2008) and the European Respiratory Society Task Force 
report (Baur et al. 2012). 
1. Assessing asthma
•	 Medical history
•	 Symptoms – onset / nature / timing
•	 Spirometry and bronchodilator response
•	 Bronchial hyperresponsiveness (histamine or methacholine challenge test)
•	 Diurnal variation in peak expiratory flow
•	 Sputum eosinophilia
•	 Exhaled nitric oxide
2.  Assessing exposures / factors that can cause or exacerbate asthma
•	 Occupational history
- allergens, irritants at work
- exertion, cold, infections
- type of work process / setting
- ventilation / use of respiratory protection
- material safety data sheets
- co-workers – symptoms
- magnitude / timing of exposures
•	 Environmental history
- pets, hobbies, home exposures, ambient air pollution
3. Assessing relationship between asthma and work
•	 Tests that identify the workplace as the cause of respiratory symptoms
- Respiratory symptoms that improve on days away from work or  
during holidays
- Serial PEF monitoring
- Bronchial hyper-responsiveness / spirometry / assessment of airway 
inflammation (induced sputum, exhaled nitric oxide) – changes   
related to work
- Workplace challenges 
•	 Tests that identify the agent causing work-related asthma
- Immunological tests (specific IgE, skin prick tests)
- Specific inhalation challenge tests (SIC)
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2.4.5 Work-exacerbated asthma
The term WEA refers to asthma triggered by various work-related factors 
in workers with pre-existing or concurrent asthma (Tarlo et al. 2008) 
(Figure 2). Instead of WEA, some authors use the term work-aggravated 
asthma (Baur et al. 2012).
Exacerbations of asthma symptoms are common and belong to the 
natural course of asthma (Enriquez-Matas et al. 2007; GINA 2011). 
While exacerbation is often attributed to viral infections or failures in 
therapy, environmental conditions also make a substantial contribution. 
A wide variety of conditions at work can exacerbate asthma symptoms, 
like dusts, irritant chemicals, second-hand smoke, common allergens 
that are not specific to the work environment, low or high temperatures, 
strong emotions, stress, odors, and physical exertion (Henneberger et 
al. 2011).
In a Finnish population-based, cross-sectional, questionnaire survey, 
21% of the 969 asthmatics that were currently employed reported WEA 
symptoms at least weekly during the past month (Saarinen et al. 2003). A 
recent review resulted in a median prevalence of 21.5% for WEA among 
adults with asthma, on the basis of epidemiological studies involving 
general populations (Henneberger et al. 2011).
Although WEA is probably common, it has received much less sys-
tematic study than OA (Tarlo et al. 2008). Interest has been increasing 
in the 2000s, however. It has been discovered that the socioeconomic 
impacts of WEA (in terms of unemployment, reduction in income, 
productivity loss) and the clinical characteristics (level of severity, medi-
cation needs) are at least as severe as those of OA (Henneberger et al. 
2011). The recent American Thoracic Society statement summarizes 
that, compared with asthma unrelated to work, WEA is associated with 
more symptomatic days, a greater utilization of health-care resources, 
and a lower quality of life (Henneberger et al. 2011). It has also been 
suggested that WEA may be associated with higher rates of symptoms 
and exacerbations than asthma unrelated to work (Vandenplas and 
Henneberger 2007).
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Case definition of work-exacerbated asthma
Confirming WEA depends on 1) clarifying that a person has asthma and 
2) demonstrating a relationship between work exposures and asthma 
exacerbations, most commonly documented by changes in symptoms 
or medication use temporally related to work (Tarlo et al. 2008; Hen-
neberger et al. 2011). Improvement in asthma symptoms while off work 
or on vacation is however not specific to WEA (or OA), as patients with 
other asthma can also feel better when not at work (Tarlo et al. 2008). 
For a more accurate diagnosis, more objective tests are needed.
Identification of a specific causative agent for WEA is often not 
possible, and mixed exposures are common (Henneberger et al. 2011). 
Identification is however important not only for confirming WEA, but 
also for reducing or eliminating harmful conditions to prevent future 
problems for the index case worker and co-workers (Henneberger et al. 
2011).
In clinical practice, WEA can be identified as a ”byproduct” of OA 
investigations after OA has been excluded. In settings where SIC is 
commonly used, a case is classified as OA if the test results are positive 
and as WEA if the results are negative (Henneberger et al. 2011). In a 
Canadian study, more than half of the WEA (SIC negative) cases had 
serial PEF measurements that were more variable for work than for away 
from work (Chiry et al. 2007). Immunological tests and assessments of 
work-related changes in spirometry or metacholine responsiveness may 
be helpful in the diagnostics (Tarlo et al. 2008).
2.4.6 Asthma-like symptoms
Clinics investigating occupational asthma have often found that workers 
referred for suspected WRA turn out to have respiratory symptoms only, 
without asthma. In a Canadian study conducted in a clinic specialized in 
the field of WRA, 57.5% of the patients with work-related respiratory 
symptoms did not have asthma (Chiry et al. 2009). A high proportion 
of both those with work-related symptoms and WRA were employed 
in work environments with respiratory irritants such as dust, vapors, 
solvents, and welding fumes (Chiry et al. 2009). In a British study, the 
corresponding figure was 40.4% (Fishwick et al. 2007). 
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In addition to asthma, several recognizable causes of chronic lower 
respiratory symptoms, such as chronic obstructive pulmonary disease 
(COPD), infections, lung cancer, sarcoidosis, idiopathic pulmonary 
fibrosis, and heart failure, will be obvious after clinical examinations 
(Pavord and Chung 2008). Other common conditions to be consid-
ered are, for example, gastroesophageal reflux disease, medication with 
angiotensin-converting enzyme (ACE), chronic sinusitis or rhinitis, and 
postnasal drip syndrome (also called upper-airway cough syndrome) 
(Pavord and Chung 2008). A spectrum of clinical responses may occur 
after exposure to occupational and other environmental irritants and 
odors (Tarlo et al. 2008).
Vocal cord dysfunction (VCD) is one of the work-related laryngeal 
syndromes important in the differential diagnostics of asthma. VCD can 
be difficult to clinically differentiate from asthma, and the conditions 
co-exist. It has been reported that 33%–56% of patients have VCD 
accompanying asthma. The syndrome is characterized by paroxysms 
of glottic obstruction due to vocal cord adduction primarily during 
inspiration, resulting in symptoms like dyspnea, cough, and hoarseness. 
The diagnosis is confirmed with laryngoscopy, but it often remains un-
recognized. A psychological origin for VCD has been established, but 
it may be also induced by, for example, gastroesophageal reflux disease, 
nonspecific airway irritants, chemicals, odors, and exercise (Morris and 
Christopher 2010). A recent review of work-related laryngeal syndromes 
highlights the fact that occupational exposures such as upper-airway 
irritants may be associated with the onset of symptoms of VCD (Hoy 
2012). A broader term, work-associated irritable larynx syndrome, in-
cluding VCD, dysphonia due to laryngeal muscular tension, globus, and 
chronic cough, has also been introduced (Hoy et al. 2010). The symp-
toms are often provoked by odors that would not usually be associated 
with asthma exacerbation, they usually start immediately on exposure, 
and they are not usually controlled by asthma medication, even at high 
doses (Hoy et al. 2010). People with this syndrome are more likely to 
be female (Hoy et al. 2010).
Exposures to irritants or odors can lead to asthma-like symptoms with 
cognitive complaints similar to those of multiple chemical sensitivity 
(MCS), also known as idiopathic environmental intolerance (Tarlo et 
al. 2008; Dalton and Jaen 2010). The symptom variety is broad and can 
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be divided into three groups, those affecting the central nervous system, 
those affecting the respiratory system, and those affecting the gastroin-
testinal system. The symptoms overlap with several symptom complexes, 
for example, the chronic fatigue syndrome, fibromyalgia, and also SBS 
(NICNAS and OCS 2008). The sufferers of MCS attribute it to expo-
sure to low levels of a wide variety of environmental chemicals, which 
are well-tolerated by most of the population. The efforts for chemical 
avoidance limit their access to environments where such exposures may 
occur, such as grocery stores, libraries, community meetings, and offices 
(Gibson and Lindberg 2011). Therefore, it may be a difficult problem 
to manage in the workplace (Dalton and Jaen 2010). The available re-
ports suggest that there is no typical dose–response reaction following 
exposure to triggering agents. No medical consensus exists on whether 
MCS symptoms are due to a psychological response to perceived chemi-
cal toxicity or to a physiological–pathological interaction between the 
chemical agents and organ systems. The most credible physiological 
mechanism is sensitization of the olfactory, limbic, mesolimbic, and re-
lated pathways in the central nervous system (NICNAS and OCS 2008). 
The prevalence in the general population varies between 0.2% and 4% 
in studies that have reported the prevalence of medically assessed MCS, 
whereas the prevalence range is 15%–36% in studies that have reported 
the prevalence of chemical sensitivity or reactions to chemicals. There 
are no international diagnostic criteria, even though several attempts 
have been made to establish diagnostic criteria for MCS (NICNAS and 
OCS 2008). The diagnosis is currently based on self-reported symptoms.
The term airway sensory hyper-reactivity has been used to describe 
patients with pronounced airway sensitivity to environmental irritants 
like odorous chemicals and scents, but without asthma or allergy, and 
who have increased sensitivity to inhaled capsaicin (Millqvist 2011). A 
suggested explanation for the condition is hyper-reactivity of the sen-
sory nerves of the entire airways. It is regarded as a discrete entity from 
MCS and is reported to affect more than 6% of the adult population of 
Sweden (Millqvist 2011).
In some studies, lower respiratory symptoms, cough, wheezing, and 
dyspnea, as well as chest tightness in the absence of lung function distur-
bances compatible with asthma, have been called asthma-like inflamma-
tion and even pre-asthma (Haahtela 1999; Rytilä et al. 2008). Patients 
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suffering from this condition run a markedly increased risk of developing 
asthma (Puolijoki and Lahdensuo 1987; Remes et al. 1998). In particular, 
recurrent or persistent cough has been considered a harbinger of future 
asthma (Puolijoki and Lahdensuo 1987; Dicpinigaitis 2006).
2.4.7 Prevention of work-related asthma
OA is unique in that it is the only type of asthma that is readily prevent-
able (Nicholson et al. 2005). In fact, as all WRA is potentially preventable, 
better prevention efforts are needed to diminish the burden of WRA 
worldwide (Tarlo et al. 2008). Prevention can be classified as primary, 
secondary, or tertiary. Primary prevention consists of reducing hazards 
before disease or damage has occurred, secondary prevention is aimed 
at preventing advanced disease by intervening early in the course of the 
disease (e.g., at a preclinical or very early stage), and tertiary prevention 
provides treatment for advanced disease (Tarlo et al. 2008).
The reduction or elimination of work exposures can be accomplished 
in several ways and can contribute to all levels of prevention (Henneberger 
et al. 2011). The actions include modifying, isolating, or enclosing the 
process to eliminate the asthma trigger or asthmogen, substituting  a 
new agent for common causative ones, improving ventilation, educat-
ing workers about avoidance maneuvers, and finally, using respiratory 
personal protective devices (Tarlo et al. 2008; Henneberger et al. 2011). 
There is much evidence to indicate that exposure elimination is the 
strongest preventive approach to reducing the disease burden of WRA 
(Baur et al. 2012). Therefore it is the preferred primary prevention ap-
proach (Baur et al. 2012). 
From the perspective of secondary prevention, the ERS Task Force 
recommends early recognition and diagnosis of WRA, as there is evidence 
that a shorter symptomatic period after diagnosis is associated with a 
better outcome (Baur et al. 2012). Medical surveillance at high-risk 
worksites plays an important role in secondary prevention by identifying 
cases early (Henneberger et al. 2011). 
The guidelines for clinical practice recommend that further exposure 
to the cause be avoided as soon as OA has been diagnosed (Nicholson et 
al. 2005; Tarlo et al. 2008). A Cochrane Collaboration Review Group 
recently concluded that both the removal and reduction of exposure 
64
2 Review of the liteRatuRe
reduces asthma symptoms significantly when compared with continued 
exposure (de Groene et al. 2011). Total removal from exposure led to the 
disappearance of asthma symptoms and job loss or an appreciable loss of 
income significantly more often than the reduction of exposure did (de 
Groene et al. 2011). Most data were available for low-molecular-weight 
agents, and the quality of the reviewed studies was considered low (de 
Groene et al. 2011). In addition, another systemic review found evidence 
that the reduction of exposure is associated with a less beneficial effect on 
asthma outcome than complete avoidance is (Vandenplas et al. 2011).
OA is usually a persistent disease once it has developed. A systematic 
review of 39 original publications with a median follow-up of 31 months 
suggested that only one-third of patients with OA recover completely 
from their asthma despite avoiding exposure to the initiating agent 
(Rachiotis et al. 2007).
While the best option for managing OA has been shown to be com-
plete avoidance of exposure, it is recommended that the management 
of WEA focus on reducing work exposures and optimizing standard 
medical management. If these measures are not successful, a change of 
job may be an option (Henneberger et al. 2011).
According to the ERS Task Force, the pharmacological treatment of 
WRA should be adapted to the level of asthma control, in accordance 
with the general recommendations for asthma (Baur et al. 2012). One 
study found that regular treatment with inhaled corticosteroids seemed 
to prevent respiratory deterioration over a 3-year period among patients 
with OA still exposed to the work environment cause of their disease 
(Marabini et al. 2003).
2.4.8 Compensation practices for occupational   
 asthma in finland
In Finland, employers must insure their employees against work accidents 
and occupational diseases through the statutory accident insurance sys-
tem (TVL 2011). Those self-employed often have voluntary insurance. 
The statutory accident insurance is defined by law and is operated by 13 
private insurance companies, with the exception of insurance for farmers, 
which is provided by the Farmers’ Social Insurance Institution and that 
for state employees, which falls under the sphere of the State Treasury. 
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Compensation for occupational diseases takes priority over other forms 
of social insurance (TVL 2011). Because the cost liability through the 
insurance belongs to the employer, it is regarded as an incentive for 
preventive activities enhancing occupational safety (Tola 2004).
According to the Occupational Diseases Act, an occupational disease 
is a disease that is probably primarily due to physical, chemical, or biolo-
gical factors associated with work done during a period of employment, 
and it therefore must be compensated in accordance with accident in-
surance legislation (Ammattitautilaki 1988). The Occupational Diseases 
Ordinance gives a sample list of causative factors and typical forms of the 
diseases they may cause (Ammattitautiasetus 1988). In addition diseases 
not on the list can be compensated, as a general clause system is in use 
according to which any disease that can be proven to be due in all pro-
bability to work can be considered an occupational disease (TVL 2011). 
The compensation benefits include medical examinations, costs of 
treatment, medical rehabilitation, inconvenience allowance and, in cases 
of work disability, vocational rehabilitation, and compensation for loss 
of earnings in connection with the disease (Tola 2004, TVL 2005). The 
costs of the medical examinations needed to establish the existence of an 
occupational disease are paid in full, even when the examinations do not 
prove the disease to be occupational. The examination must, however, 
be based on a suspicion of an occupational disease by a physician who 
knows the work conditions, and the employee must be exposed at work 
to an agent capable of causing the occupational disease in question. If 
the disease is accepted for compensation, the benefits are usually better 
than they would be for a non-occupational disease covered by general 
social security (Tola 2004). Medical treatment expenses (e.g., medicines 
and medical examinations) are compensated up to their full amount 
without one’s own risk, and without a time or cost limit. Benefits for 
vocational rehabilitation are also good and the system facilitates rapid 
initiation of rehabilitation measures. A change of occupation may be 
supported with, for example, a work trial or retraining, during which 
full accident pension (or daily allowance, if not more than one year has 
passed since the disease occurred) is paid. When the worker transfers to 
another, more suitable job without harmful exposure, but with a lower 
salary, 85% of the difference is compensated. Only a 10% reduction in 
work capacity is required to get compensation for income loss due to an 
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occupational disease (compared with a requirement of at least a two-fifth 
reduction to get a partial disability pension due to a non-occupational 
disease). The pension for total disability is 85% of the former annual 
earnings of the worker, and 70% after the age of 65. In comparison, in 
general social insurance, the pension is usually no more than 60% of the 
former annual earnings. If the disease results in permanent functional 
impairment, an inconvenience allowance is paid. Various injuries and 
illnesses are grouped into 20 disability categories according to their 
seriousness. In categories 1–10, the allowance is a lump sum, and, in 
higher categories, the worker can choose between continuous and lump 
sum compensation (Tola 2004, TVL 2011).
In Finland, compensation benefits for OA are paid if a specific agent 
at work is the probable main causative factor of asthma. Proving causa-
lity means extended examinations, including exposure assessment and 
medical history. In practice, the relationship between the specific agent 
and asthma is usually identified by SIC testing or, sometimes alterna-
tively, by demonstrating sensitization to a known sensitizer and serial 
PEF measurements (Nordman et al. 1999; Piipari and Keskinen 2005).
2.5 Recognition of occupational asthma   
 induced by indoor dampness and mold
Estimates of work-related asthma, including OA, come from population-
based studies. Another approach with which to obtain estimates of the 
incidence of OA is to use the existing national surveillance systems, which 
are based on reporting by physicians or data from compensation schemes, 
or a combination of these (Finland), or on self-reporting by individuals 
(Sweden). Great differences exist in the reported incidences between 
countries. The comparability of the reports is poor, as the reporting of 
data is influenced by diverse national legislation and compensation sys-
tems and no common definition of OA or classifications for occupations 
and causative agents have been used (Nordman et al. 1999).
Eurostat (the statistical office of the European Union) collects data on 
recognized cases of occupational diseases from national authorities in the 
European Union (European occupational diseases statistics). However, 
data are not yet available as a means for matching the quality criteria 
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for coverage and comparability (Eurostat 2011). The differences in the 
reporting level and national compensation practices have a remarkable 
impact in these data, and the figures observed are influenced not only by 
the real incidence of the diseases, but also by other factors (Karjalainen 
and Niederlaender 2004). 
2.5.1 Occupational asthma induced by indoor    
 dampness and mold in finland
The coverage of the Finnish occupational reporting system is regarded as 
one of the most complete in the world, producing high incidence rates of 
OA, namely, 174 new cases per million workers yearly (years 1989–1995) 
(Karjalainen et al. 2000). The high incidence of reported OA in Finland 
is likely to be a consequence of comparatively good compensation levels 
(Karjalainen et al. 2000). Each new recognized or suspected case of an 
occupational disease is registered by the Finnish Register of Occupatio-
nal Diseases (FROD), which is maintained by FIOH. The data come 
from the compensation system (the Federation of Accident Insurance 
Institutions and the Farmers’ Social Insurance Institution). The OA cases 
are diagnosed and notified by central hospitals, as well as FIOH (Piipari 
and Keskinen 2005).
According to FROD, the most common causative agent for OA has 
been molds since 2001 (Piipari and Keskinen 2005). Until then, about 
half of the cases of OA were reported among farmers, the causative 
agents being animal epithelia, hair and secretions, or flours, grain and 
fodders (Karjalainen et al. 2000). The OA cases in farming decreased 
after Finland joined the European Union in 1995, when the number 
of active farms began to dramatically decrease (Piipari and Keskinen 
2005). Figure 4 shows the annual numbers of OA induced by molds 
and the total number of OA cases in 1992–2010. From 1995 on, an 
increased number of OA cases caused by molds has been notified. The 
increased figures represent white-collar employees without exposure to 
traditional work-related sensitizing agents, but who work in moisture-
damaged buildings (Piipari and Keskinen 2005). Due to changes in the 
data collection and principles regarding compensation (following the 
renewal of the Accident Insurance Act), the data for 2005–2010 should 
not be directly compared with earlier FROD data (Oksa et al. 2010; 
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Oksa et al. 2011). Therefore, trends cannot be reliably assessed for OA 
induced by molds. Due to the arrangements regarding changes in data 
collection, FROD did not register cases in 2003 and 2004.
The annual numbers of OA cases caused by molds have been higher 
since from 2005 than earlier, probably due to the aforementioned 
reasons. Earlier, the insurance companies only received OA notifications 
of verified cases from hospital pulmonary clinics. Since 2005, the hos-
pitals have been able to invoice the insurance companies for the costs of 
medical examinations (Lehtinen and Rahkonen 2004), and this change 
in procedure has probably increased the activity of notifying cases, in-
cluding suspected ones. In recent years, the quality of the data coming 
to FROD has improved and therefore has allowed a better classification 
of the cases (Oksa et al. 2011). As a result, some of the cases that had 
earlier been classified in the group ”others” have been classified as OA 
in recent statistics (Oksa et al. 2011). This development explains the 
substantial rise in OA cases in 2009, which is reflected in both the total 
and mold-caused figures (Oksa et al. 2011).
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Figure 4. The recognized and suspected cases of occupational asthma caused by 
molds listed in the Finnish Register of Occupational Diseases (FROD) in 1992–2010. 
The figures for the years 2003–2004 are not available. The data for 2005–2010 
should not be directly compared with earlier FROD data (Source: FROD).
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In 2008–2010, FROD published the number of cases approved for 
compensation by the insurance companies. Of all suspected OA cases, 
105 (16%) were compensated in 2008 (Oksa et al. 2010), 150 (18%) 
in 2009 (Oksa et al. 2011), and 102 (13%) in 2010 (Oksa et al. 2012). 
Of the cases suspected of being caused by molds, 40 (16%) were com-
pensated in 2008, 73 (20%) in 2009, and 27 (9%) in 2010 (source: 
FROD; unpublished data). It can be calculated that, in 2008, 38% of 
all the compensated OA cases were caused by exposure to molds, the 
corresponding figures being 49% for 2009 and 26% for 2010.
2.5.2 Occupational asthma induced by indoor    
 dampness and mold in other countries
From a clinical case series of occupational health clinics in New York 
State, poor indoor-air quality or molds were suggested as causative 
agents in over one-fifth of the cases of new-onset OA (Fletcher et al. 
2006). The material comprised altogether 214 cases in 1988–1999 in an 
area with 8.4 million employed adults. The diagnosis of OA was based 
on a health-care professional’s diagnosis of asthma and an association 
between symptoms of asthma and work, and, in addition, either work-
place exposure to an agent or process previously associated with asthma 
or objectively verified work-related changes in lung function or airway 
responsiveness (Matte et al. 1990).
The data from the Sentinel Event Notification System for Occupa-
tional Risks (SENSOR) Program from four states in the United States 
– California, Massachusetts, Michigan, and New Jersey – indicated that, 
in a list of the 10 most frequently reported agents associated with new-
onset OA and RADS in 1993–2003, indoor pollutants were on top, 
with 1047 cases (Bernstein et al. 2006c). In the four SENSOR states, 
the educational services industry was the third most frequently reported 
industry associated with WRA in 1993–2000 (Mazurek et al. 2008). 
New-onset OA was diagnosed for 182 persons, caused by indoor-air 
pollutants in 64 cases and by molds in 32 cases (Mazurek et al. 2008). 
The cases were ascertained using the same criteria as described earlier. 
Workers’ compensation claim data were not used. The objectives of the 
SENSOR Program are to identify potentially harmful sentinel cases in 
various occupational settings, and, consequently, to initiate investigations 
70
2 Review of the liteRatuRe
and implement preventive interventions in such workplaces, and not 
primarily to estimate disease frequency (Matte et al. 1990). 
In Quebec, Canada, the diagnostics resemble those of Finland in that 
OA diagnoses are ascertained with a high degree of probability, often 
with an SIC test (Piipari and Keskinen 2005; Bernstein et al. 2006c). 
Molds were not among the recognized causative agents of compensated 
OA in Quebec in 1988–2002 (Bernstein et al. 2006c).
In a Belgian survey, new-onset cases of OA were gathered by voluntary 
reporting from pulmonary and occupational specialists during a period 
of three years (2000–2002) (Vandenplas et al. 2005). Seven cases of a 
total of 260 were reported to be caused by molds, but the source of the 
molds was not described (Vandenplas et al. 2005). The ”Observatoire 
National des Asthmes Professionnels” (ONAP) program in France is a 
monitoring system for OA that is based on voluntary reporting of oc-
cupational and chest physicians, who reported 24 cases of OA suspected 
to be induced by molds, of a total of 2359 cases in 1996–1999 (Ameille 
et al. 2003). Likewise, as in the Belgian report, there was no indication 
of building-relatedness to mold (Ameille et al. 2003).
The data on OA frequency from national surveillance schemes of 
other European countries, found in a literature search, indicate that 
indoor-air factors or mold are not among the most frequently reported 
causative agents of OA (Leira et al. 2005; McDonald et al. 2005; Orri-
ols et al. 2006; Paris et al. 2012). Statistics on occupational diseases in 
Norway are based on physicians’ notifications to the Labour Inspection 
Authority, obliged by law, and 1508 cases of OA in 1995–1999 were 
reported (Leira et al. 2005). In the United Kingdom, the Surveillance 
of Work-Related and Occupational Respiratory Disease (SWORD) 
scheme receives reports on new occupational lung diseases from special-
ists in occupational or respiratory medicine all over the country, and, 
for 1992–2001, the result was an annual average number of cases of OA 
cases of 604 (McDonald et al. 2005). From Catalonia, Spain, a total of 
174 cases of OA were reported during one year (2002) by the voluntary 
reporting of occupational and chest physicians and other specialists (Or-
riols et al. 2006). The French national network of occupational health 
surveillance and prevention (comprising 32 occupational health depart-
ments located in university hospitals) reported 2914 cases of WRA in 
2001–2009, with no differentiation between OA and WEA (Paris et al. 
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2012). None of the aforementioned reports referred to molds or other 
indoor-air factors (Leira et al. 2005; McDonald et al. 2005; Orriols et 
al. 2006; Paris et al. 2012).
2.6 Symptom persistence after exposure to  
 building dampness and mold
According to clinical experiences, non-specific, building-related symp-
toms usually improve or disappear when people are away from the build-
ing, but long-lasting symptoms appear to be common for some people 
(Edvardsson et al. 2008; Al-Ahmad et al. 2010). There are otherwise no 
known long-term adverse health effects. However, little has been pub-
lished about the long-term health effects of exposure to building damp-
ness and mold. The same facts that hamper the gathering of evidence 
on health effects in general also hamper the gathering of evidence on 
long-term health effects, for example, difficulties in defining exposure, the 
non-specific nature of symptoms that overlap other conditions, and also 
the lack of objective biomarkers that show a relation between symptoms 
and indoor exposures. In a Swedish study, long-lasting, building-related 
symptoms were found 1–13 years after the diagnosis (Edvardsson et al. 
2008). The researchers followed a total of 189 patients, 92% of whom 
were female and who had been examined at an occupational and environ-
mental clinic because of building-related symptoms. Almost half of the 
patients had been exposed to environments with visible water damage, 
and the rest to environments with other indoor-air quality problems. 
Nearly half of the patients claimed that their symptoms were unchanged 
after 7 years or more, despite actions taken at the workplace. The symp-
toms were often aggravated by different situations in everyday life, such 
as visiting a shop or using public transportation. One-fifth of the patients 
were on disability pension due to persistent symptoms. On the basis of 
their findings, the authors concluded that a subgroup of patients who 
are clinically diagnosed as having a non-specific building-related illness 
had long-lasting symptoms that had a significant impact on their social 
life (Edvardsson et al. 2008).
A Canadian group followed a total of 32 adult patients seen in To-
ronto Western Hospital asthma, allergy, or occupational lung disease 
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clinics (Al-Ahmad et al. 2010). The patients had asthma or asthma-like 
symptoms attributed to exposures to mold, including S. chartarum, 88% 
of them having symptoms at work. Seventeen patients, six of whom had 
previous asthma, returned questionnaires after a mean follow-up of 3.1 
(SD 0.5) years. The symptom spectrum was compared with symptoms of 
a patient group previously assessed for “darkroom disease” (sick building 
type symptoms). Among the mold-exposed group, persisting asthma-like 
symptoms and non-specific symptoms were frequent. The researchers 
concluded that at least a subgroup of mold-exposed persons had long-
term respiratory symptoms that cannot be explained on the basis of 
asthma. Non-specific symptoms attributed to mold exposure appear to 
represent findings similar to SBS, but are persist despite removal from 
or remediation of mold exposure (Al-Ahmad et al. 2010). 
Some knowledge on long-term health effects is available from in-
tervention studies, which study the effectiveness of remediating build-
ings damaged by dampness and molds in order to reduce or prevent 
symptoms. The studies vary with respect to their study designs and have 
differing outcome measures, and both the persistence and alleviation of 
symptoms after building repairs have been reported. A Cochrane Col-
laboration Review Group found very low-quality evidence that repairing 
moisture-damaged houses and offices decreases asthma-related symptoms 
and respiratory infections when compared with no intervention among 
adults, as well as very low-quality evidence that repairing schools did not 
significantly change the respiratory symptoms among the staff (Sauni 
et al. 2011).
A study by Rudblad et al. (2002) suggested that nasal hyperreactivity 
due to moisture damage may persist and only slowly decrease for years. 
After a 2-year follow-up, nasal mucosal hyper-reactivity to histamine was 
still higher among teachers in a renovated moisture damage school than 
among teachers in a control school. The difference between the groups 
was smaller than at the baseline (Rudblad et al. 2002).
Respiratory symptoms may also persist despite building repairs. One 
year after remediation among 56 teachers of three moisture-damaged 
schools, fatigue and headache were significantly reduced but respiratory 
symptoms did not improve (Patovirta 2004a). In another study by the 
same authors, a 3-year follow-up after building repairs was conducted 
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among 27 teachers in a moisture-damaged school and among 12 teach-
ers in a non-damaged control school. No decrease in respiratory symp-
toms was detected in either school during the follow-up (Patovirta et 
al. 2004b). With a same type of study design (controlled before–after), 
Åhman et al. (2000) found a post-intervention disappearance of excess 
symptoms after 7 months among 44 teachers who were compared with 
29 teachers in a control school.
A 3-year follow-up of a 97-person cohort in a water-damaged office 
building found that substantial remediation did not result in an overall 
improvement of respiratory health, as reflected by symptom scores, 
overall medication use, spirometry abnormalities, or sick leave (Iossifova 
et al. 2011).
Haverinen-Shaughnessy et al. (2008) reported seven case studies of 
buildings that underwent moisture and mold damage remediation in 
order to develop methodology for assessing the success of the remedia-
tion process. Health effects studies (based on self-reported health status) 
after 6–12 months of follow-up showed improvement in one case (after 
moving to another building), partial improvement in two cases, and no 
improvement in two cases, even though the remediation was considered 
technically successful. No follow-up was conducted in one case, and in 
one case, the follow-up failed due to a low response rate. The authors 
hypothesized that the reason for the persistence of symptoms could be 
that the remediation was only partially successful and, in one case, that 
the extended duration of the remediation process could have created 
additional stress among the occupants and therefore affected perceived 
health (Haverinen-Shaughnessy et al. 2008).
Jarvis and Morey (2001) did not find improvements in respiratory 
symptoms 4 months after occupants of a large office building were 
relocated to a dry building. Four years later, before the re-occupation 
of the remediated building, the respiratory symptom prevalences had 
decreased when compared with the prevalences before the relocation, 
but they were still double when compared with those of the comparison 
population (Jarvis and Morey 2001).
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2.7 Concepts for evaluating health and   
 well-being in this thesis
2.7.1  Illness and disease
By simplifying, patients suffer illnesses while physicians diagnose and 
treat diseases. Disease is a pathological process or a combination of 
pathological abnormalities that, at least in theory, is amenable to objec-
tive external verification (Coggon 2005). Illness is a subjective state, an 
absence of well-being. Commonly diseases make a person feel ill. On the 
other hand, disease may not have an impact on well-being, or a person 
may feel ill in the absence of any objective evidence of underlying disease 
(Coggon 2005).
According to a WHO expert committee (1985), work and health 
interact in many ways. Work often plays a role in promoting both physi-
cal and mental health. Physical, chemical, and biological occupational 
hazards, if they exceed tolerable limits, are recognized causative factors 
of occupational diseases. There is a direct cause-and-effect relationship 
between hazard and disease in occupational diseases. The relationship 
to specific causative factors at work can be established, and the factors 
concerned can be identified, measured, and eventually controlled (WHO 
1985). Occupational diseases differ from one country to another, as they 
are defined according to national legislation.
The work environment can play a role, together with other risk fac-
tors, in the development of diseases with a complex multiple etiology 
(WHO 1985). Such diseases can be called work-related. In addition 
to the fact that work-related diseases can be partially caused by work, 
they may also be aggravated, accelerated, or exacerbated by workplace 
exposures, and they may impair work capacity. Personal characteristics 
and other environmental and sociocultural factors usually play a role 
as risk factors for these diseases. Work-related diseases are much more 
common than occupational diseases (WHO 1985).
2.7.2 Disability
According to WHO (2001), when an individual experiences a decre-
ment in health, he or she thereby experiences some degree of disability. 
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The International Classification of Functioning, Disability and Health 
(ICF) of WHO provides a framework for the description of health and 
health-related states and disability (WHO 2001). The ICF is based on 
the biopsychosocial model of disability into which medical and social 
models of disability have been integrated (WHO 2001). The medical 
model of disability views disability as a feature of a person, directly caused 
by disease, trauma, or other health condition, that requires medical or 
other treatment or the elimination of the pathological cause, to “correct” 
the problem with the individual. The social model sees disability as a 
socially created problem and not at all as an attribute of an individual. 
The perspective of both models is too narrow alone to define the complex 
phenomenon of disability.
The ICF views disability and functioning as outcomes of interactions 
between health conditions and contextual (environmental and personal) 
factors (Figure 5). In the ICF, the term functioning refers to all body 
functions (physiological, including psychological functions), activities, 
and participation, while disability is similarly an umbrella term for im-
pairments (problems in body function or structure), activity limitations, 
and participation restrictions (WHO 2001).
Figure 5. The WHO model of disability (WHO 2001).
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According to the ICF, disability involves dysfunctioning in one or 
more of three domains (impairments, activity limitations, and restricted 
participation). In clinical terms, impairment in asthma refers to a decre-
ment in lung function below an expected norm, determined through 
physiological testing. There are multiple approaches to the physiological 
testing of lung function, both at rest and in exercise, the most conven-
tional of which are spirometry and airway hyper-responsiveness (Ber-
nstein et al. 2006c). The impairment in lung function may have only 
minor adverse consequences for a person when asthma is controlled with 
appropriate treatment (GINA 2011). Medication use and symptom se-
verity are clinical measures that provide information for asthma control. 
Activity limitations in asthma are difficulties in executing such activities 
as climbing stairs, hurrying, or carrying or moving objects. Participation 
restrictions are problems a person may experience in involvement in life 
situations, which, in asthma, could mean restrictions involving household 
cleaning, hobbies, or visiting friends or restrictions in the performance 
of work tasks. Disability does not mean a total loss of functioning in 
any of the three domains, but is a continuum.
Chronic diseases produce symptoms of varying severity and affect pa-
tients’ assessments of their health status. Traditional methods of assessing 
health through physiological and clinical practice do not provide insight 
into a person’s well-being. There is evidence showing that correlations 
between clinical measures and how people are able to function in daily 
activities are only weak to moderate (Juniper 1999).
2.7.3 Quality of life
Quality of life (QOL) has emerged as an important outcome in health 
research. It is used to describe the function and well-being of popula-
tions with medical conditions (epidemiological perspective) and as an 
outcome criterion for treatment interventions (clinical perspective) 
(Heinonen et al. 2004). 
The term QOL is intuitively familiar, but it is often vaguely used 
without conceptual clarity. In the medical literature, investigators fre-
quently use QOL as an interchangeable term for health status (McDowell 
2006), although there is criticism that one should not do so because the 
constructs are distinct (Smith et al. 1999). The term health-related QOL 
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is often used. It originated to distinguish outcomes relevant to health 
research from earlier sociological research on subjective well-being and 
life satisfaction in general populations (Smith et al. 1999). Health-related 
QOL is meant to capture the experience of health and disease from the 
viewpoint of the individual (Blanc 2004).
A starting point for defining QOL in health research is the WHO 
classic definition of health as ”a state of complete physical, mental and 
social well-being, and not merely the absence of disease or infirmity” 
(WHO 1948). Therefore, many of the QOL scales cover at least the 
physical, emotional, and social dimensions of health. Furthermore, as 
with the WHO classification of disability and health, the ICF stresses 
functioning alongside of health (WHO 2001); also components related 
to functional health status have become apparent in QOL assessment. 
As a consequence, QOL is generally recognized as a multi-dimensional 
construct including the following four broad dimensions: physical well-
being, functional well-being, mental or emotional well-being, and social 
well-being (Heinonen et al. 2004). 
There is a range of instruments for measuring QOL, as different scales 
have been developed for different purposes. In health research, QOL 
measures are divided into two main types, condition or disease-specific, 
and generic (Juniper 1999). 
The specific instruments may be specific for a group of patients (e.g., 
the elderly), a particular function (e.g., pain, sexual function), or a dise-
ase (Juniper 1999). Asthma-specific instruments measure the problems 
and limitations that patients with asthma experience in their everyday 
lives (Juniper 1999). Examples of asthma-specific instruments are the 
Asthma Quality of Life Questionnaire (AQLQ) (Juniper et al. 1993) and 
the Marks Asthma Quality of Life Questionnaire (Marks et al. 1992). 
The strength of generic instruments is their ability to be used for 
comparing the health status of patients with different conditions. 
They are also useful for monitoring patients with multiple conditions 
and for comparing patients with the general population (McDowell 
2006). Among the most commonly used and the best validated generic 
instruments are the Medical Outcomes Survey Short Form 36 (SF-36 
or RAND-36) (Ware and Sherbourne 1992; Hays et al. 1993), the 
Nottingham Health Profile (NHP) (Hunt et al. 1981), and the Sickness 
Impact Profile (SIP) (Bergner et al. 1981). Shorter versions of some of 
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these original instruments are available, for example, the Short Form 
Health Survey-12 Questionnaire (SF-12) (Ware et al. 1996).
In addition, there are QOL instruments that are classified as global 
(or general) on the basis of a single item. The Visual Analogue Scale 
(VAS) is an example of a global instrument in which patients indicate 
their QOL on a line from 0 to 100 while considering an overall view 
of the QOL (de Boer et al. 2004). A global measure is simple and easy 
to use, but too rough for certain purposes, for example, for comparing 
treatments. Therefore, a single-item measure is often accompanied by 
multi-item questionnaires (de Boer et al. 2004).
Others types of QOL instruments, valuable in health economics, are 
utility-based measurements allowing cost-utility analyses in health care, 
often used for estimating quality-adjusted life years (QALYs) (Räsänen 
et al. 2006).
Finally, QOL is defined by WHO as ”individuals’ perceptions of 
their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards 
and concerns” (WHO 1995). The WHO definition highlights the view 
that QOL is subjective, includes both positive and negative facets of life, 
and is multi-dimensional (WHO 1995).
2.7.4 Work ability and work disability
In the Western world, work disability has become a major public health 
and economic concern. Work disability is usually defined as time off 
work, reduced productivity, or working with functional limitations as a 
result of either traumatic or non-traumatic clinical conditions (Schultz 
et al. 2007).
The concept work ability concentrates on “something that exists” 
(Gould et al. 2008), whereas (work) disability is explained as “something 
that restricts or limits” (Martimo 2010). Work ability is not necessarily 
dependent on health, although health is considered one of the most 
important work ability determinants (Gould et al. 2008). According to 
definitions, work ability can be related to a deterioration in health or to 
other resources of the worker, to factors related to work and the work-
place, or even to the environment outside work (Ilmarinen and Tuomi 
2004; van den Berg et al. 2009). Ilmarinen (2006) has illustrated the 
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dimensions of work ability in the form of a work ability house (Figure 
6). The first three floors, the resources of the individual, form the core 
structures of the house. The fourth floor is that of work. In the imme-
diate surroundings of the work ability house are the family and close 
community, and the outermost layer is society. The term work ability 
has often been used in the context of promoting or maintaining work 
performance. Different indicators of work ability have been developed 
with the aim of detecting deteriorating work ability as early as possible 
in order to prevent work disability (Gould et al. 2008). Work ability 
studies use outcomes like self-rated work ability, work ability index, or 
early retirement plans.
Figure 6. Dimensions of work ability from the point of view of human 
resources, work, and the environment. The diagram is based on Ilmar-
inen’s (2006) Work Ability House Model (Lundell et al. 2011).
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3 AImS Of ThE STuDY
This thesis is based on four studies. The aim of each study below is fol-
lowed by a rationale that includes the hypothesis that was tested.
1. To assess and develop methods for the diagnostics 
of occupational asthma (OA) induced by workplace 
dampness and mold (study I).
The hypothesis of the study was that molds, as known sensi-
tizers, induce new-onset adult asthma in people who work in 
damp and moldy environments. When the study was being 
planned, there was only limited epidemiological evidence of 
an association between exposure to indoor dampness and 
mold and new-onset asthma. 
2. To assess whether prolonged asthma-like symptoms 
appearing in relation to workplace dampness and mold 
lead later to the development of asthma (study II).
The hypothesis of the study was that workers who display 
prolonged symptoms suggestive of asthma, but whose lung 
function is normal, may later run an increased risk of devel-
oping clinical asthma. And if so, to study whether continued 
exposure to workplace dampness has an impact on the devel-
opment of asthma.
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3 Aims of the study
3. To evaluate long-term effects on the quality of life of 
workers with asthma related to damp indoor work 
environments (study III).
Based on clinical experience, the hypothesis was that asthma 
related to damp and moldy workplaces is persistent, and 
patients experience substantially deteriorated health and 
well-being.
4. To evaluate long-term effects on work ability and re-
lated factors of workers with asthma in damp indoor 
work environments (study IV).
The hypothesis was that workers with asthma related to damp 
indoor work environments commonly have long-term work 
disability, along with persistent symptoms. In particular, the 
aim was to study whether OA leads to impaired work ability 
and whether persistent indoor-air symptoms or social factors 
at work have an impact on work ability.
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4.1 Description of the source population
The basis for the studies was the 2200 workers who had been referred 
to the Finnish Institute of Occupational Health (FIOH) in the period 
1995–2004 because of a suspicion of an occupational respiratory disease 
(Figure 7). All of them had work-related respiratory symptoms appearing 
in workplaces with suspected moisture and mold damage. The symptoms 
consisted of upper- or lower-airway symptoms, or both. The workers had 
been referred to FIOH from all over Finland, mainly by occupational 
health physicians or pulmonologists.
Figure 7. The patient material.
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4 Materials and Methods 
The FIOH examinations had included exposure assessments, detailed 
occupational and medical histories, and advanced clinical examinations. 
For the evaluation of the workplace conditions, reports on technical 
inspections, quality measurements of the indoor air, and structural mea-
surements of the workplace had been requested from the workplace. In 
addition, the work environments had been described in the referrals by 
the physicians, and the information had been corroborated in interviews 
with the patients.
The medical history of the patients had been taken to assess the 
symptoms. The work-relatedness of the symptoms had been investigated 
by asking the patient if the symptoms appeared or worsened at work or 
improved away from work. The medical records of previous examina-
tions had been acquired.
The patients who had complained of work-related symptoms com-
patible with asthma (cough, dyspnea, wheezing) had been clinically 
assessed with respect to possible OA. The investigations had included 
the assessment of specific sensitization to moisture-damage microbes, 
lung function tests, histamine challenge tests, serial recordings of peak 
expiratory flow (PEF), and specific inhalation challenge (SIC) tests with 
commercially available mold extracts. The possibility for other diseases, 
like allergies, chronic sinusitis, or chronic obstructive pulmonary disease 
(COPD), had been assessed.
In the beginning of 2007 (3–12 years after the initial examinations), 
the patients were followed up with the use of a questionnaire. Those with 
a definitive other-than-building-related cause for their symptoms (66 
patients) were not included in the follow-up. In addition, 20 patients 
had died during the follow-up. Altogether 1295 of the 2114 persons 
participated (61%) (Figure 7).
The non-respondent analysis showed that compared with the non-
respondents, the participants were older [mean age 54.3 (SD 9.2) years 
versus 52.0 (SD 9.5) years], more often female (87% versus 84%), and 
more often diagnosed with OA (10% versus 6%). The frequency of WEA 
at baseline was similar for the participants and the non-respondents.
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4.2 Study population
Retrospective review of the patients (study I). In study I, a retrospective 
review was conducted of the patients who were suspected of having OA 
caused by workplace dampness and molds. In the period 1995–2004, 
SIC was a routine procedure used to demonstrate an association between 
asthma and indoor molds. Therefore the patients were selected for the 
analysis from the 694 patients for whom SIC had been carried out. In-
formed consent to review patient files was obtained from 676 patients. 
For 425 (63%) of them, acceptable serial PEF records were available.
The 676 patients were placed into three categories according to the 
probability of OA. The discharge diagnosis given to the patient by FIOH 
was not considered. Instead, the patient files were reviewed clinical data, 
and the diagnostic criteria presented in Table 4 were used. The criteria 
were consistent with the international diagnostic criteria for OA (Fish-
wick et al. 2008). Thus 156, 45, and 475 patients were categorized as 
Table 4. Criteria used for allocating patients into different categories 
according to the probability of occupational asthma (OA). 
Probable Possible Unlikely
Exposure to indoor-air 
molds at work
Yes Yes Yes
Work-related asthma 
symptoms
Yes Yes Yes
Onset of symptoms or 
asthma temporarily 
associated 
with work in a 
moisture-damaged 
environment
Yes Yes Yes
Asthma diagnosed Yes Yes Yes or asthma-
like symptoms 
only
Serial PEF measure-
ments at and away 
from work and a 
specific inhalation 
challenge (SIC) test
PEF measure-
ments compat-
ible with OA 
and/or 
positive SIC
PEF measure-
ments sugges-
tive of OA and 
negative SIC
PEF measure-
ments incon-
sistent with 
OA (or not 
performed) 
and negative 
SIC
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having probable, possible, or unlikely mold-induced OA, respectively. 
The clinical details of the 201 patients with probable or possible OA 
and those of a sample of patients (57 of 475) unlikely to have OA were 
reviewed. The sample was randomly selected from those for whom an 
acceptable serial PEF record was available. In all, particulars of 258 
patients were reviewed. 
For study I, the patient files concerning the follow-up visit 6 months 
after the baseline examinations were also reviewed. Of the patients cat-
egorized as having probable mold-induced asthma, most (136 of 156) 
had participated in the follow-up examinations.
Follow-up questionnaire studies (II–IV). Studies II–IV were based 
on the follow-up questionnaire in 2007, 3–12 years after the baseline 
examinations (Figure 7). The design of studies II–IV was cross-sectional.
In study II, the study group was comprised of 483 respondents who 
fulfilled the following inclusion criteria: 1) work-related asthma-like 
symptoms (cough, dyspnea, wheezing) without objective evidence of 
asthma in the initial examinations, 2) exposure to indoor dampness or 
molds or both at work before the initial examinations, 3) absence of 
indoor dampness at home (as reported by the patients in the initial ex-
aminations), and 4) asthma having never been diagnosed earlier. “Work-
related symptoms” signified symptoms repeatedly appearing or worsening 
at work or improving away from work. Patients whose asthma had been 
diagnosed prior to the investigations at FIOH were likewise excluded. 
The absence of clinical asthma was ascertained from the medical records 
of all the patients finally included in the study group.
In studies III and IV, the 28 respondents were first excluded who were 
diagnosed with alveolitis in the baseline examinations. Thereafter, the 
study population in study III consisted of 1267 respondents. In study 
IV, to examine work limitation among the persons of a typical working 
age, the analyses were restricted to the respondents who were under 65 
years of age. Thus the study population in study IV consisted of 1098 
respondents.
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4.3 Exposure assessment (study I)
In study I, an experienced indoor-air researcher made a retrospective 
evaluation of each patient’s exposure at work by classifying the inten-
sity of microbial exposure on the basis of the available information in 
the patient case records. The documents usually included reports on 
damage to the building structure and, in most instances, microbial 
measurements. The moisture damage and microbial growth had been 
described by indoor-air researchers with a background in construction 
engineering and occupational safety or health service personnel. In most 
cases, material samples had been analyzed for the presence of microbes, 
which had been identified. In addition, air samples had been taken for 
the measurement of microbial air concentrations with six-stage impac-
tors. In the assessment of microbial exposure, only winter measurements 
were considered in the study, as fungal concentrations in outdoor air in 
the winter are very low in subarctic countries like Finland. The personal 
exposure was classified into the following four categories of exposure to 
microbes: low, intermediate, high and not classifiable (Table 5).
The exposure time was calculated on the basis of the first date of 
employment in a moisture-damaged building, the time the water dam-
age occurred, whenever known, or the date when moisture damage had 
been first reported. The duration of exposure was estimated as <1 year, 
1–5 years, 6–9 years, and ≥10 years.
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Table 5. Classification of personal exposure to microbes.
Classification Definition
Low An adequate and reliable description of mold damage was 
available. Single, small mold damage of < 0.5 m2 was found 
in the patient’s workspace, or limited mold damage (< 1 m2) 
was detected in the patient’s work environment near the 
permanent workspace.
Intermediate An adequate and reliable description was available of the 
mold damage, the damaged areas were limited in number 
and size (< 1 m2), and the total viable concentrations 
were <100 cfu/m3  for airborne fungi and <10 cfu/m3 for 
actinobacteria. Fungal species requiring high water activity 
were not dominant in the environmental samples.
High An adequate and reliable description of the extent of  
microbial growth (>1 m2) was reported, or the total viable 
concentrations of airborne fungi were > 100 cfu/m3, or the 
level of airborne actinobacteria was > 10 cfu/m3, or fungal 
species requiring high water activity were dominant in 
the environmental samples. This category usually included 
extended moisture and mold damage, for example, in the 
base floor.
Not classifiable The evidence of exposure to microbes was inadequate or 
unreliable. Investigations of moisture and mold damage or 
indoor air measurements had not been undertaken or were 
not available in the patient files, or the exposure data were 
not associated with the patient’s work area.
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4.4 Clinical examinations (study I)
Assessment of sensitization. To assess sensitization to molds, skin prick 
tests (SPTs) and measurements of specific serum immunoglobulin (Ig) 
E had been carried out using methods reported previously (Ceska and 
Lundkvist 1972; EAACI 1989).
The SPTs had been carried out with combinations of 29 different com-
mercially available mold allergens (ALK-Abelló A/S, Copenhagen, Den-
mark) with histamine hydrochloride (10 mg/mL) as a positive control. A 
positive reaction indicating sensitization was defined as a weal diameter 
of ≥3 mm that was equal to or greater than half of that of the histamine 
reaction. Mold-specific serum IgE antibodies had been determined for 
the same mold species, if available, using Pharmacia CAP system RAST 
RIA (Pharmacia, Uppsala, Sweden) until 1996; thereafter the UniCAP 
system (Pharmacia & Upjohn, Uppsala, Sweden) was introduced and 
used. Specific IgE values of >0.35 kU/L were defined as positive.
Sensitization to common environmental allergens had been tested 
by SPT with the following allergens (ALK-Abelló A/S, Copenhagen, 
Denmark): pollens of birch, alder, timothy, meadow foxtail, mugwort 
and dandelion; epithelia of horse, dog, cat and cow; dust mites (Der-
matophagoides farinae, Dermatophagoides pteronyssinus); and molds A. 
alternata and Cladosporium herbarum. Atopy was defined as the patient 
having had at least one positive SPT reaction.
For the purpose of study I, atopic history was defined as the patient 
having had infantile eczema, atopic dermatitis, hay fever, non-occupa-
tional allergic rhinitis, or allergic asthma.
Lung function measurements. Flow-volume spirometry had been 
carried out at FIOH with a pneumotachograph spirometer connected to 
a microcomputer (Medikro 909 or Medikro 904; Medikro Ltd, Kuopio, 
Finland). Spirometry had been performed according to guidelines of the 
European Respiratory Society (Quanjer et al. 1993). The bronchodilator 
test had been carried out with either rimiterol hydrobromide or (from 
1997) salbutamol sulfate. An increase of 15% or 200 mL in the forced 
expiratory volume in 1 s (FEV1) and an increase of 33%, or at least 0.4 
L/s, in maximum mid-expiratory flow were regarded as significant. The 
histamine challenge testing had been performed according to the method 
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described by Sovijärvi et al. (1993). The provocative dose of inhaled his-
tamine aerosol causing a 15% fall in FEV1 (PD15) was measured. The 
hyper-responsiveness was graded as strong (PD15 <0.10 mg), moderate 
(PD15 0.11–0.40 mg), or mild (PD15 0.41–1.6 mg). The single breath 
diffusion capacity for carbon monoxide and specific diffusion capacity 
had been measured by a Masterlab Transfer or a Compact Lab Transfer 
device using Finnish reference values (Viljanen et al. 1982). 
Serial PEF monitoring. Serial PEF monitoring at and away from 
work had been carried out according to Burge (1993). PEF graphs had 
been drawn, and the diurnal variations had been calculated (the daily 
maximum minus the daily minimum divided by their mean), the in-
terpretation of the PEF values being based on direct visual analysis and 
supported by the percentage decreases in PEF. When the patients were 
allocated into the diagnostic categories of probability, the following prin-
ciples were adopted: 1) PEF record compatible with OA = ≥20% diurnal 
variation on at least two workdays and relatively more often on workdays 
than on non-workdays (Liss and Tarlo 1991; Tarlo et al. 2008); 2) PEF 
record suggestive of OA = no diurnal variations exceeding 20% but the 
lowest recordings on workdays, or a ≥20% change longitudinally across 
workdays with decreasing values towards the end of the work period; 
3) PEF record not compatible with OA = <20% diurnal variation with 
no marked difference between the workdays and non-workdays; 4) PEF 
record indicating asthma lability = ≥20% diurnal variation both at and 
away from work.
SIC tests. The challenge tests had been carried out according to in-
ternational guidelines (Cartier et al. 1989; EAACI 1992). Commercial 
freeze-dried allergen extracts of A. fumigatus, Acremonium kiliense, and 
Cladosporium cladosporioides (for a few tests C. herbarum) had been used 
(ALK-Abelló). They had been the only mold extracts commercially avail-
able for bronchial inhalation tests during the study period. The mold 
species used for the SIC tests had been selected primarily among the 
species identified in the microbial samples from the workplace. If none 
of the available species had been identified, the testing had been started 
with A. fumigatus extract. During the 1990s, an increased serum level 
of IgG antibodies to molds had been used for selecting fungal allergens 
for the SIC. At the time, IgG antibodies had been considered a proxy 
90
4 Materials and Methods 
for exposure. Allergen extracts diluted with ALK solvent (ALK-Abelló) 
had been inhaled with the use of an inspiratory synchronized dosimetric 
device (Spira Electro 2; Spira Respiratory Care Center Ltd, Hämeenlinna, 
Finland) with the following settings: driving pressure 0.2 kPa (2 bars), 
inhalation time 0.8 s, starting volume 50 mL, inspiratory flow 0.5±0.1 
L/s, and amount of allergen mixture 0.8–1.0 mL. The used starting 
allergen dilution had been 1:10 000–1:1000 weight/volume (wt/vol) 
depending on the severity of the patient’s symptoms and the strength 
of the sensitization. The allergen dose had been increased 5- to 10-fold 
every 15 minutes if the patient did not react to the previous dose, until 
the dilution of 1:5 wt/vol had been achieved. The control tests had been 
carried out with the pure diluent.
After the challenge, the FEV1 and PEF values had been followed using 
a pocket-size spirometer (One Flow; STI Medical, St Romans, France) 
for 24 hours according to a protocol described previously (Keskinen et 
al. 1996). A decrease in FEV1 or PEF of ≥15% from the pre-challenge 
value during the first hour after the challenge was regarded as a significant 
immediate reaction. The criterion for a late reaction was a drop of ≥20% 
after more than 1 h after the challenge. A combination of these reaction 
types was considered a dual reaction. A prerequisite for a positive test was 
the absence of a significant reaction (≥10%) to a control SIC test with 
the pure diluent. The axillary temperature had been routinely followed 1 
h and 4 h after the SIC, once in the evening and once the next morning.
4.5 Diagnostic criteria of asthma    
 (studies I and II)
The diagnostic criteria used for asthma were 1) significant improvement 
(≥15% and at least 200 mL) in the FEV1 or forced vital capacity (FVC) 
in response to short-acting bronchodilating medication in a broncho-
dilator test or 2) a repeated daily variation of ≥20% or improvement of 
≥15% (and at least 60 L/min) in response to short-acting bronchodilating 
medication in a 2-week diurnal PEF follow-up.
91
4 Materials and Methods 
4.6 Questionnaire (studies II–Iv)
Asthma development during the follow-up (study II). The develop-
ment of new-onset asthma during the follow-up period was established 
by the question “Have you been diagnosed with asthma by a physician 
after the examinations at FIOH?”
In order to validate the self-reported asthma diagnoses of the ques-
tionnaire study, all those who had reported having received a physician’s 
diagnosis of asthma were contacted. The patients were interviewed by 
phone and asked for written consent to study their clinical files, which 
were acquired from respective hospitals and physicians. The same afore-
mentioned diagnostic criteria for asthma (Section 4.5) were used in the 
assessment of the medical records.
Quality of life (study III). For health-related QOL, the validated 
Short Form Health Survey-12 Questionnaire (SF-12) (Ware et al. 1996) 
was used; it consists of 12 items that measure physical and mental di-
mensions of health. It allows for the calculation of the following two 
summary scores: a physical component score (comprised of questions 
on physical functioning, role limitation due to physical health problems, 
bodily pain, and general health) and a mental component score (ques-
tions on vitality, social functioning, role limitation due to emotional 
health problems, and mental health). The respondents were also asked to 
evaluate their QOL on a visual analogue scale (VAS) (0—100), which is 
a single-item instrument with good validity in measuring QOL (de Boer 
et al. 2004). It is simple to perform and relies on the patient’s ability to 
form an overall judgment of QOL.
Work ability outcomes (study IV). As an indicator of work ability, 
the participants were asked to estimate their current work ability compared 
with their lifetime best on a scale from 0 to 10. A score of 0 represented 
full work disability and a score of 10 indicated work ability at its best. The 
question is an item included in the Work Ability Index (WAI), which is a 
validated tool for measuring self-assessed work ability (Tuomi et al. 1998). 
Those who were on pension were not permitted to answer this question.
Withdrawal from work was used as another, more severe outcome 
than perceived work ability. The criteria for withdrawal from work were 
1) early retirement because of disability (being on disability pension 
or on a workers’ compensation pension), or 2) unemployment. In the 
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Finnish social security system, a disability pension is paid to a person 
who is incapable of work due to illness, handicap, or injury. Disability 
caused by an occupational disease or a work accident entitles workers 
to a compensation pension.
Exposure continuation (study II). The assessment of continued 
exposure to workplace dampness was based on a questionnaire inquiry 
into the measures taken at the workplace and, in cases of relocation, the 
presence of building-related indoor dampness in the new work environ-
ment.
Asthma medication (study III). The current need for asthma medi-
cation was inquired about as an estimate of asthma severity. The respon-
dents were asked to name the pharmaceutical products they regularly 
used to treat asthma. The need for asthma medication was grouped as 
1) no need for regular asthma medication, 2) inhaled steroid alone, 3) 
inhaled steroid combined with a long-acting beta-agonist or leukotriene 
antagonist, 4) a combination of all of the three medicine groups. 
The number of oral steroid bursts needed to control asthma during 
the past year was also asked. The following four categories of the number 
of steroid bursts were created: 1) no need during the past year, 2) once 
a year, 3) twice a year, 4) more often.
Long-term indoor air-symptoms (study IV). Whether or not 
indoor-air symptoms had been long-lasting was inquired into by the 
question “How much do the same symptoms that were initiated in the 
moisture-damaged workplace bother you nowadays?” The respondents 
were asked to rate the following 14 symptoms on a scale from 1 (not at 
all) to 5 (very much): eye irritation, hoarseness, nasal congestion, rhi-
norrhea, sneezing, sinus symptoms, dyspnea, cough, wheezing, fatigue, 
fever and chills, dermal symptoms, arthralgia or myalgia, and headache. 
Ratings 1–3 were considered non-significant (= 0) and only ratings 4–5 
(much or very much) were taken into consideration (= 1). A symptom 
sum variable with four categories was constructed as 0 = no significant 
long-term symptoms, 1–3 symptoms, 4–5 symptoms, or >5 long-term 
indoor-air symptoms.
Social climate at work (study IV). Social climate at work was mea-
sured by three items adapted from the General Nordic Questionnaire 
(QPSNordic) (Lindström et al. 2000). It is a validated tool measuring 
psychological and social factors at work. The given question was “What 
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was the climate like in your workplace with moisture problems?” with 
the following alternative responses 1) “encouraging and supportive”, 2) 
“relaxed and comfortable”, 3) “rigid and rule-based”. The scale ranged 
from 1 (little or not at all) to 5 (very much). The Cronbach’s alpha (a 
measure of the internal consistency) was 0.85. A sum variable was cal-
culated, with the third item reverted. The sum variable was grouped into 
the following three equal-sized categories: poor, moderate, and good. 
Supervisor’s cooperation (study IV). With three items, the respon-
dent’s experiences with the supervisor’s cooperation were inquired about. 
Non-validated items were used as no established questionnaire for the 
issue was available. Responses were requested to the following statements 
on a scale from 1 (disagree totally) to 5 (agree totally): 1) “The supervi-
sor reacted appropriately when I suspected workplace dampness as a 
cause of my symptoms”; 2) “The supervisor took measures to investigate 
the damage in a reasonable time”; 3) “The supervisor took measures to 
remediate the damage in a reasonable time”. The Cronbach’s alpha was 
0.91. A sum variable was calculated, and it was grouped into the three 
equal-sized categories of low, intermediate, and high.
Anxiety and depression (studies III and IV). For psychological 
status, the widely used 14-item Hospital Anxiety and Depression Scale 
was employed (Zigmond and Snaith 1983). This scale is a brief screening 
instrument. It was selected because its items avoid any reference to physi-
cal symptoms. Seven questions relate to anxiety and seven to depression, 
with total scores for both subscales in the range of 0—21. A value of ≤7 
is interpreted as nonclinical, 8—10 indicate possible clinical relevance, 
and values of ≥11 show important relevance.
Somatization (studies III and IV). Tendencies towards somatiza-
tion were measured with a 12-item somatization subscale (SCL SOM) 
from the Hopkins Symptom Checklist (SCL-90) (Derogatis et al. 1973). 
This subscale is widely used and screens for multiple physical symptoms, 
focusing on cardiovascular, gastrointestinal, and other systems with 
autonomic mediation. The Finnish version of the subscale has been 
validated (Holi et al. 1998).
Hypochondria (study III). To measure the cognitive or emotional 
dimension of somatization, hypochondriasis, the 7-item version of the 
Whiteley Index (Whiteley-7) was used (Fink et al. 1999). It reflects the 
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patient’s health anxiety, beliefs, and fears of illness and the attribution of 
physical sensations to physical illness. The responses for both symptoms 
and beliefs were rated on a 5-point Likert scale (not at all – very much).
Background variables (studies II–IV). On the basis of job titles, 
the respondents were classified into the following occupational groups: 
upper white-collar (e.g., managers and senior officials, teachers, physi-
cians, and other professionals), lower white-collar (e.g., nurses, secretaries, 
office and customer service clerks, and technicians), and blue-collar (e.g., 
cleaners, cooks, kitchen helpers, hospital ward assistants, door keepers, 
repairmen, and machinery mechanics) employees.
Atopic history was defined as a history of infantile eczema or atopic 
dermatitis, hay fever, or other allergic rhinitis or conjunctivitis.
Current symptoms (studies II and III). The prevalence of current 
respiratory symptoms was estimated by rating each symptom (cough, 
dyspnea, and wheezing) on a scale of severity ranging from 1 (not at 
all) to 5 (very much). In study III, ratings 1–3 were considered non-
significant (= 0), and only ratings 4–5 (much or very much) were taken 
into consideration (= 1).
Co-morbid conditions (studies II–IV). The respondents were 
asked to mark a list for the presence or absence of their current chronic 
diseases or injuries diagnosed by a physician. The conditions included 
accidental injury, musculoskeletal disease, cardiovascular disease, mental 
disorder, endocrine or metabolic disease, neurological or sensory disease, 
malignancy, and other disease (Tuomi et al. 1998). Respiratory diseases 
were excluded. Co-morbidity was classified as 1) no, 2) one, or 3) two 
or more chronic conditions.
4.7 Statistical analyses
The proportional data in the studies were compared using the chi-square 
test or Fisher’s exact test. In study II, the severity of the symptoms at 
the follow-up displayed a non-normal distribution. Therefore, when the 
symptom severities were compared among those still exposed and those 
unexposed, the Wilcoxon two-sample test was used. The significance 
level was always set at 0.05.
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Logistic regression analysis was used for studying the association 
between atopy in the SPTs and IgE mold sensitization in study I. 
Multiple logistic regression analyses were used to determine the risk 
estimates in the studies in which the outcome variable was dichoto-
mous. The odds ratios (OR) with 95% confidence intervals (95% 
CI) are presented.
The data in studies III and IV included both categorical and continu-
ous variables. In the preliminary study, there was a need to determine 
whether the study groups (i.e., those who had OA, WEA, asthma-like 
symptoms, or upper-respiratory symptoms) differed from each other. 
When the differences between the groups were compared, chi-square tests 
for categorical variables and the one-way analysis of variance (ANOVA) 
for the means of continuous variables were used. However, the main 
interest was to examine the associations between the determinants and 
the outcome variables. At first, the associations were studied through 
the application of cross-tabulations. After these preliminary studies, 
models were built. 
In study III, the physical and mental component scores and the 
QOL on the VAS scale were used as the outcome variables. All of the 
outcome variables were considered continuous, and linear regression 
models were applied. As some explanatory variables were categorical and 
some continuous, the analysis of covariance (ANCOVA) was applied. 
The model building strategy was to add independent variables step by 
step into the model. Only the results of the last models with estimates, 
standard deviations (SDs), and p-values are presented.
Before the modeling in study IV, the outcome variables were dichoto-
mized. The outcome variable for self-assessed work ability was dichoto-
mized as follows: 0–7 = “poor”, 8–10 = “good”. The outcome variable 
“early withdrawal from work” was dichotomized as no/yes. With the use 
of models, the goal was to estimate the risks for reduced self-assessed work 
ability and “early withdrawal from work”. Logistic regression analyses 
were used when the associations were examined between the different 
explanatory factors and the dichotomized outcome variables. The model 
strategy was as follows: in the beginning, the univariate models were 
estimated using asthma group, number of long-term indoor-air symp-
toms, and social climate at work or cooperation of the supervisor as an 
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explanatory variable. Then, through the addition of potential confound-
ers into the models, multivariate regression models were estimated. The 
ORs with their 95 % CIs have been presented.
All of the analyses were performed using SAS 9.1 (SAS Institute Inc., 
Cary, NC, USA).
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5.1 Retrospective review of the patients   
 suspected with occupational asthma   
 (study I)
Patient characteristics and symptoms. The mean age of the study 
patients was 45.2 (SD 8.4, range 23–61) years. Altogether 90% of the 
patients were female. Prior to the investigations at FIOH, asthma had 
been diagnosed and regular medication initiated for 195 (76%) of the 
patients. In addition to asthma symptoms, the patients had reported 
symptoms such as eye irritation and hoarseness. General symptoms, 
including fatigue and a sensation of elevated temperature, had also been 
reported (Table 6). The mean duration of the respiratory symptoms be-
fore the asthma diagnosis was 3.2 (SD 3.0, range 0–17.0) years. Of the 
patients, 65% were life-long nonsmokers, 12% were ex-smokers, and 
23% were current smokers.
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Exposure. According to their work histories, all of the patients had been 
exposed to molds. In most instances (66%), the exposure had taken 
place in schools, hospitals, various office environments, or day-care 
centers. Correspondingly, most of the patients were teachers, nurses, 
office workers, or children day-care workers, which explains why most 
of the workers were female. 
Table 6. Prevalence of work-related symptoms and respiratory 
infections among the patients.
Symptom/disease All
n=258
n (%)
Probable 
OA
n=156
n (%)
Possible 
OA
n=45
n (%)
Unlikely 
OA
n=57
n (%)
Upper-respiratory and ocular 
symptoms
     Eye irritation 145 (56) 92 (59) 24 (53) 29 (50)
     Hoarseness 129 (50) 79 (51) 18 (40) 32 (56)
     Nasal congestion 122 (47) 70 (45) 25 (56) 27 (47)
     Rhinorrhea 120 (46) 72 (46) 21 (47) 27 (47)
     Sneezing 46 (18) 24 (15) 10 (22) 12 (21)
Lower-respiratory symptoms
     Dyspnea 207 (80) 121 (78) 38 (84) 48 (84)
     Cough 182 (70) 110 (70) 29 (64) 43 (75)
     Wheeze 49 (19) 31 (20) 8 (18) 10 (18)
     Asthma symptoms from 
     non-specific irritants
99 (38) 57 (36) 21 (47) 21 (37)
Other symptoms
     Fatigue 109 (42) 68 (44) 16 (36) 25 (44)
     Fever and chills 108 (42) 61 (39) 20 (44) 27 (47)
     Dermal symptoms 60 (23) 34 (22) 12 (27) 14 (25)
     Headache 54 (21) 35 (22) 8 (18) 11 (19)
     Arthralgia 48 (19) 31 (20) 10 (22) 7 (12)
     Nausea 14 (5) 8 (5) 1 (2) 4 (7)
     Myalgia 13 (5) 7 (4) 1 (2) 5 (9)
     Vertigo 10 (4) 6 (4) 0 4 (7)
Recurrent respiratory infections 105 (41) 67 (43) 14 (31) 24 (42)
OA=occupational asthma
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Table 7. Sensitization to molds.
All 
n=258
Probable 
OA 
n=156
Possible 
OA 
n=45
Unlikely 
OA 
n=57
Positive SPT to molds, 
n/nt (%) *
36/245 (15) 29/148 (20) 2/45 (4) 5/52 (10) p=0.022
Elevated serum IgE to 
molds, n/nt (%)
22/181 (12) 18/113 (16) 1/30 (3) 3/38 (8) p=0.114
Either positive SPT or 
elevated serum IgE to 
molds, n/nt (%)
39/254 (15) 31/153 (20) 2/45 (4) 6/56 (11) p=0.019
OA=occupational asthma; nt=number of tested patients; SPT=skin prick test; 
IgE=immunoglobulin E.
In the analysis of the exposure data, the level of exposure was classified 
as high or intermediate for 79% of the patients. For 15%, the exposure 
classification was not made due to insufficient data. The duration of 
exposure exceeded 5 years for 69% of the patients. The level of exposure 
was significantly higher in the probable OA group than in the unlikely 
OA group (p=0.049).
Sensitization. Atopy (i.e., sensitization to at least one common envi-
ronmental allergen in the SPTs) was determined for 33% of the patients. 
Atopy was equally distributed among the three categories of OA. An 
elevated level of serum total IgE was significantly more common in the 
probable and possible OA categories than in the unlikely OA category.
Sensitization to molds, as demonstrated by either SPT or serum 
IgE, was determined for 15% (39 of 254) of the patients (Table 7). 
Altogether 26 of these 39 patients (67%) were atopic according to the 
SPTs. Atopy significantly increased the risk of sensitization to molds 
(OR 6.5, 95% CI 3.0–14.0). Sensitization to molds occurred the most 
frequently among the patients in the probable OA group (Table 7). The 
association between mold sensitization and OA category was statistically 
significant (p=0.019).
* An SPT to molds was performed for 253 patients, but, for 8 of them, the result 
could not be interpreted because of dermographism.
100
5 results
In the SPTs with mold extracts, A. fumigatus induced a positive 
reaction the most often (25 of 36 patients, 69%), followed by C. clado-
sporioides and Rhodotorula rubra (seven positive reactions each), and A. 
kiliense and Penicillium expansum (five positive reactions each). One-third 
of the patients with positive SPTs to molds (13 of 36 patients) displayed 
a positive reaction to more than one mold.
For the patients with a high, intermediate, or low level of exposure, 
the IgE sensitization to molds occurred in 9 of 99 (9%), 17 of 97 (18%), 
and 4 of 15 (27%) patients, respectively.
Lung function. In the baseline examinations at FIOH, most of the 
patients (89%) showed mild or moderate obstruction in the spirometry. 
Some degree of hyperresponsiveness was present in 45% of the patients, 
whereas the bronchial reactivity was normal for 55%.
Serial PEF records of acceptable quality at and away from work were 
available for 193 (75%) of the 258 patients included in the analyses. 
According to interpretations of the PEF records, 47 (24%), 77 (40%), 
and 69 (36%) were compatible, suggestive, or not consistent with OA, 
respectively.
SIC tests. The SIC test was positive for 133 patients. The positive 
bronchial reactions were immediate in 35 patients (26%), dual in 35 
patients (26%), and late in 63 patients (47%). The decreases in PEF 
ranged between 15% and 41%, and the FEV1 reductions were between 
15% and 49%. Sensitization to molds, demonstrated either by SPT or 
specific serum IgE, was present for 30 of the 130 patients (23%). [Mea-
surements were not available for 3 of the 133 patients.] Sensitization did 
not differ in relation to type of reaction (immediate or dual versus late).
The most common mold extract to induce positive reactions in the 
SIC was A. fumigatus (85 positive tests versus 26 with C. cladosporioides, 
19 with A. kiliense, and 3 with C. herbarum). Of the mold-sensitized 
patients, 26 (87%) had a positive SIC reaction to the same mold as 
shown by the SPT or serum IgE measurement. 
During the positive SIC with an active test agent, but not with the 
control agent, a post-challenge rise of >0.5°C in the axillary body tem-
perature was measured for 11 patients (8%, range of maximum tem-
perature 36.6–38.9). All of these increases occurred after the SIC with 
mold extract (none after the SIC with a diluent). For 10 of the patients 
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with an increase in temperature, the pre- and post-challenge diffusing 
capacity had been measured, but no differences were noted. The type of 
the bronchial reaction was late for 7 of the 11 patients (immediate for 
2 and dual for 2 patients).
Due to the lability of asthma despite optimal treatment, the SIC tests 
had to be carried out for 40 (16%) of the analyzed patients with ongoing 
inhaled corticosteroid medication. 
Agreement between the serial PEF records and the SIC tests. The 
agreement between the PEF and SIC tests (i.e., both the SIC and serial 
PEF monitoring were either positive or negative) was 56%. When the 
SIC was positive, the serial PEF monitoring was compatible or sugges-
tive of OA for 78% of the patients. In the case of a negative SIC, the 
proportion of patients with a PEF record compatible with or suggestive 
of OA was 56% (Table 8).
The comparison between the SIC testing and the proof of specific IgE 
mold sensitization (SPT or serum IgE measurement) showed a level of 
agreement of 57%. Type I mold sensitization was more common for the 
patients with the positive SIC than for the negative SIC (23% versus 7%).
Table 8. Agreement between the serial PEF measurements and SIC 
tests.*
SIC positive
n=69
SIC negative
n=124
Serial PEF compatible 
with OA (n=47)
25 (53%) 22 (47%) p=0.002
Serial PEF suggestive 
of OA (n=77)
29 (38%) 48 (62%)
Serial PEF inconsistent 
with OA (n=69)
15 (22%) 54 (78%)
OA=occupational asthma; PEF=peak expiratory flow; SIC=specific inhalation challenge.
* Only those included who had both tests available.
Follow-up examinations. A total of 136 of the 156 patients who were 
classified with probable OA participated in the follow-up examinations 6 
months after the diagnosis. Of these persons, only 79 patients (58%) had 
returned to work, while 53 patients (39%) were not currently working 
and 4 (3%) were attending vocational training. Altogether 13 patients 
102
5 results
were still exposed to the original damp work environment, and 4 reported 
moisture damage also in their new work environment.
Nearly all of the patients (98%, 133 of 136) used asthma medica-
tion regularly: 43% (59 of 136) using inhaled steroids alone, 35% (48 
of 136) using inhaled steroids and a long-acting β2-agonist, and 17% 
(23 of 136) additionally using a leukotriene modifier or theophylline. 
For most of the patients (89%), spirometry showed mild or moderate 
obstruction. The histamine challenge test showed no bronchial hyper-
responsiveness for 52% and mild bronchial hyperresponsiveness for 
30% of the patients. Asthma medication was continued by all except 
one patient, asthma lability requiring additive treatment for 23 patients 
(17%). The symptom status was unchanged for 73 (54%) patients, 
improved for 60 (44%), and was worse for 3 (2%). None of those still 
exposed reported improvement in their symptoms. 
None of the 11 patients who had reacted with a rise in temperature 
during a positive SIC reported a deterioration in symptoms in the follow-
up examination. The overall symptoms were unchanged for 6 of them 
(55%) and had improved for 5 (45%).
5.2 Long-term outcomes
5.2.1 from asthma-like symptoms to the    
 development of asthma (study II)
Most of the 483 persons studied were female (88%), the mean age being 
45.3 (SD 8.6) years. The mean time from the onset of symptoms to the 
initial examinations at FIOH was 4.8 (SD 3.3) years. The mean time 
from the examinations at FIOH to the point of the questionnaire study 
was 8.3 (SD 2.6) years.
A total of 62 patients (13%) claimed to have developed clinical 
asthma as diagnosed by a physician during the study period. The mean 
period from the examinations at FIOH to the asthma diagnosis was 4.8 
(SD 3.1) years. During the follow-up, the incidence rate of asthma was 
267 per 10 000 person-years. The mean time elapsed from the onset of 
symptoms to the time of receiving a diagnosis of asthma was 9.2 (SD 
5.2) years. 
103
5 results
There were no differences in the age or gender distribution between 
the patients who developed asthma and those who did not. The mean 
age of the groups was 44.8 (SD 8.8) years and 45.2 (SD 8.6) years, re-
spectively. Most of the patients (78%) worked in office-like surroundings, 
schools, hospitals, or children’s day-care centers.
A variety of work-related symptoms was reported prior to the initial 
examinations at FIOH. The prevalence of symptoms of the upper-
respiratory tract and the eyes had been high. A high prevalence of general 
symptoms, such as fever or chills, myalgia, arthralgia, headache, and 
fatigue, had also been reported. The prevalence of none of these irritant 
or systemic symptoms differed between the persons who developed 
asthma and those who did not. At the follow-up, the current nasal 
and eye symptoms were significantly (p<0.01) less severe among those 
no longer exposed to indoor dampness at work than among those still 
exposed. In addition, the symptom scores for fatigue, fever or chills, my-
algia or arthralgia, and headaches were lower for the unexposed patients 
(p<0.0004). Of the three asthma symptoms, the prevalence of dyspnea 
was higher for those who developed asthma, whereas cough and wheez-
ing did not differ between the groups.
An atopic history, either allergic rhino-conjunctivitis or atopic der-
matitis, was a moderate risk factor for asthma (adjusted OR 2.6, 95% 
CI 1.5—4.6).
Among the patients who were working at the time of the follow-up, a 
larger proportion of those who developed asthma, than patients who did 
not, reported that they were still working in the same non-remediated 
environment (7% versus 2%). A significantly lower proportion of those 
who had developed asthma had been relocated within the same company 
or organization than those who had not developed asthma (13% versus 
29%). Continued exposure to indoor dampness in the same or new 
work environment was reported by 19% of the asthmatics and 11% 
of the non-asthmatics. The proportion of those currently unemployed 
was higher among those who had developed asthma (48% versus 32%).
Among the currently employed (i.e., working at the time of the 
questionnaire study) the risk of new-onset asthma in relation to con-
tinued workplace exposure was increased more than fourfold (adjusted 
OR 4.6, 95% CI 1.8–11.6) (Table 9). Continued work in the former, 
non-remediated work environment was associated with a further increase 
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in the risk (adjusted OR 6.4, 95% CI 1.5–27.7). Working for a new 
employer but still exposed to building-related dampness at work was 
associated with a similarly increased risk (OR 5.7, 95% CI 1.6–20.7). 
When stratified by atopic history, the risk of asthma in the continu-
ing exposure situation was only slightly higher among the atopics (OR 
5.1, 95% CI 1.4—19.1) than among the non-atopic persons (OR 4.68, 
95% CI 1.2—18.6).
Table 9. Risk of asthma development in relation to the continuation 
of workplace exposure.*
Development 
of new asthma
Crude odds 
ratio
Adjusted odds 
ratio#
Yes
n=34†
No
n=290§
n n OR 95% CI OR 95% CI
Cessation of exposure†† 
(reference)
12 170 1.00 1.00
Continuation of exposure
Working in the 
same, nonremediated 
environment
4 10 5.7 1.5–20.8 6.4 1.5–27.7
Relocated in the same 
organization, moisture 
damage
3 24 1.8 0.5–6.7 2.9 0.7–12.4
Working for a new 
employer, moisture 
damage
5 13 5.4 1.7–17.8 5.7 1.6–20.7
Any of the 
aforementioned exposure 
situations
12 47 3.6 1.5–8.6 4.6 1.8–11.6
Working in the same, 
remediated environment
8 63 1.8 0.7–4.6 2.0 0.7–5.4
OR=odds ratio; CI=confidence interval.
* Only currently employed persons included.
† Information was unavailable for two patients.
§ Information was unavailable for ten patients.
# Adjustment for age, gender, atopic history, and smoking.
†† Relocated in the same organization or working for a new employer, and no 
moisture damage in the workplace.
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Some medical records were obtained for 46 of the 62 patients who 
reported having developed physician-diagnosed asthma. In 31 cases, the 
records fulfilled the diagnostic criteria for asthma, which were the same 
as in the initial examinations, whereas the available clinical records of 15 
cases did not. According to the questionnaire study, 48 of the 62 patients 
were using inhaled steroids regularly. When the excess risk of developing 
asthma in relation to continued exposure was analyzed for only the 18 
persons who had an acceptable physician-diagnosed case of asthma and 
who were working at the time of the questionnaire study, the statistical 
significance remained (adjusted OR 4.9, 95% CI 1.3–18.2).
5.2.2 Quality of life (study III)
The study population (n=1295) has been described in Table 1 of article 
III. The mean time from the initial examinations to the point of follow-
up with the questionnaire was 8.0 (SD 2.8, range 3.0–12.0) years. At 
the time of the follow-up, there were no significant differences in age or 
smoking habits in comparison with the groups of OA, WEA, asthma-
like symptoms, and upper-respiratory symptoms. A total of 60% of the 
patients had never smoked. The patients with WEA had an atopic his-
tory more often than did the patients with OA or those with no asthma. 
Both asthma groups more often reported coincident chronic diseases or 
injuries than did the non-asthmatics. Altogether 88% of the respond-
ents were white-collar employees (e.g., teachers, nurses, office workers, 
or administrators), and 12% were blue-collar employees (e.g., cleaners, 
kitchen helpers, or doormen).
Of the OA group, a statistically significant proportion was outside 
worklife at the time of the follow-up. Altogether 41% of the patients 
with OA received a pension, either because of disability (workers’ com-
pensation pension or disability pension) or retirement because of age 
(63–68 years). In the other groups, pension was not as common (26% 
of the WEA patients, 23% of the patients with asthma-like symptoms, 
and 19% of those with upper-respiratory symptoms).
The scores of the generic QOL, depression, anxiety, somatization, and 
hypochondria indicators are shown in Table 2 of article III. Statistically 
significant differences were observed between the four groups according 
to the asthma and symptom status at the baseline. The OA patients had 
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the lowest scores, indicating worse QOL, in all of the QOL domains. For 
the mental component score of the SF-12, the differences between the 
groups were smaller and not significant. When the asthma groups were 
combined, 33% of all of the asthmatics had an important or possible 
clinical relevance for an anxiety disorder versus 37% of the respondents 
in the non-asthma groups. Correspondingly for depression, 13% of the 
asthmatics and 11% of the non-asthmatics had an important or possible 
relevance for an anxiety disorder. Surprisingly, patients with OA seemed 
to display less anxiety than the other groups. However, this tendency 
was not statistically significant. The scores of the somatization subscale 
of the Hopkins Symptom Checklist did not differ significantly between 
the groups, whereas the Whiteley Index for hypochondria showed sta-
tistically significant differences.
Table 10 presents the scores of the QOL domains for those who were 
working at the time of the follow-up and those who were not. Among 
those who were not working, the persons with OA had the lowest scores 
for QOL on the SF-12 physical component scale and the VAS scale.
In a multivariate linear regression analysis, the group status was as-
sociated with QOL with respect to the SF-12 physical component score, 
but not for the SF-12 mental component score. An association could 
also be shown for the overall QOL measured on the VAS scale. The 
differences in the QOL scores were compared between each group. For 
the SF-12 physical component score, the difference between the groups 
with asthma-like symptoms and upper-respiratory symptoms was not 
statistically significant (p=0.411). Between all of the other groups, the 
differences were statistically significant (p<0.001). For the SF-12 men-
tal component score, there were no statistically significant differences 
between the groups, whereas, for the VAS scale, the differences were 
statistically significant when the OA group was compared with each of 
the other groups (p<0.05). Not being employed was a determinant for 
a poorer QOL in regard to all three QOL dimensions. Adding anxiety, 
depression, somatization, and hypochondria to the model did not remove 
the differences between the groups. 
The need for regular asthma medication (p<0.001) and the need 
for oral steroid bursts to control asthma (p<0.001) was higher for the 
patients with OA than for those with WEA. A worse QOL (measured 
by the SF-12 physical component scale or the VAS scale) was associated 
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with a higher need for asthma medication (p<0.001 on both scales) and 
a more frequent need for oral steroid bursts (p<0.001 on both scales). 
Significant cough and dyspnea were more prevalent among the OA pa-
tients than among the WEA patients: 27% versus 17% (p=0.011), and 
28% versus 17% (p=0.004), respectively. For wheezing, the difference 
was not statistically significant (p=0.591).
In a multivariate model including the OA and WEA groups, frequent 
oral steroid use was a strong determinant for a poorer SF-12 physical 
component score and the overall QOL on the VAS. When regular asthma 
medication was included in the model as an explanatory variable, it was 
found to explain worse QOL with respect to the physical component 
score (p-value 0.001), but not regarding the other QOL dimensions. 
Oral steroid use and regular asthma medication could not be added to 
the same model because of their strong mutual correlation. 
5.2.3 Work ability (study Iv)
The study population consisted of 1098 persons aged 26–64 years. The 
characteristics of the study group according to the asthma or symptom 
group are described in Table 1 of article I. The mean time from the initial 
examinations at FIOH to the follow-up questionnaire was 7.8 (SD 2.8) 
years. Most of the patients in the study were female, the vast majority 
of whom worked in occupations with only light physical demands. 
Altogether 88% of the respondents were upper or lower white-collar 
employees (e.g., teachers, health and day-care nurses, other professionals, 
office workers, or administrators). The initial exposure had most often 
taken place in office-like workplaces (23%), hospitals and health clinics 
(22%), schools and colleges (18%), or children’s day-care centers (10%).
The OA patients rated their work ability with the lowest scores, 31% 
of them assessing their work ability as very poor (score 0–5) versus 9% 
of the respondents in the group with upper-respiratory symptoms. The 
work ability score for both asthma groups was lower than that of the 
symptom groups.
At the follow-up, 40% of the OA group was outside worklife. Re-
tirement because of disability or being without a job was also the most 
frequent (33%) in the OA group, whereas 13% of the WEA patients, 
13% of the patients with asthma-like symptoms, and 13% of the patients 
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with only upper-respiratory symptoms belonged to this category. Of all 
of those who were retired because of disability or who were without a 
job, 91 (61%) claimed that the disability or unemployment was a con-
sequence of persisting dampness-related symptoms.
Altogether 128 (12%) of the respondents reported that they had 
changed occupation. In addition, 136 (13%) reported having changed 
employer because of dampness-related symptoms.
The distributions of both of the work ability outcomes are presented 
in Table 2 of article IV, according to the determinants and other explana-
tory variables.
The OA patients had a markedly increased risk of poor work ability. 
When adjusted for individual variables (age, gender, occupational group, 
smoking, atopic history and co-morbidity), the OR was 2.6 (95% CI 
1.4–4.7) (Table 11). In addition, the WEA patients had an increased 
risk for poor work ability (OR 1.8, 95% CI 1.2–2.8). OA had a strong 
association with withdrawal from work due to early retirement or un-
employment (adjusted OR 5.7, 95% CI 2.8–11.9) (Table 11). For the 
WEA and asthma-like symptoms groups, the associations with early 
withdrawal from work were not statistically significant. When depression 
and somatization were added to the model, the risks remained statisti-
cally significant.
Multiple long-term indoor-air symptoms at the follow-up increased 
the risk of poor self-assessed work ability. When adjusted for individual 
factors, the OR was 2.7 (95% CI 1.9–3.8) for those with 1–3 symptoms, 
increasing to 9.7 (95% CI 5.7–16.5) for those with >5 symptoms (Table 
11). After adjustment for depression and somatization, the risks remained 
significantly elevated. Multiple long-term symptoms were not associated 
with early withdrawal from work.
A poor social climate at the workplace and poor experiences with 
supervisor’s cooperation were associated with both poor self-assessed work 
ability and early withdrawal from work, when adjusted for the individual 
variables (Table 11). When depression and somatization were added to 
the models, the associations remained for early withdrawal from work, 
but not for self-assessed work ability (Table 11).
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6 DISCuSSION 
6.1 Diagnostics of occupational asthma
6.1.1 Exposure assessment
Demonstrating the exposure (i.e., identifying an occupational agent at a 
workplace that is a potential cause of OA) is a prerequisite for making a 
diagnosis of OA. With respect to indoor dampness and related factors, 
the issue is not straightforward. When this study was being planned, 
there were no accurate guidelines for the exposure assessment, and in-
consistent practices were used. In Finland in the 1990s, IgG antibodies 
were considered a proxy for exposure. Their value in clinical diagnostics 
was contradicted already in 1998 in the so-called Majvik recommenda-
tion (Majvik 1998), which included guidelines by an expert group for 
the diagnostics of diseases induced by building moisture and mold. The 
review of scientific evidence by IOM in 2004 concluded that there is a 
lack of valid quantitative methods for assessing exposure (IOM 2004). 
The current knowledge is the same. There are still no health-based lim-
its for harmful or safe mold exposure. According to the latest literature 
review (Mendell et al. 2011), conventional quantitative measurements 
of fungi or other microbiological exposures, such as counts of cultur-
able airborne fungi, have shown less consistent associations with health 
effects than have qualitative assessments, such as visible dampness and 
mold or mold odor. 
A major obstacle to demonstrating a building-related factor as a 
cause of an occupational disease is the difficulty of identifying a spe-
cific causative agent among a multitude of candidates. As several mold 
species have been reported to specifically trigger allergic asthma, much 
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6 Discussion
research has focused on fungal spores as the main offending agent 
(Portnoy et al. 2008; Sahakian et al. 2008). Most studies that demon-
strate an association between asthma development and damp indoor 
spaces are based on the presence of visible mold or mold odor (WHO 
2009; Mendell et al. 2011). Apart from indoor allergens (e.g., from 
pets) other hazardous factors in indoor air have not been shown to be 
risk factors for asthma development. For example, several studies have 
found associations between VOCs and asthma symptoms, but literature 
reviews have found no consistent evidence for an association between 
the commonly measured indoor VOC exposures and the onset of new 
asthma (Nielsen 2007). 
Molds are ubiquitous in our environment, indoors as well as outdoors. 
If there is excess mold growth in the work environment, exposure to 
molds is however not restricted to the workplace. As Finland is a subarctic 
country, the outdoor concentrations of airborne fungi are very low in the 
winter (Reponen et al. 1992). In indoor air, winter concentrations are 
usually below 100 cfu/m3 in home environments (Reponen et al. 1992), 
and even lower, <50 cfu/m3, in office environments (Salonen et al. 2007) 
and school environments (Meklin et al. 2003). These limits signify the 
probability to identify abnormal microbial sources indoors, and many 
contributing factors must be considered when the concentrations of the 
spores are interpreted. Distinguishing harmful occupational exposures 
is therefore challenging.
For study I, a three-level classification was established for the in-
tensity of microbial exposure. The exposure of each patient case was 
classified on the basis of the data in patient files. In most of the cases, 
a characterization of moisture damage, as well as microbial growth, 
had been undertaken. Exposure to molds could be retrospectively 
verified from technical and microbial reports. Therefore, a rough grad-
ing according to the extent and location of the damage was usable. 
The assessment was semi-quantitative. For 85% of the cases, reliable 
data were available in the patient files and confirmed the exposure to 
dampness and molds. “The high-level category” of exposure showed 
a statistically significant association with the probable OA category. 
This finding suggests that the exposure assessment that was used had 
some validity.
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There are no valid methods for quantitative exposure assessment. 
Mold growth in relation to moisture damage can be regarded as an indica-
tor of the total exposure to all dampness-related factors (like spores and 
hyphal fragments of fungi, spores and cells of bacteria, toxins, chemical 
degradation products of building materials) (WHO 2009). Inflamma-
tory responses have been found to many microbiological agents related 
to dampness, and this finding supports the biological plausibility of a 
potential causal association between dampness-related factors and asthma 
(see Section 2.3.9). No single causative agent has been identified relevant 
to asthma or other health effects; instead, the mechanisms are likely to 
be complex and multifactorial (WHO 2009). Mold growth is always 
considered to be the result of excess dampness, and excess dampness 
is invariably accompanied by mold before long (Fisk et al. 2007). The 
results of study I support the existing literature that the demonstration 
of excess mold growth in association with workplace moisture damage 
is a relevant criterion for the assessment of exposure. In OA diagnostics, 
an individual exposure assessment is needed, and it can be based on 
descriptions of the extent and location of the moisture and mold dam-
age in the building structures, as well as on microbial measurements as 
described in study I. 
6.1.2 Specific inhalation challenge tests
In the diagnostics of OA, the SIC test is generally considered to be as 
close as possible to a gold standard (Newman Taylor et al. 2004; Ni-
cholson et al. 2012). It represents an important tool for confirming a 
diagnosis of OA, for identifying the agent responsible for asthma when 
there are multiple possible agents in the workplace, and for identifying 
new agents responsible for asthma (Vandenplas et al. 2006). When SIC 
tests are available in a specialized center, they have been recommended 
to be preferred to other means in the confirmation of WRA (Vandenplas 
et al. 2006). According to current guidelines, for people with suspected 
sensitizer-induced OA, using SIC test is suggested when the diagnosis 
or causative agent remains equivocal (Tarlo et al. 2008). As FIOH is a 
national reference institute, SIC is a routine method for ascertaining 
causality in the diagnostics of OA.
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From the 1990s on, asthma induced by indoor molds has been com-
pensated as OA in Finland. As molds are generally known as sensitizers, 
SIC testing was adopted for the OA diagnostics of building-related 
asthma. Although the epidemiological evidence was limited with respect 
to an association between dampness and mold and asthma, positive re-
actions to mold extracts in SIC testing were considered to demonstrate 
a relationship with mold exposure and asthma. Therefore, for study I, 
there were results available for routinely performed SIC tests that could 
be used in the retrospective review. 
For the SIC testing, there had been access to three commercial test 
extracts (A. fumigatus, A. kiliense, and C. cladosporioides). The extracts 
were not standardized. SIC test agents contain a small amount of proteins 
and carbohydrates (Esch 2004). The A. fumigatus extract elicited most 
of the positive reactions in the study patients and, therefore, reflects the 
fact that most tests were performed with A. fumigatus. The rationale for 
using A. fumigatus as the primary test extract had been that Aspergillus 
species represent dominant genuses in mold-damaged buildings (Simon-
Nobbe et al. 2008), and Aspergillus species are also known to cross-react 
and share epitopes with other mold species (e.g., Cladosporium) (Horner 
et al. 1995; Vojdani 2004; Simon-Nobbe et al. 2008).
Sensitization to molds was found in 23% of the SIC positive cases. In 
a previous study on rhinitis patients with positive nasal provocation tests 
with microbial extracts, specific IgE had been determined similarly for a 
small proportion of patients only (Karvala et al. 2008). The mechanisms 
behind the positive SIC reactions remain unknown.
The usefulness of the SIC test is however modest with respect to 
dampness and molds at workplaces. The exposure situation at work in-
cludes a multitude of other components as well (e.g., spores, metabolic 
products of microbes, toxins, and chemicals emitted from construction 
and interior materials). Thus the choice of one or several microbes 
identified on a single sampling occasion may be totally wrong. A broad 
spectrum of microbial genera and species can be found on building ma-
terials and in indoor air, and species and concentrations fluctuate over 
time. Sampling microbes on single occasions does not necessarily reveal 
the relevant species. On the other hand, as the mechanisms and caus-
ative factors of dampness-related asthma are unknown, and the SIC is a 
method with which to identify sensitizer-induced OA, SIC with fungal 
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allergens may not serve as an ideal test. Thus a negative SIC contributes 
little, if any, information.
6.1.3 Serial PEf monitoring
In study I, serial PEF monitoring could be compared to the SIC results. 
The overall agreement between the serial PEF monitoring and the SIC 
testing (both being either positive or negative) was 56%. For the patients 
with a positive SIC test, the agreement with the serial PEF monitoring 
was 78%. Considering the flaws of the SIC, this figure is fairly high 
(figures 80%–100% could be regarded as high).
In the diagnostics of OA, serial PEF recordings have a high sensitivity 
and specificity when tested against SIC tests, averaging 80% and 90% 
respectively (Newman Taylor et al. 2004). Acceptable serial PEF records 
are possible to obtain for about two-thirds of those for whom OA is 
being considered (Newman Taylor et al. 2004). The percentage in the 
material (study I) was only slightly lower (63%). If occupational health 
services fail to initiate serial PEF monitoring in association with damp 
buildings, this opportunity is often lost. As there is generally a time lag of 
1–3 years before a patient arrives for examinations at FIOH, the moisture 
damage has often already been repaired – sometimes the entire building 
has been demolished, the work contract has ended, or the patient simply 
refuses to go back to the workplace. In addition, deficiencies have been 
reported in the quality of serial PEF measurements performed in health 
care units before referral to FIOH (Sauni et al. 2009).
By comparison, serial PEF records are superior to SIC testing in 
reflecting the entire complex exposure situation at the workplace. Thus 
serial PEF recording is the principal and most reliable diagnostic tool 
available. It is however, essential that serial PEF monitoring be carried 
out correctly. It should be initiated without delay, preferably before the 
initiation of any anti-inflammatory medication. The reliability of serial 
PEF monitoring using ordinary peak flow meters has been questioned 
(Malo et al. 1995, Quirce et al. 1995). It may be advisable to use a 
computerized peak flow meter in order to improve both quality and 
reliability. Increases in bronchial hyper-reactivity (Nicholson et al. 2005) 
or exhaled nitric oxide (Lemiere 2007) over an exposure period may 
be a way to improve the reliability of PEF recording. While serial PEF 
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records do demonstrate the association with work, the major weakness is 
that they do not accurately differentiate between WEA and OA (Chiry 
et al. 2007). For the diagnosing of OA, other aspects, like the exposure, 
disease history, and immunological assessment, have to be included. 
6.1.4 Differentiation between OA and WEA
Differentiating OA (which is asthma caused by workplace exposures) 
from WEA (which is asthma exacerbated by workplace exposures) is 
the main difficulty in establishing the diagnosis of OA. There are several 
reasons for a possible diagnostic misclassification concerning asthma re-
lated to building dampness and mold. In study I, the category of unlikely 
asthma represented WEA. This group may well have included cases of 
OA. As a negative SIC test does not exclude the possibility that some 
other microbe or agent was the cause of asthma, the uncertainty of the 
diagnoses was probably greatest in this category, especially if serial PEF 
recordings were not available. Thus not all cases of OA are recognized, 
and, on the other hand, serial PEF measurements are not specific to OA 
(Chiry et al. 2007). However, all of the patients had been exposed to a 
damp environment and had suffered from work-related exacerbations 
and deterioration of their asthma. Therefore, from the point of view 
of secondary prevention, the distinction between WEA and OA is less 
important (Wagner and Wegman 1998). The need for proper asthma 
treatment, building repairs, or relocation is the same regardless of the 
type of diagnosis.
An accurate separation between the two types of WRA is not always 
possible. For compensation purposes, the diagnostic practice in Finland 
has been to determine OA cases. Inequality experiences are yet in many 
cases unavoidable so that, with similar symptoms, which even worsen 
in similar work environments, one person gets a diagnosis of OA and 
another person does not. For a patient, it is difficult to understand the 
difference between causality and exacerbation. Remaining without an 
OA diagnosis may be a disappointment because of lost benefits, but also 
because of experienced injustice. This situation has often led to prolonged 
appeal processes among patients with building-related asthma.
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6.2 Long-term outcomes
6.2.1 Asthma development
The results of study II suggest that asthma-like symptoms in relation to 
exposure to a damp and moldy work environment are associated with 
an increase in the risk of developing asthma later. The study population 
had been exposed to indoor dampness and molds at their workplaces. A 
significant proportion of the patients reported having developed asthma 
during the follow-up period (mean 8.3 years). The incidence of new-
onset asthma in this group was high, 267 per 10 000 person-years. By 
comparison, the incidence of asthma in a Finnish birth cohort born in 
1966 was 18.5 per 10 000 person-years (Kujala et al. 2005) and that of 
a population cohort in Helsinki was 37 per 10 000 person-years (Pal-
lasaho et al. 2011). Study II was based on a clinical patient series, and 
therefore direct comparisons cannot be made.
The finding that asthma-like symptoms may increase the risk of de-
veloping asthma is supported by the results of some earlier studies, but 
such a relationship has not earlier been shown for occupational environ-
ments. The findings may apply to other occupational environments with 
irritant and sensitizing exposures as well. A follow-up study (mean time 
4.4 years) on adults suffering from chronic cough without having clini-
cal asthma revealed that 16% (29 of 182 patients) were diagnosed with 
asthma (Puolijoki and Lahdensuo 1987). In another Finnish study on 
children aged 7–12 years, who had lower-airway symptoms but did not 
fulfill the criteria for asthma, one-third (11 of 33 children) developed 
asthma during a 2-year follow-up period (Remes et al. 1998). In study 
II, the proportion of those who developed asthma was lower (13%). 
However, the 62 patients who had developed asthma by the time of the 
questionnaire study had developed asthma slowly. They reported hav-
ing suffered from work-related asthma-like symptoms for a mean of 4.8 
years earlier and a further mean of 4.8 years after the examinations at 
FIOH before the diagnosis of asthma was established. The percentage 
would probably have been higher if the study had had a prospective study 
design in which also those with a shorter symptomatic period prior to 
developing asthma would have been included.
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Impact of exposure continuation on asthma development
The most important risk factor for developing clinical asthma in study 
II was continuing exposure to indoor dampness in the work environ-
ment. The results suggest a clear association between factors related to 
indoor dampness and the development of asthma. The continuation 
of any exposure to dampness was associated with a more than fourfold 
increase in the risk of asthma (OR 4.6, 95% CI 1.8–11.6). Continued 
work in the former, non-remediated work environment was associated 
with a further increase in the risk (OR 6.4, 95% CI 1.5–27.7). When 
the results are interpreted, the limitations of self-reported data should 
be considered (discussed in more detail in Section 6.4.2).
Working in a remediated work environment was associated with 
a decrease in the risk of developing asthma, although the excess risk 
remained statistically non-significant (OR 2.0, 95% CI 0.7–5.4). 
The statistical non-significance was likely due to the small number of 
workers in this category. The remaining excess risk for repaired work 
environments found in the study may indicate that the remediation of 
the buildings had been insufficient. In a report of seven case studies of 
buildings that underwent remediation for different degrees of moisture 
and mold damage, the results showed that successful remediation is dif-
ficult (Haverinen-Shaughnessy et al. 2008). Only in one of seven cases 
was the remediation completely successful (Haverinen-Shaughnessy et 
al. 2008).
The findings of study II agree with the results of some recent studies 
showing that the successful remediation of moldy buildings has signifi-
cantly reduced asthma morbidity (Jarvis and Morey 2001; Patovirta et 
al. 2004b). In the intervention study of Jarvis and Morey (2001), a high 
rate of asthma was found for the 488 occupants of a mold-contaminated 
office building. After thorough repairs, no excess building-related illness 
occurred in the 5-year follow-up. In another study, a cluster of asthma 
cases was identified in a school with indoor dampness and molds, and 
after building repairs no new cases of asthma appeared among the 31 
teachers in a 3-year follow-up (Patovirta et al. 2004b). Similarly, a well-
designed intervention study by Kercsmar et al. (2006) showed that the 
removal of sources of dampness and molds was followed by a signifi-
cant decrease in the exacerbation of asthma among children. However, 
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intervention studies on the effect of the remediation of moisture- and 
mold-damaged buildings are sparse, and the study designs and outcome 
measures have varied.
A Cochrane Collaboration Review Group conducted a systematic 
review of the effects of repairing buildings damaged by dampness and 
mold on respiratory health (Sauni et al. 2011). The group found only 
moderate to very low-quality evidence that repairing mold-damaged 
houses and offices decreases asthma-related symptoms and respiratory 
infections when compared with no intervention among adults (Sauni 
et al. 2011). The group demanded better quality studies to determine 
the most effective way to carry out the remediation of damp and mold-
damaged buildings to minimize respiratory health hazards (Sauni et al. 
2011). Thus it seems important that further studies on this topic be 
conducted to corroborate the associations that were found in study II.
The results of study II suggest that preventive measures to avoid fur-
ther exposure are relevant to prevent asthma development. In practice, 
this finding means that the remediation of moisture and mold damage or 
the relocation of workers with asthma-like symptoms to a non-moisture-
damaged environment is necessary. This conclusion agrees with the 
WHO recommendation that, in order to avoid adverse health effects, 
persistent building dampness and microbial growth on interior surfaces 
should be prevented or minimized. This effort requires well-designed, 
well-constructed, and well-maintained buildings with proper control of 
ventilation and temperatures (WHO 2009).
6.2.2 Quality of life and work ability
One clinical impression is that some of the patients whose symptoms 
initiated in moisture-damaged workplaces suffer from prolonged symp-
toms that deteriorate their well-being. Some patients report symptoms 
that they attribute to mold odor or low-level exposures to environmen-
tal chemicals, even if there is no major moisture damage or microbial 
growth in the present environment. However, the subject has not been 
widely studied. For example, a recent Swedish literature review on the 
association between adult asthma and dampness and mold stated that 
the prognosis of symptoms induced by damp and moldy environments 
is unclear (Torén et al. 2010).
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Study III showed that a high proportion of patients with OA caused 
by indoor-air dampness and molds had impaired QOL 3–12 years after 
their initial diagnosis when they were compared with patients with WEA 
and patients with no asthma but with symptoms related to the exposure. 
In a multivariate model adjusted for age, gender, smoking, atopic his-
tory, co-morbidity, and psychological factors, the differences between the 
groups remained for the physical component of the QOL but not for 
the mental component. One of the first articles on QOL and OA was a 
study by Malo et al. (1993), in which the authors investigated persons 
with OA after their removal from exposure for two or more years. In 
comparison with persons with non-OA, the OA group showed greater 
impairment in QOL; this finding corresponds to the results of study III.
Not being employed was a strong determinant of deteriorated QOL 
in all of its dimensions. The finding that those who were employed had 
the best QOL scores has earlier been shown for workers diagnosed with 
OA induced by Western red cedar (Dimich-Ward et al. 2007).
In the follow-up (study IV) among workers previously examined 
because of a suspicion of an occupational disease related to respiratory 
symptoms in damp and moldy workplaces, OA and WEA were found to 
be associated with impaired self-assessed work ability. The diagnosis of OA 
was associated with a strong, nearly sixfold risk for withdrawal from work 
due to unemployment or retirement because of disability, in a comparison 
with a reference group with upper-respiratory symptoms only. 
The participants rated their work ability as being worse than in 
an earlier population-based study from Finland (Gould et al. 2008). 
Altogether 44% of the entire study population, and even 57% of the 
OA group, assessed their work ability as 7 or lower (on a scale of 0–10) 
compared with the lifetime best versus 19% of women aged 45–54 years 
in the Finnish general population (Gould et al. 2008). Self-assessed work 
ability has been proven to be a good predictor of retirement due to work 
disability (Ilmarinen and Tuomi 2004).
In the OA group of study IV, the major reason (31%) for work ces-
sation was retirement because of disability. In comparison, 7% of the 
Finnish general population aged 16–64 years was on a disability pension 
in 2007, as was 20% of the age group of 55–64 years (ETK 2008). The 
proportion of employed persons appears to be surprisingly low, as most of 
the patients with OA were in occupations with no high physical demands 
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(i.e., teachers, nurses, office-workers, etc.). They should not become dis-
abled to work when adequately medicated and removed from exposure 
to moist and moldy environments. In previous studies, OA has been 
found to be associated with significant socioeconomic impacts (Ameille 
et al. 1997; Larbanois et al. 2002; Vandenplas et al. 2003; Vandenplas 
et al. 2011) related to the need of leaving a job, changing occupation, 
and finding alternative work. To avoid exposure, there is no need for 
patients with building-related asthma to change occupation, unlike for 
OA induced by more traditional work sensitizers. Instead, building re-
pairs or a change of workplace is required. In OA studies, removing the 
worker from the workplace has been linked to better medical outcomes, 
but invariably to worse socioeconomic outcomes (Henneberger et al. 
2011; Vandenplas et al. 2011).
In general, the results of studies III and IV corroborate the clinical 
impression that a large proportion of patients with OA in relation to 
exposure to moisture and mold-damaged workplaces has long-standing 
limitations in everyday life and remains symptomatic and unable to work. 
The studies may have a wider relevance, as a considerable number of 
asthma cases has been considered attributable to building dampness and 
mold (Mudarri and Fisk 2007), even though not generally recognized 
as OA in many countries. 
The results may reflect the fact that the remediation of a building may 
be time-consuming and not always successful (Haverinen-Shaughnessy 
et al. 2008; Iossifova et al. 2011), and arrangements for relocation are 
not always easy to achieve. These factors may, at least at an early stage 
of symptoms, lengthen sickness absences and delay return to work, 
which in turn may lead to permanent disability. Several studies have 
shown evidence indicating that lengthy periods of sickness absence are 
associated with an increased risk of disability pension (Lund et al. 2008; 
Wallman et al. 2009).
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6.2.3 Why did the outcomes differ between OA and   
 WEA patients 
Compensation benefits
It could have been expected that the OA patients would be better off than 
the other groups due to a liberal compensation system for occupational 
diseases. In Finland, OA is compensated through the statutory accident 
compensation system, whereas WEA is not. Compensation covers, for 
example, medical expenses, income replacement, and vocational reha-
bilitation. Benefits due to occupational diseases are better than those 
due to non-occupational diseases, which are covered by general social 
insurance. Despite compensation benefits, the OA patients clearly had 
a lower QOL than all of the other groups of patients, they rated their 
work ability as being lower, and they more often withdrew from work.
Asthma severity
It is unclear whether asthma severity explained the differences between 
the asthma groups in studies III and IV. As estimated by the use of asthma 
medication, the asthma symptoms of the OA patients were more per-
sistent, as well as more severe, than those of the WEA patients in study 
III. A large proportion of the OA patients were using heavy medication 
still 3–12 years after the diagnosis. Only 11% of the OA patients did 
not use inhaled steroids, and the need for oral steroid bursts was clearly 
greater. Both parameters correlated well with QOL—the more medica-
tion taken, the worse the QOL. This finding tallies well with the results 
of a study by Miedinger et al. (2011), in which objectively measured 
disease activity seemed to be the principal determinant of QOL among 
73 patients with OA 2 years after the diagnosis. 
According to a systemic review of cohort studies, asthma severity has 
been found to have a weak positive relation to work disability. One study 
found a positive relation, while another study found no such relation 
(Detaille et al. 2009). In a study conducted among OA patients, the sever-
ity of asthma was not an important determinant of work status (Ameille 
et al. 1997). Asthma in general has been shown to be associated with 
an increased risk of long-term all-cause disability (Hakola et al. 2011).
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There may be various reasons for the persistence and severity of the 
disease, both individual and environmental. To avoid exposure, the op-
tions are building remediation or a change to an alternative work envi-
ronment. Moisture and mold damage in buildings has been excessively 
common in Finland (Salonen et al. 2007), and often other deficiencies 
worsening the quality of indoor air, like poor ventilation, occur in 
connection with moisture problems. Successful repairs are not always 
easy to achieve. The success estimate of the remediation is dependent 
on the expectations and the type of measure used (technical criteria, 
concentration of microbes, or the level of discomfort of the occupants) 
(Haverinen-Shaughnessy et al. 2008). In some buildings, the inhabit-
ants may exhibit persisting symptoms despite multiple environmental 
improvements, and even if the remediation is considered technically 
successful (Haverinen-Shaughnessy et al. 2008; Norbäck 2009). A 3-year 
follow-up of a 97-person cohort in a water-damaged building found that 
substantial remediation did not result in an improvement in respiratory 
health, as reflected by symptom scores, overall medication use, spirometry 
abnormalities, or sick leave (Iossifova et al. 2011).
To objectively investigate differences in asthma severity between OA 
and WEA, clinical follow-up studies are needed. If the difference exists, 
it is possible that originally the more severe cases of asthma have been 
diagnosed as OA or that mold-induced asthma has a worse prognosis. 
With a longitudinal study design, uncertainties about the direction of 
the cause and effect can be minimized.
mental disorders
After adjustment for depression and anxiety, the differences in QOL 
between the groups remained. For the patients in study III, the rates of 
anxiety and depression were lower than shown by Björnsson et al. (1998), 
who reported positive associations between building-related symptoms 
and anxiety and depression, as measured by the Hospital Anxiety and 
Depression Scale. In addition, compared with the results of previous 
studies on asthmatics, psychological distress was lower than expected 
among our patients (Lavoie et al. 2006; Kullowatz et al. 2007; Yacoub 
et al. 2007; Malo et al. 2009). Yacoub et al. (2007) reported significant 
rates of depression and anxiety, close to 50%, 2 years after the cessation 
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of exposure among persons with sensitizer-induced OA. In a study by 
Malo et al. (2009), the rates were up to 40% 3–22 years after the diag-
nosis of acute irritant-induced asthma. The rates seem to be higher for 
OA than for non-OA, as Lavoie et al. (2006) observed rates of 23% for 
anxiety disorders and 20% for depressive disorders in a study on tertiary 
care patients with asthma. 
Neither somatization nor hypochondria explained the differences in 
QOL between the groups. Earlier, a tendency towards somatization was 
shown to be associated with symptoms related to the SBS (Berglund and 
Gidlöf Gunnarsson 2000), which is the reason somatization was included 
in the present study. The mean scores of the somatization subscale of 
the Hopkins Symptom Checklist for a community sample of the Finn-
ish population in a study by Holi et al. (1998) were clearly lower than 
those of our patients, and in an outpatient sample of psychiatric Finn-
ish patients the scores were higher. Higher somatization scores (Mattila 
et al. 2008), as well as higher hypochondria scores (Rief et al. 2001), 
have been shown to be associated with female gender, and females were 
overrepresented in the material of the present study. Similarly, there is 
an association with somatic diagnoses (Mattila et al. 2008), as all of the 
symptoms on the somatization subscale may be reflections of a physi-
cal illness. In study III, the results did not point to any greater degree 
of somatization among OA patients than among the other groups. The 
hypochondriac features measured by a self-rating scale, the Whiteley 
Index, did not seem to be high in any group; yet a somewhat lower value 
was scored by the upper-respiratory symptoms group.
In study IV, the models were adjusted for depression and somatiza-
tion. The adjustment did not markedly modify the risks of poor self-rated 
work ability and early withdrawal from work among the OA patients. 
In conclusion, mental disorders did not explain the differences in QOL 
and work ability outcomes between the OA and WEA patients. 
The stressful nature of an OA diagnosis
A recent report has argued that the sudden onset of OA in a previously 
healthy person may have a psychological impact (Figure 8) (Lavoie et 
al. 2009). The stressful nature of an OA diagnosis could have been true 
especially for the patients in the present study, many of whom had seri-
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ous health concerns. This possibility may at least partly explain the worse 
outcomes in the OA group when it was compared with the WEA group. 
Although mental disorders (anxiety, depression, somatization, or 
hypochondria) did not explain the differences in outcome between the 
OA and WEA patients, the lack of difference does not rule out distress 
related to an OA diagnosis as a contributing factor. In general, several 
psychosocial factors, which are not mental disorders, have been recog-
nized as risk factors for disability, such as attitudes or beliefs, emotional 
reactions such as fear or distress, or relational factors such as conflict or 
lack of support (Sullivan et al. 2005).
6.2.4 Impact of the symptom picture on work ability
Those with multiple persistent indoor-air symptoms considerably more 
often perceived their current work ability to be poor when compared 
with that of those with less significant symptoms. After adjustment for 
individual variables (e.g., co-morbidity, depression, and somatization), 
the association between multiple persistent symptoms and impaired 
self-assessed work ability remained. In a previous study, long-lasting 
symptoms were shown to be common in some persons with earlier 
exposure to building dampness and mold (Al-Ahmad et al. 2010), but 
 
 
 
Figure 8. Potential mechanisms linking psychological distress to worse OA outcomes (Lavoie et al. 2009). 
OA=occupational asthma. 
 
Psychological 
stress/distress 
Cognitive 
mechanisms 
 
· Biased 
symptom 
reporting 
· Reduced self-
efficacy 
Behavioral 
mechanisms 
 
· Decreased 
adherence to 
daily 
medication 
· Increased 
tendency to 
self-medicate 
to cope with 
stress 
Physiological 
mechamisms
 
· Autonomic 
nervous 
system 
dysregulation 
· Immune 
system 
dysregulation 
OA outcomes 
 
· Increased 
asthma symptom 
burden 
· Increased 
health service 
use 
· Increased 
occupational and 
functional 
impairment 
Figure 8. Potential mechanisms linking psychological distress to worse OA 
outcomes (Lavoie et al. 2009). OA=occupational asthma.
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the association with impaired work ability that was found in the present 
study is a new finding. Multiple persistent symptoms were not found 
to be associated with early withdrawal from work, and this finding may 
reflect the heterogeneity of the groups. Along with leaving work, the 
symptoms become alleviated or not. The findings of Al-Ahmad et al. 
(2010) suggest that mold-exposed persons whose symptoms could ini-
tially be attributed to asthma or other allergic responses have long-term 
respiratory symptoms that cannot be explained on the basis of asthma 
and that overlap with sick building symptoms. In the present study, the 
patients in both asthma groups had a non-specific symptom complex 
similar to that of the SBS, which was common for all of the groups at 
the baseline (study I).  It seems that asthma amplifies the effect of non-
specific symptoms with respect to work disability.
In study I, the study population consisted of workers with asthma 
symptoms who also experienced a variety of non-specific symptoms, 
like fatigue, fever and chills, dermal symptoms, headache, and arthralgia 
(Table 4 in article I). The findings concerning the symptom spectrum are 
in accordance with that of several previous reports (Reijula and Sundman-
Digert 2004; Brightman et al. 2008; Wolff et al. 2009; Al-Ahmad et al. 
2010). According to the literature, asthma symptoms may also overlap 
with asthma-like symptoms caused by, for example, vocal cord dysfunc-
tion or other disorders (Morris and Christopher 2010; GINA 2011). In 
other words, people with asthma may also perceive asthma-like symptoms 
that cannot be explained on the basis of asthma, and this phenomenon 
is worth noting in the management and control of asthma.
The results of Al-Ahmad et al. (2010) suggest that the non-specific 
symptom complex related to indoor dampness and mold (described in 
study I) has similarities to MCS. The researchers studied some features 
associated with MCS (e.g., sensitivity to detergents, new carpets, and 
chemical taste) among the patients with earlier exposure to building 
dampness and mold. The MCS follow-up scores of the mold-exposed 
group were similar to those of the sick building group and showed marked 
differences from the normal control group, the finding suggesting a 
possible degree of overlap for the mold-exposed group with MCS (Al-
Ahmad et al. 2010). Overlapping with SBS and MCS has been previously 
reported (Kipen and Fiedler 2002), and asthma has been recognized as 
a risk factor for MCS (Kreutzer et al. 1999).
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6.2.5 Impact of workplace psychosocial factors on   
 work ability
Perceived poor social climate at work and poor experiences with a super-
visor’s cooperation at an early stage of the symptoms were determinants 
for impaired self-assessed work ability and early withdrawal from work. 
The findings agree with those of previous studies showing a correlation 
between the psychosocial work environment and indoor-air symptoms 
(Mendelson et al. 2000; Lahtinen et al. 2004; Runeson et al. 2006; Bakke 
et al. 2007). Low social support has been found to be associated with 
indoor-air complaints and symptoms (Mendelson et al. 2000; Runeson 
et al. 2006). In a Finnish study, Lahtinen et al. (2002) found problems 
with cooperation for 71% of the workplaces with moisture and mold 
damage, the employees being more dissatisfied with the cooperation 
than the superiors. The employees generally felt that the problems they 
experienced were being downplayed by the management, and they also 
felt mistrust towards the implemented measures (Lahtinen et al. 2002). 
According to study IV, it appears that those who perceive their psycho-
social work environment more negatively were at an increased risk of 
long-term adverse work outcomes.
The results are in accordance with the widely recognized fact that 
causes of disability are multifactorial and not associated with medical 
conditions alone.
6.3 Limitations of the risk paradigm
Occupational medicine first emerged as a specialist discipline in response 
to chemical, physical, and biological hazards at work that caused seri-
ous and often fatal disease (Coggon 2005). Considerable progress has 
been made to reduce and eliminate many serious occupational hazards, 
particularly in developed countries (Blair 2005). Diseases, such as lead 
poisoning, chemical-induced cancers, and pneumoconiosis had identifi-
able causes and so proved readily preventable (Baxter et al. 2010). How-
ever, the understanding of occupational exposures in the development of 
chronic diseases and conditions is far from complete (Blair 2005). Not 
all hazards are under control; the continuing high incidence of disorders 
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such as WRA is evidence of this problem (Coggon 2005). According to 
epidemiological studies, occupational causes are not a minor contribu-
tor to the disease burden of the population, and there is still potential 
for prevention. 
Simultaneously, there are disorders, including a relationship with 
work, that cannot be wholly explained by their assumed occupational 
causes (Baxter et al. 2010). The focus of occupational medicine in 
developed countries has shifted to these work-related disorders that 
cause substantial disability and that do not always arise from detectable 
organic pathology, but rather are responses to triggering exposures that 
are conditioned by individual characteristics and cultural circumstances 
(Coggon 2005). Examples of such work-related disorders are low-back 
pain, occupational stress, and also MCS and SBS. The classical approach 
to risk management – that a noxious agent or activity produces an injury 
that can be prevented by eliminating or reducing exposure – has served 
well in the past, but it may not work for these conditions due to a lack 
of knowledge and the complexity of the interaction (Räsänen 1998; 
Coggon 2005). This situation has important implications for the way 
in which such illnesses can be managed and prevented (Coggon 2005). 
It is probable that multiple mechanisms combine to contribute to 
these expressions of illness. Environmental exposures may have direct 
health effects, or they may act as symptom triggers, but the mechanisms 
may be very complex where susceptibility factors (e.g., immunological 
responses regulated by genetic factors) and modifying factors (e.g., knowl-
edge, beliefs, emotions, and social support) interact  (Figure 9) (Kipen 
and Fiedler 2002). Control of exposures may not always be effective or 
is not effective enough to reduce the occurrence of illness or disability. 
The recognition that many kinds of factors may be involved enhances 
preventive opportunities because control over illnesses can be achieved 
by the effective management of different dimensions.
As disability is not merely a single disease, simple medicalization of 
indoor-air problems has not resulted in the successful management of dis-
ability. The situation is not only unsatisfactory to the patient, but also to 
physicians who have been educated to search for precise medical diagnoses. 
Regarding non-specific low-back pain, which constitutes 95% of low-back 
pain, it has been recognized that the term non-specific fails to meet the 
expectations of a “proper” diagnosis and leaves some uncertainty about its 
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treatment and prognosis, and may lead to a failure of communication and 
a lack of confidence (Waddell 2005). Another approach is to demedicalize 
the problem by seeing disability in a larger, biopsychosocial context and 
to search for disability determinants and focus on disability prevention.
It seems that asthma in damp indoor work environments occurs as a 
part of a larger disorder. Asthma as a specific disease is relatively easy to 
diagnose and, in most cases, easy to treat. When asthma is amplified by 
the non-specific symptom complex, the person suffers from an illness 
Figure 9. Model of the interrelationships between exposures, susceptibility, 
modifying factors, and symptoms (Kipen and Fiedler 2002).
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that may cause substantial disability. At one end of the continuum are 
asthmatics whose symptoms improve after building repairs or relocation 
away from damp environments, and at the other end are persons who, 
despite these efforts, remain symptomatic. 
At the individual level, multifactorial illnesses do not agree with the 
definition of an occupational disease, which requires that a specific factor 
inducing the disease be identified and a causal relationship to the fac-
tor at work be established. It can be discussed whether OA diagnostics 
rather harm than benefit individuals, as the accurate separation between 
OA and WEA induced by indoor dampness and mold is not possible. 
For medico-legal reasons, the prevailing practice in Finland has been to 
diagnose asthma induced by workplace dampness and mold as an oc-
cupational disease. As with traditional sensitizer-induced OA, defining 
the exposure and establishing a causal relationship between the exposure 
and asthma is not possible with the same accuracy. Therefore, clear clini-
cal guidelines for the diagnostics are required to minimize discrepancies.
6.4 Work disability prevention
Regarding building-related conditions or asthma, there has been little 
research on work disability prevention. Most of the literature on work 
disability prevention involves low-back pain, which is the most com-
mon reason for long-term absence and work disability in industrialized 
countries (Loisel et al. 2005). Recently, there has been increased interest 
in the prevention of work disability regardless of the underlying health 
condition. Studies have identified some consistent results about the 
risk factors of work disability and interventions, which, according to 
front line researchers on the subject, appear to be generalizable across 
different conditions (Pransky et al. 2011). Therefore, it is interesting to 
glance through the literature concerning musculoskeletal disorders and 
the prevention of work disability.
Early investigators of low-back pain noted that persons with similar 
clinical conditions and severity often had very different work outcomes 
(Pransky et al. 2011). Back schools teaching correct ergonomic techniques 
or workplace modifications did not succeed in preventing musculoskeletal 
disability. A biomedical model, based on anatomy and biomechanics 
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began to evolve into a biopsychosocial model, in which disability is 
considered a result of human functioning influenced by biomedical, 
psychological, workplace, health care and compensation system factors 
(Feuerstein 1991; Loisel et al. 2005). Several significant psychosocial 
risk factors in the vast literature have been identified, such as those that 
exist primarily within the individual (e.g., inappropriate fears and beliefs, 
catastrophizing, disability perceptions, little hope of healing, loss of self 
efficacy, depressed mood, and anxiety), but also those that are workplace 
or system-related (e.g., job stress, work dissatisfaction, and lack of social 
support at work) (Sullivan et al. 2005). Epidemiological evidence suggests 
that personal circumstances, pain beliefs, and other non-medical factors 
are more important in the perpetuation of chronic pain and disability 
(Shaw et al. 2009). The researchers point out that psychosocial risk fac-
tors are not mental disorders nor would they necessarily be considered 
indices of mental dysfunction (Sullivan et al. 2005). They further claim 
that fear of pain is associated with avoidance behavior, which accentuates 
anxiety and the long-term negative functional impact (Dupeyron et al. 
2011). Patients develop a negative interpretation – catastrophizing – in 
which physical activity supposedly causes damage and exacerbates pain 
(Dupeyron et al. 2011).
The researchers dealing with disability due to low-back pain have 
recognized the difficulties concerning how to implement the knowledge 
in practice and how to use it in clinical decision making (Lambeek 
2009). Work disability prevention should focus on the psychosocial and 
environmental factors that impede return to work and self-management 
approaches, together with both clinical and occupational interventions 
(Waddell and Burton 2005; Costa-Black et al. 2010). For example, 
therapeutic patient education appears to be critical in order to help 
patients to better understand their condition and reduce the negative 
consequences of fear-avoidance behavior (Dupeyron et al. 2011). The 
education not only includes traditional biomedical information and 
advice, but also information and organized activities, all of which 
are designed to overcome fear-avoidance beliefs and promote self-
responsibility and self-care (Waddell and Burton 2001; Dupeyron et 
al. 2011). Patients must be able to understand and manage low-back 
pain to stay active and improve their QOL (Dupeyron et al. 2011). 
Workplace interventions, like changes in work design, work conditions 
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or the work environment, have been shown to reduce sickness absence 
among workers with musculoskeletal disorders when compared with 
usual care (van Oostrom et al. 2009). In these interventions, the worker, 
the supervisor or employer, and a professional in occupational health 
are involved in formulating a return-to-work plan, but stakeholders 
from outside the workplace are frequently not, as reviewed a Cochrane 
Collaboration review group. The authors reported that return to work 
seems to be influenced by a worker’s ability to function and adapt to 
pain and symptoms rather than to a complete disappearance of pain 
and other symptoms (van Oostrom et al. 2009).
6.5 validity issues
6.5.1 The patient series
The large number of persons included in a study is one of its strengths. 
FIOH acts as a reference institute in the diagnostics of occupational 
diseases in Finland, and therefore a large material of patient cases was ac-
cumulated nationwide. Thus the study participants were derived from the 
same source population. In addition, in an international comparison, the 
experience of FIOH in the diagnostics of occupational diseases related to 
workplace dampness and molds is large. Due to the thorough diagnostic 
procedures used, the study material can be considered well-characterized. 
The patients were carefully examined according to diagnostic practices 
of the time period. 
Still, the possibility of diagnostic misclassification is inevitably a weak-
ness of the study. As discussed in Section 6.1.4, a differentiation between 
OA and WEA caused by building dampness and molds is difficult to 
achieve. In the 10-year period during which the patient material was 
collected, SIC tests with mold extracts were routinely used at FIOH in 
the diagnostics of OA. Thus the diagnostic practices were homogeneous 
throughout the study period, although some differences between clini-
cians cannot be ruled out. In addition, the accessibility to test extracts 
varied throughout the years. Therefore, in study I, the discharge diagnoses 
given to the patient by FIOH were not used. Instead, the patients were 
retrospectively classified into groups of probable, possible, and unlikely 
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OA according to clinical information and test results gathered from the 
patient files, and also using internationally recommended diagnostic 
criteria. As the information on SIC tests was available, the utility of PEF 
monitoring at and away from work as compared with the use of SICs 
could be assessed.
Exposure was also retrospectively assessed by an experienced indoor-
air researcher to insure that the exposure was verified as objectively as 
possible by homogeneous principles. The evaluation of exposure was 
based on objective data from the technical reports on building struc-
ture damage and analyses on microbial sampling from the workplace. 
The workplace investigations had not necessarily been performed with 
aim of proving an occupational disease for the worker in question, but, 
instead, for solving the indoor-air problem of the workplace. Thus 
inadequate documents on exposure could mean unreliably performed 
investigations specifically from the patient’s work area. The limitations 
in defining exposure and assessing causality belong to the nature of the 
problem and the lack of knowledge concerning exposure, dose–response 
relationships, causal relations, and, consequently, a paucity of diagnostic 
tools to prove causal relations.
6.5.2 The questionnaire
The response rate, 61%, for the questionnaire can be regarded as ad-
equate when the long follow-up time is considered. The analysis of 
non-respondents showed that the OA patients had been more likely 
to participate in the study. There is, however, little reason to believe 
that the OA patients with a poor QOL or poor work ability would 
have been more prone to respond than those with a good value. Even 
if there would have been a difference in the response rates in relation 
to the outcome, it would apply to the participants in each group, and, 
therefore, this potential for bias is limited. A large proportion of those 
initially referred for investigations did have upper-respiratory symptoms 
only, the work-relatedness was probably never substantiated, and many 
never did receive any diagnosis at all. All these people would presumably 
have lost their interest in participating in a study specifically concerned 
with work-related respiratory disorders. Similarly it can be assumed that 
patients still suffering from symptoms were more interested in participat-
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ing than those totally symptomless. It may be a source of bias, but it is 
unlikely to be a major one.
Although studies II–IV were based on a follow-up of the patient series, 
the study design of all of them was cross-sectional, limiting the interpre-
tation of the results. The outcome variables and the determinants were 
measured at the same time; hence conclusions about causal relationships 
cannot be drawn. For example, the assessments of social climate at work 
were measured at the same time as the outcomes; therefore temporal order 
could not be demonstrated. If a person attributes disability to workplace 
conditions, he or she may be more inclined to criticize factors at work 
when these variables are measured simultaneously. Likewise, in study II, 
the study design did not allow for the establishment of a causal relation 
between exposure continuation and asthma development. The results 
of the studies are instead associations.
The follow-up was based on self-reported data, which is one of the 
limitations of the study. In the interpretation of the results, limiting the 
data collection to a questionnaire must be taken into account. Because 
of the large size of the study population, a clinical re-examination of the 
patients was unfeasible. The same was true for a thorough investigation 
of home and workplace conditions at the time of the follow-up. In study 
II, the information on exposure conditions at the time of the follow-up 
was based on self-reported data. The information may have been in-
fluenced by the participants’ awareness of the exposure of interest (i.e., 
indoor dampness at their workplaces). The persistence of symptoms at 
work and a physician’s diagnosis of asthma at follow-up may have made 
them more inclined to observe and report dampness at work as compa-
red with those whose symptoms had ceased or attenuated. However, the 
highest risk of asthma was associated with continued work in the same 
non-remediated environment. The information on the measures used 
to repair these workplaces should be reliable. 
In addition, the outcome of study II (the development of asthma) 
was established using questionnaire information on physician-diagnosed 
asthma. The question is widely used in epidemiological investigations 
and has been considered to be highly specific (99%) with respect to 
asthma (Torén et al. 1993). The sensitivity is moderate (Torén et al. 
1993) and selective for the severity of disease (Torén et al. 2006). The 
high specificity makes the question suitable for comparisons of risk 
135
6 DISCUSSION
estimates, whereas the moderate sensitivity would lead to an underesti-
mation of incidence, especially for mild disease (Torén et al. 1993; Torén 
et al. 2006). Although the question concerning a physician’s diagnosis 
of asthma has been shown to be remarkably reliable, the possibility of 
diagnostic misclassification was considered, and a retrospective assess-
ment of the validity of the patients’ allegations was attempted. All those 
who had reported having received a physician’s diagnosis of asthma were 
contacted. As there was a proportion of cases that could not be reached 
and 15 cases that did not fulfill the diagnostic criteria, a certain degree 
of misclassification could not be ruled out. The extent of this bias is dif-
ficult to assess. However, the analysis of the 18 verified cases who were 
still working (an association with an over fourfold risk remained between 
continued exposure and asthma development) strongly supported the 
finding of an association between exposure and the risk of developing 
asthma. In summary, it is unlikely that information bias would explain 
the associations found between continued exposure to indoor dampness 
and the development of asthma.
In study IV, two outcomes were used to avoid being dependent solely 
on self-rating. The two outcomes supplement each other in that self-rated 
work ability is a good predictor of disability and the second outcome, 
early withdrawal from work, is a more objective measure of disability, 
even though dependent on the social context. 
Some selection bias, especially in studies II–IV, cannot be ruled out. 
A series of patients who had been referred to FIOH because of a suspi-
cion of an occupational disease was followed up, and the practices of the 
referral physicians may have varied. With regard to studies III–IV, the 
patient series included a representative sample of patients with dampness-
related asthma, as most of the OA cases in the country were diagnosed 
at the FIOH clinic, with known expertise in occupational diseases. For 
the same reason, the reference group (with upper-respiratory symptoms 
without asthma) may have had a more severe condition than all of the 
symptomatic, exposed persons in general, and this possibility may have 
diluted the effect. 
It can be debated whether or not a comparison group of OA or WEA 
due to conventional, specific asthmagens should have been used in studies 
III and IV. Such a study design could have introduced other uncertain-
ties and comparison biases, for instance, which exposures causing OA 
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would have been the most suitable for comparison. Most conventional 
OA cases have professions with higher physical demands and represent 
social groups other than the employees in studies III and IV. However, 
adjustment was practicable for most of the factors that, based on the 
literature and prior knowledge, are related to indoor-air symptoms (Nor-
bäck 2009) or work disability among asthmatics, for example, gender 
and occupation type (blue- versus white-collar) (Detaille et al. 2009).
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This thesis aimed at answering the study questions by testing the hy-
potheses of the four studies related to asthma and workplace dampness 
and molds.
1. The review of the clinically examined patients in study I 
supports the epidemiological evidence that indoor damp-
ness and mold are associated with new-onset adult asthma. 
For the primary and secondary prevention of asthma, the 
current evidence is sufficient to recommend remediation 
of workplace moisture and mold damage.
In the OA diagnostics, the presence of excess mold 
growth can be used as an indicator of exposure. Although 
there are no valid, quantitative methods for assessing ex-
posure to dampness-related factors, qualitative exposure 
assessment is sufficient for OA diagnostics. It can be based 
on descriptions of the extent and location of the moisture 
and mold damage in the building structures and on mi-
crobial measurements. The agreement between the two 
diagnostic tests, SIC testing with mold extracts and serial 
PEF monitoring, proved to be acceptably high, in order to 
regard serial PEF monitoring as an applicable method in 
the clinical evaluation of OA induced by indoor dampness 
and molds. This in particular considering the flaws of the 
SIC, for example due to the complex exposure situation. 
Specific IgE-mediated sensitization to molds occurs, 
but in a small proportion of cases only. The mechanisms 
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of asthma induced by indoor dampness and mold remain 
largely unknown.
2. The results suggest that, for workers with work-related 
asthma-like symptoms occurring in relation to indoor 
dampness and molds at work, continuing to work in such 
environments creates a risk for developing asthma. The as-
sociation appeared strongest if the worker continued in his 
or her former unremediated workplace or in any work with 
continued exposure to indoor dampness. The avoidance of 
further exposure seemed to decrease the risk significantly. 
Continued work in the former, but remediated workplace 
was associated with a reduced risk. Preventive measures 
to avoid further exposure seem to be relevant in order to 
prevent asthma development. In practice, such measures 
would involve remediation of moisture and mold damage 
or relocation of the worker with asthma-like symptoms 
to a non-moisture-damaged environment. Follow-up by 
occupational health services is recommended for patients 
with respiratory symptoms related to workplace dampness.
3. The results corroborate the clinical impression that a pro-
portion of patients with asthma in relation to exposure to 
moisture- and mold-damaged workplaces has long-standing 
limitations in everyday life and remains symptomatic and 
unable to work. 
Patients diagnosed with OA had worse outcomes than 
did those with WEA or only respiratory symptoms without 
asthma. They had a lower QOL and poorer work ability, 
and they were more often withdrawn from work. Mental 
disorders did not explain the impact of OA, QOL, or work 
ability. As estimated by the use of asthma medication, OA 
seemed to be more severe than WEA. Greater use of asthma 
medication was a determinant for a worse QOL physical 
component. Clinical follow-up studies investigating the 
severity of asthma objectively could add to the knowledge 
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on the nature of indoor dampness-induced asthma. The 
acknowledgement of and compensation for dampness-
induced asthma as an occupational disease does not seem 
to be beneficial in preventing disability. More apt measures, 
like early support and workplace management practices 
concerning work ability are required.
4. Persons who evaluated their social work environment more 
negatively and those with multiple, persisting indoor-air 
symptoms appeared to have an increased risk for poor 
work ability outcomes. This finding agrees with the widely 
recognized fact that causes of disability are multifactorial 
and not associated with medical conditions alone. Some 
still unknown factors may contribute to an impaired QOL 
and work ability.
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8 POLICY ImPLICATIONS AND    
 RECOmmENDATIONS 
On the basis of the findings of this thesis and prior scientific 
literature, the following recommendations can be made:
1. In the diagnostics of OA induced by workplace dampness 
and molds, serial PEF monitoring is the principal diagnostic 
tool available for demonstrating an association between 
workplace exposure and asthma. SIC testing, which is 
generally regarded to be the most reliable method for iden-
tifying an agent causing OA, is not suitable for diagnosing 
OA induced by dampness and mold. Unlike SIC testing, 
serial PEF measurements reflect the entire complex expos-
ure situation at the workplace. The major weakness is that 
they do not accurately differentiate between WEA and OA.
Serial PEF monitoring should be initiated without delay 
once the patient reveals that his or her lower-respiratory 
symptoms worsen at work or improve away from work. 
Guidelines for clinicians with respect to the diagnostics of 
OA induced by workplace dampness and mold are presented 
as algorithms in Appendices 2 and 3. Appendix 2 explains 
how to investigate asthma symptoms in occupational health 
services, and Appendix 3 considers how to proceed in in-
vestigations in special health care. 
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2. Clinical follow-up in occupational health care is recom-
mended for patients with respiratory symptoms related to 
workplace dampness. The follow-up, the frequency of which 
depends on the symptoms, includes monitoring symptoms 
and repeating lung function tests for the early detection and 
management of asthma. Occupational health profession-
als have a role in encouraging the workplace to remediate 
moisture and mold damage from the health point of view. 
Relocation of the worker to non-moisture damaged work 
environments is an option.
3. Asthma related to damp indoor work environments is as-
sociated with long-term disability. This is a novel health 
problem, for which it is not wholly clear whether traditional 
risk management works well. Together with eliminating or 
reducing exposure to workplace dampness and dampness-
related factors, an approach using a biopsychosocial model 
is needed for disability prevention. 
4. An action model for use in occupational health services for 
the disability prevention of workers with asthma related to 
workplace dampness is presented in Appendix 4. Together 
with occupational health services, the worker and the work-
place should be involved in planning and processing work 
retention and return-to-work.
5. Research is required for the causes of disability and the 
effectiveness of preventive measures (e.g., building repairs, 
relocation of workers, or other interventions aimed at dis-
ability prevention).
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APPENDICES
Appendix 1.
Studies on associations between asthma development and dampness, 
mold, or agents associated with dampness in children
Appendix 2.
Flow chart for the investigation of suspected OA related to workplace 
dampness, for use by occupational health services
Appendix 3.
Flow chart for the investigation of suspected OA related to workplace 
dampness, for use by special health care
Appendix 4.
A suggestion for an individual-level practical approach to disability 
prevention for workers with asthma related to workplace dampness, for 
use by occupational health services. The suggestion is based on current 
literature.
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Appendix 2 
Flow chart for the use of occupa onal health services in the inves g  of suspected occupa onal asthma related 
to workplace dampness 
 
 with the onset of asthma symptoms related to workplace indoor air 
CLINICAL INVESTIGATIONS 
1. Consider asthma 
- Begin with serial PEF monitoring at and away from work 
(guidelines www  
- Spirometry and other standard tests (e.g. skin prick tests, chest/ sinus 
radiographs) 
- e with diurnal PEF monitoring (1-2 weeks) 
(if asthma not already veriﬁed on the basis of serial PEF or spirometry) 
2. Consider other diseases  treat 
Asthma 
e asthma treatment
No asthma 
3. Assess individual exposure 
- Assess technical reports and indoor-air measurements, if available 
- Assess other possible exposures at work/ home/ hobbies  
  Inves ga ons if necessary 
- If uncertain, consult occupa nal medicine clinic* 
Indoor-air problems without 
evidence of dampness and molds
Evidence of dampness 
and molds at work 
4. Evaluate serial PEF records  
- If uncertain, consult occupa nal medicine clinic* or FIOH
 asthma treatment
Monitor ent 
Consider need for 
 asthma treatment 
Monitor ent 
Consider need for   
 sugges ve of OA 
or uncertain 
 Suspected OA 
No pa  of OA
WORKPLACE INVESTIGATIONS
- Work site visit 
- Consider need for indoor-air 
que aire 
- Recommend further inves ga ons, 
if situa on is unclear 
- Contribute to risk assessment 
(health issues) 
- Encourage to   
if necessary 
Consider further inves ga s
Monitor ent 
Consider need for  
5. Refer to pulmonary/occup  medicine clinic* or FIOH
Appendix 2.
Flow chart for the investigation of suspected OA related to workplace damp-
ness, f r use by occupational health services
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*at a central hospital; OA=occupational asthma; PEF=peak expiratory flow; FIOH=Finnish Institute of Occupational 
Health 
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ness, for use by special health care
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Appendix 3 
Flow chart for the use of special health care in the inves g  of suspected occupa onal asthma related to 
workplace dampne s 
 
with the onset of asthma symptoms related to workplace indoor air
1. Conﬁrm asthma
- Begin with serial PEF monitoring or repeat, if not reliably done
- Histamine/methacholine challenge test 
- Other standard asthma inves g s 
- Consider other diseases 
Asthma No asthma
2. Assess symptoms
- Are symptoms  on rest days or worse at work? 
- Are asthma onset and g related to work exposure? 
Symptoms or asthma
onset not related
to work exposure
Symptoms and
asthma onset related
to work exposure
3. Assess exposure
- Assess technical reports and indoor air measurements 
- If documents missing, consult OHS 
- Assess other possible exposures at work/ home/ hobbies  
  Inves ga ons if necessary 
- If uncertain, consult an occupa l medicine clinic*
Indoor air problems
without evidence of
dampness and molds
Evidence of
dampness and
molds at work
4. Evaluate serial PEF records
- If uncertain, consult occupa nal medicine clinic* or FIOH 
Consider other causes of
asthma like symptoms
Refer for OHS monitoring
(if any n to work)
asthma treatment
Refer for OHS monitoring
asthma treatment
Refer for OHS monitoring
(if any n to work)
asthma treatment
Refer for OHS monitoring
of OA
 OA diagnosis
No pa of OA
 No OA diagnosis
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*at a central hospital; OA=occupational asthma; PEF=peak expiratory flow; OHS=occupational health services; 
FIOH=Finnish Institute of Occupational Health
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Appendix 4 
An individual-level practical approach to disability prevention for workers with asthma related to workplace 
dampness, for use by occupational health services (OHS) 
Investigate according to best clinical practices  Symptoms may refer to a variety of conditions, and
are not speciﬁc to indoor air pollutants
Aim to achieve and maintain clinical control of asthma
(GINA 2011, Baur et al. 2012)
 Regular medication
 Asthma education and guided self management
 Weight loss for the obese
 Smokers: counseling and oﬀering smoking cessation
programs
 Regular follow up
Recognize and treat co-existing diseases (GINA 2011)  Rhinitis, chronic sinusitis, nasal polyps
 Gastroesophageal reﬂux disease
 Obstructive sleep apnea
 Psychiatric disorders
Assess occupational and environmental factors that 
trigger symptoms (SCHER 2007, Tarlo et al. 2008, STM
2009, Henneberger et al. 2011, GINA 2011)
 Good risk management at the workplace, including
risk communication, is needed:
 Abnormal sources of indoor air pollutants are
identiﬁed and the risks are assessed, followed
by necessary actions (remediation, repairs and
evaluation of their success)
 Viral infections, common allergens and irritants
Guidance for symptom management (NICNAS and OCS
2008, GINA 2011)
 As total avoidance of low level irritants and odors
generally proves impossible, advise ways to
minimize contact with perceived triggers
Provide the patient with information about the nature 
of the symptoms (NICNAS and OCS 2008, GINA 2011)
 Asthma is usually a persistent disease
 Symptoms run a varying course
 Cautiously reassure the patient that grave medical
diagnoses have been ruled out or that he or she
does not have a progressive disease
 Sometimes the symptoms are persistent; in that
case the focus is on improving functional status
rather than on eradicating symptoms
Encourage to remain at work (NICNAS and OCS 2008;
Costa Black et al. 2010)
 Involvement of the worker, the employer, and OHS
in planning work retention and return to work
 Favor temporary work modiﬁcations (e.g.,
relocation, remote work) instead of long sickness
absences
 Identify obstacles to (return to) work and provide
support to overcome them
Encourage to maintain normal activity levels (NICNAS
and OCS 2008; Costa Black et al. 2010, GINA 2011)
 Encourage to resume activities, (e.g., gently
graduated exercise program)
 Counsel to avoid avoidance behavior
Involve the patient actively in the treatment process
(NICNAS and OCS 2008)
 Encourage self management
 Set realistic goals
 Focus on coping, not on sick role
Provide an empathic relationship to oﬀer 
understanding and support (NICNAS and OCS 2008)
 Accept that the person feels ill and is disabled by the
illness
 Encourage the person to try to come to terms with
his or her disability
 Maintain a long term positive approach
 Develop a positive attitude toward the future
Appendix 4.
A suggestion for an individual-level practical approach to disability preven-
tion for workers with asthma related to workplace dampness, for use by 
occupational health services. The suggestion is based on current literature.
Asthma in damp indoor work 
environments
People and Work
Research Reports 97
Kirsi Karvala
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Indoor dampness and mold in work environments are associated 
with adverse respiratory health effects, of which asthma is the 
most frequently diagnosed disease. 
This study assessed methods for the diagnosis of occupational 
asthma induced by indoor dampness and mold. A retrospective 
analysis of a group of patients examined at the Finnish Institute 
of Occupational Health in 1995–2004 was conducted. All of the 
examined 2200 workers had respiratory symptoms appearing in 
workplaces with suspected moisture and mold damage. A fol-
low-up survey with a questionnaire was carried out 3–12 years 
later to determine whether prolonged asthma-like symptoms 
appearing in relation to workplace dampness and mold lead to the 
development of asthma later. In addition, the long-term effects on 
the quality of life and work ability of these workers were evaluated. 
Finally, for the use of occupational health services, the book pre-
sents a suggestion for an individual-level, practical approach to 
disability prevention for workers with asthma related to workplace 
dampness.
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